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GENERAL INTRODUCTION
The generation and maturation of neurons and the formation of synaptic neuronal 
contacts are key events in the assembly of the highly organized circuitry for cell com-
munication during growth and development of the mammalian brain. Exchange of 
chemical or electrical information between different brain regions and processing 
of this information occurs by neurons that form branched extensions, represent-
ing multiple dendrites, and one long axon. Dendrites relay signals towards the cell 
body (soma), whereas the axon conducts messages away from the cell body, to oth-
er cells (figure 1). The actual transmission of signals over the cell membrane takes 
place at the synapses, the specialized spots for cell to cell communication, where it 
is mediated by either direct current flows through gap junctions or by secretion of 
neurotransmitters by the sending neuron and binding to postsynaptic receptors on 
the receiving neuron. 
 
Dendrites
Axon
Synapse
Figure 1 - General Introduction - ME
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Signal direction
During the lifespan of an organism, the brain circuitry remains flexible to adapt itself 
to external cues, a process that is called neuroplasticity. This capacity of the brain, 
that forms the basis of its amazing ability to learn and memorize, is predominantly 
achieved by changes in the formation and the strength of neuronal contacts, but 
generation of new neurons is also possible. Errors in neuronal differentiation or 
plasticity may result in incorrect brain functioning with consequences that depend 
on the region that is involved. Therefore, strict control is exerted by diverse regula-
Figure 1: Communication between neurons. Multiple dendrites receive signals from pr-
esynaptic neurons and relay the signal towards the soma. The postsynaptic cell conducts the 
signal via one axon and innervates other neurons at the synapses.  
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tory systems, which - at the cellular level - often include protein phosphorylation 
and dephosphorylation events performed by protein kinases and protein phos-
phatases, respectively. Here we will present new information about the intracellular 
interactions and the role of isoforms from one specific type of protein phosphatase, 
protein tyrosine phosphatase receptor-type R (PTPRR). New findings on how these 
enzymes participate in the control of mouse behaviour, neuronal signalling and cell 
differentiation will be disclosed after an introduction into relevant signal transduc-
tion principles, background on protein tyrosine phosphatases (PTPs) and neurosci-
ence knowledge in this chapter. 
Phosphotyrosine-based signals in growth and differentiation
One key mechanism of signal transmission is initiated by cell surface receptors. 
One particularly important class of signalling receptors is made up by members 
of the receptor tyrosine kinase (RTK) family, enzymes which transmit signals from 
external stimuli to steer many essential cellular processes, such as cell proliferation, 
differentiation, migration, metabolism, and survival [1]. In general, RTKs are mono-
meric membrane-spanning receptors, consisting of an extracellular ligand-binding 
domain linked via a transmembrane part to an intracellular region that harbors a 
conserved protein tyrosine kinase core. Upon ligand binding, the receptor dimer-
izes and thereby induces autophosphorylation of different tyrosine residues in the 
cytosolic domains. Tyrosine phosphorylation within the kinase domain usually po-
tentiates catalytic activity, leading to subsequent phosphorylation of tyrosine resi-
dues outside the kinase domain. These then serve as docking sites for adaptor pro-
tein complexes of which the composition dictates activity in signalling cascades that 
are further downstream, including the Phospholipase Cγ (PLCγ), phosphatidylino-
sitol-4,5-bisphosphate 3-kinase (PI3-K), signal transducer and activator of transcrip-
tion (STAT), cell division cycle 42 (Cdc42), and most notably the mitogen-activated 
protein kinase (MAPK) pathway [1-3]. The latter is one of the best-studied cascades. 
Its core is composed of three sequential kinase groups: MAP kinase kinase kinases 
(MAPKKKs), MAP kinase kinases (MAPKKs), and MAP kinases (MAPKs) [4, 5]. The 
classic MAPKs comprise the extracellular signal-regulated kinases  (ERK1, 2 and 5), 
the c-Jun N-terminal kinases (JNK1, 2 and 3) and the p38 proteins (p38α/β/γ/δ) 
(figure 2). Activated MAPKKKs will induce the activity of MAPKKs by phosphoryla-
tion of a serine and threonine residue. Once active, MAPKKs phosphorylate both 
a threonine and a tyrosine residue in the catalytic loop of the MAPKs, which sub-
sequently phosphorylate membrane-bound, cytosolic and ultimately also nuclear 
targets. 
At first sight, the RTK signalling system looks a simple and straightforward con-
trollable process. In vivo, however, distinct protein-protein interactions, feedback 
mechanisms and spatiotemporal organization collectively create highly dynamic 
and complex signalling networks around the RTK system [6]. Furthermore, one 
protein may exhibit multiple biological actions (pleiotropy), while the existence of 
protein families and isoforms may lead to proteins with overlapping biochemical 
function (redundancy), significantly adding to the complexity of signalling systems. 
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NGF-mediated signalling via receptor tyrosine kinases of the Trk family 
The versatility of such accessory systems is perhaps best illustrated by existence 
of the RTK subfamily of tropomyosin receptor kinases, consisting of TrkA, TrkB and 
TrkC, which are important for neuronal differentiation and survival [7]. The Trk recep-
tors bind to the neurotrophin family of growth factors, consisting of nerve growth 
factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and 
neurotrophin-4 (NT-4). NGF, the first discovered neurotrophin, specifically binds 
TrkA, while BDNF and NT-4 are specific for TrkB. NT-3 displays the highest affin-
ity for TrkC and is additionally able to activate, although less efficiently, each of 
the other Trk receptors. NGF signalling via TrkA has been extensively studied in 
neuroendocrine PC12 cells, derived from a pheochromocytoma of the rat adrenal 
medulla [8, 9]. NGF-induced TrkA receptor dimerization and autophosphorylation 
evokes the activation of the PLCγ, PI3-K/Akt and MAPK cascades [10]. Remarkably, 
NGF-induced TrkA signalling promotes either survival or differentiation of PC12 
cells, whereby the specific response is managed by the duration of MAPK activ-
ity [11]. TrkA signalling at the cell membrane, induces activation of the small G-
protein Ras, leading to sequential phosphorylation and activation of c-Raf, MEK1/2 
and rapid and local activation of ERK1/2 (figure 3) [10]. In contrast, to drive the 
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Figure 2 - General Introduction - ME
Figure 2: Classical MAPK cascades. A wide variety of extracellular stimuli (top) induces mul-
tiple biological responses (bottom) through MAPKKK – MAPKK – MAPK cascades that have 
distinct molecular compositions. Adapted from [5].
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cell into the differentiation program, TrkA endocytosis from the cell membrane and 
subsequent retrograde transport is required [12]. Once TrkA has adopted its new 
location on endocytic vesicles it signals towards the small G-protein Rap1, which in 
turn switches on the MAPK cascade via B-Raf, leading to prolonged activation and 
nuclear translocation of ERK1/2. Thus, the final cellular response triggered by NGF 
is determined by the spatio-temporal character and specific content of the down-
stream signalling modules.
NGF
TrkA
cytosolic
targets
Ras
c-Raf
MEK1/2
ERK1/2
nuclear targets
Rap1
B-Raf
MEK1/2
ERK1/2
Figure 3: NGF-induced and TrkA-mediated activation of ERK1/2. NGF is able to activate 
ERK1/2 via two distinct pathways. For both, signaling is initiated by NGF-induced TrkA ac-
tivation. Active TrkA at the cell membrane induces the small G-protein Ras to activate c-Raf 
and the subsequent activation of MEK1/2, leading to fast and local activation of ERK1/2, a 
mechanism important for cell survival. Active TrkA is meanwhile internalized from the cell 
membrane and continued TrkA activity on the endocytic vesicle leads to the activation of 
the small G-protein Rap1 and sequential activation of B-Raf, MEK1/2 and ERK1/2. Sustained 
ERK1/2 activity leads to its nuclear translocation, which is required for cell differentiation. 
Adapted from [41].
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Protein tyrosine phosphatases 
RTK signalling cascades such as the TrkA pathway, but also other neuronal sig-
nalling routes, contain many and complex phosphorylation events, which must be 
tightly regulated. Phosphorylation levels on protein tyrosine residues are controlled 
by the balanced actions of protein tyrosine kinases and counteracting protein tyros-
ine phosphatases (PTPs). The members of the PTP superfamily have been grouped 
according to distinct characteristics, including the amino acid within the catalytic 
site that initiates the catalysis (figure 4) [13-18]. A few PTPs exploit aspartic acid or 
histidine in their catalytic core, but the vast majority uses cysteine. The Cys-based 
PTP proteins are further divided into three classes based on their distinct evolution-
ary origin. The class II enzymes represent the low molecular weight (LMW) PTPs 
and in class III the cell division cycle (Cdc) 25 phosphatases are found. Class I PTPs 
comprise the largest group in the PTP family, which is further subdivided into 6 
subclasses:  subclass I - classical PTPs, subclass II - dual specificity phosphatases 
(DUSPs), subclass III - SAC phosphoinositide phosphatases, subclass IV - PTP-like 
phytases (PTP-LPs), subclass V - INPP4 phosphatases, and subclass VI - TMEM55 
phosphatases. Subclass I and II display high conservation of their catalytic PTP do-
mains. The DUSPs form a heterogeneous group of enzymes that show specificity for 
pTyr/pSer/pThr, phosphoinositides, or other phosphorylated organic moieties. The 
classic PTPs, in contrast, constitute a homogeneous group of phosphatases, which 
are as a rule strictly phosphotyrosine-specific enzymes. Notably, several transmem-
brane classical PTPs contain tandem PTP domains with only one domain displaying 
catalytic activity. The second domain presumably is involved in substrate recogni-
tion. Of great interest are the phosphatases that inhibit MAPK activity and hence 
may control critical checkpoints in cellular communication. Within the Cys-based 
Class I, subclass II contains eleven dual-specificity MAPK phosphatases (MKPs) [13, 
19] and subclass I counts three classical PTPs (HePTP, STEP and PTPRR) that are 
especially designed to target MAPKs. These fourteen MAPK PTPs all contain a KIM 
domain, which is responsible for the recognition and binding with the MAPK [20]. 
HePTP, STEP and PTPRR proteins additionally contain a kinase-specificity sequence 
(KIS) that adds to specific substrate recognition [21]. Upon formation of the PTP-
MAPK complex, MAPK-mediated phosphorylation of the KIS presumably protects 
the protein from ubiquitin-mediated degradation and hence enhances the stability 
of the PTP [22, 23]. Active HePTP, STEP or PTPRR proteins dephosphorylate the 
regulatory tyrosine residue in the activation loop of the MAPK, resulting in MAPK 
inactivation. Furthermore, due to this physical association of the kinase and the 
phosphatase, MAPK translocation to the nucleus is blocked and its nuclear signal-
ling is prevented [24, 25]. The MAPK-PTP binding itself is also tightly controlled by 
reversible phosphorylation. Protein kinase A (PKA)-mediated phosphorylation of a 
serine residue within the PTP-KIM domain prevents the association, and this can be 
counteracted by protein phosphatase 1 (PP1) [24]. HePTP, STEP and PTPRR proteins 
all target ERK, p38 and JNK, but due to their specific KIS regions they exhibit dis-
tinct preference in substrate recognition [21, 22, 25, 26]. HePTP and STEP enzymes 
prefer p38, while PTPRR proteins rather choose ERK1/2/5. HePTP is exclusively pre-
sent in cells of the immune system found in the thymus, spleen and lymph nodes, 
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and in leukocytes [27-29]. Both STEP and PTPRR are found in the brain [30-35]. Of 
these three KIM-containing classical PTPs, PTPRR is the only one that is expressed 
in PC12 cells [36].
MKPs
DUSP16 DUSP1, 2, 4, 6, 7
PTPRR, 
STEP, 
HEPTP      Class I
Cys-based
A
sp-based
H
is-bases
Class II (LM
W
-PTPs)
Class III (CD
C25s)
Cys-based
Subclass III (SACs)
KIM Pro PTP cell membraneCdc 25 homology domain
Subclass IV (PTP-LPs)
Subclass V (INPP4s)
Subclass VI (TM
EM
55s)
Subclass I (classical PTPs)
Subclass II (DUSPs)
Re
ce
pt
or
 P
TP
s
Non-receptor PTPs
Protein tyrosine phosphatase receptor type R 
By the use of distinct promoters [33], alternative splicing [34], and differential trans-
lation start sites [35] the mouse Ptprr gene gives rise to four major PTPRR isoforms, 
named PTPBR7, PTP-SL, PTPPBSγ-42, and PTPPBSγ-37 (figure 5). They are iden-
tical in their C-terminal regions, which contain the KIM, KIS, and catalytic phos-
phatase domain, but differ in their N-terminal regions [34, 37, 38]. PTPPBSγ-42 and 
Figure 4: The PTP superfamily. Protein tyrosine phosphatases in the human genome are 
grouped according to distinct features. The gray color represents members classified by their 
nucleophilic attack residue (Aps, His or Cys). The Cys-based PTPs are further grouped into 
Class I-III (green). Within Class I, Subclasses I (yellow), II (purple) and II-VI (pink) are recog-
nized. The two boxes represent the classical PTPs and DUSPs that are specialized to target 
MAPK proteins. Slice surfaces in this pie diagram are proportional to the number of group 
members. DUSP = dual specificity phosphatases, MKP = MAPK phosphatases, Pro = proline-
rich domain, PTP = protein tyrosine phosphatase domain, KIM = kinase interacting motif, 
CDC25 = cell division cycle 25. Adapted from [13, 59].
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PTPPBSγ-37, the two smallest variants, are present in the cytosol. In contrast, PTP-
BR7 and PTP-SL both contain a transmembrane domain and a hydrophobic region, 
which not only anchor the two isoforms to the membrane, but are also required for 
multimerization [39]. These latter receptor-type phosphatases are both present at 
the cell surface, at the trans-Golgi network and at late endosomal vesicles [33, 39-
41]. Additionally, PTPBR7 is found at the early endocytotic compartment and at the 
cell membrane. 
It is well feasible that the transmembrane PTPRR variants counteract retrograde 
RTK signalling. TrkA is rapidly internalized upon ligand binding and transmits the 
NGF-induced signal from the neuronal tip via active endocytotic vesicles to the cell 
body (figure 3) [42], and PTPBR7 and/or PTP-SL may have the opportunity to inhibit 
the NGF-induced effects on the MAPKs ERK1/2. Intriguingly, PTPRR transcripts be-
come upregulated after NGF treatment of PC12 cells [43]. This appears to provide 
a slow-acting negative feedback mechanism since the resulting PTPBR7 overexpres-
sion reduces NGF-induced ERK activation. Notably, neuronal growth cone motility 
displays overlapping molecular processes, including receptor and calcium signal-
ling, with cell migration [44]. A recent study showed that shRNA-mediated inhibi-
tion of PTPRR increased mammary epithelial cell motility after ERBB2 activation, 
presumably via ERK phosphorylation, although other factors cannot be excluded 
[45]. Together, these data suggest an important and pleiotrophic role for PTPRR 
proteins, making it tempting to further investigate their potential role in neuronal 
signalling and differentiation.
 
PTPKISKIMTMHRSP
PTPBR7
PTP-SL
PTPPBSγ-42
PTPPBSγ-37
Figure 5 - General Introduction - ME
Extracellular Intracellular
γ
PTPRR expression 
PC12 cells may be used as a convenient model for neuronal differentiation, but to 
learn more about the roles of PTPRR in neuronal signalling, PTPRR’s function in the 
whole brain should be evaluated. In mouse, PTPRR transcript levels are highest in 
the Purkinje cells (PCs) of the cerebellum and are additionally present at lower levels 
throughout the rest of the brain, including the olfactory bulb and hippocampus (fig-
ure 6) [33]. During early embryogenesis, PTP-SL transcripts are undetectable while 
PTPBR7 transcripts are found in the spinal ganglia and developing PCs. Postnatally, 
Figure 5: PTPRR isoforms. Schematic representation of the different PTPRR protein isoforms 
that are encoded by mouse gene Ptprr, i.e. two transmembrane variants, PTPBR7 and PTP-SL, 
and the two cytosolic proteins, PTPPBSγ-37 en -42. SP = signal peptide, HR = hydrophobic 
region, TM = transmembrane region, KIM = kinase interacting motif, KIS = kinase specificity 
sequence, PTP = protein tyrosine phosphatase domain. Adapted from [41].
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PTPBR7 is expressed throughout all other brain regions, but in the PCs the transcript 
levels decrease and are replaced by PTP-SL messenger RNA [33]. Additionally, PTP-
SL transcripts are found in the midbrain, brainstem and cortex, although at very 
low levels [35]. In mouse, the generation of PCs takes place in the ventricular zone 
of the cerebellar primordium [46, 47]. PCs migrate dorsally out of the ventricular 
zone and reorganize to yield an array of PC clusters. In the first postnatal weeks, the 
clusters disperse and PCs rearrange in monolayers to form the typical adult stripes 
of the cerebellum. PTPBR7 transcripts are detectable in newly formed PCs and also 
during their migration [33]. Around birth, PTPBR7 expression levels in PCs strongly 
decline, whereas PTP-SL mRNA transcripts increase in the first postnatal week, the 
period in which the PC monolayer is formed and the orientation and outgrowth of 
dendrites occurs. PTP-SL transcript levels reach a maximum in the third postnatal 
week in which PCs end their maturation by establishing connections with parallel 
and climbing fibers. Considering these observations and the potential role of PTPRR 
proteins in cell migration [45], it seems likely that PTPBR7 and PTP-SL isoforms are 
involved in PC maturation. PTPBSγ mRNAs are only expressed in trace amounts in 
the hippocampus, midbrain, brainstem, cortex, and cerebellum [34, 35]. Markedly, 
PTPBSγ is the only PTPRR transcript that is claimed to be expressed in non-neuronal 
tissue, including the gastrointestinal tract and - prenatally - the developing skeletal 
and intestinal systems [48]. 
Figure 6 - General Introduction - MEFigure 6: PTPRR expression in the mouse brain. Based on in situ hybridization studies, this 
adult mouse brain 3D model displays PTPRR mRNA levels, represented by a multicolor scale. 
Transcript levels peak in the olfactory bulb, hippocampus and cerebellum. The image was 
generated with Brain Explorer 2 from the Allen Brain Atlas [60].
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Olfactory bulb-, hippocampus- and cerebellum-related mouse behaviour
The presence of PTPRR in the cerebellum, hippocampus and olfactory bulb raises 
the possibility that PTPRR proteins are involved in behavioural functions controlled 
by these specific brain regions. 
From an evolutionary perspective, the olfactory system is one of the most ancient 
neural networks in mammals and the molecular mechanism of chemoreception is 
shared by all organisms, including bacteria [49]. Olfactory information provides 
clues for feeding, social behaviour and reproduction and losing the ability to smell 
is life threatening for many animals. Odorants bind to receptor neurons within the 
nose, which relay the signals via their axons bundled in the olfactory nerve to mitral 
cells in the olfactory bulb. This bulb functions thereby as the olfactory relay station. 
Subsequently, the information is transmitted via the lateral olfactory tract from the 
olfactory bulb to higher brain centers in order to identify the odorant and to initiate 
motor, visceral, and emotional responses [50].
Acquisition of new information (learning) and the encoding, storage and retrieval 
of that information (memory) require an even more complex system. Based on evi-
dence from patients and animals with specific lesion injuries in their brains, it has 
been concluded that the hippocampus is heavily engaged in the formation and 
retrieval of memories, although not in memory storage [51]. The major structures in 
the hippocampus are the CA1 region, the CA3 region and the dentate gyrus. The 
granule cells within the dentate gyrus indirectly receive polymodal sensory informa-
tion via the entorhinal cortex from many regions of the cerebral cortex and transmit 
these signals via Mossy fibers to pyramidal cells in the CA3 region. Schaffer col-
laterals, originating from the CA3 pyramidal cells, synapse amongst the pyramidal 
cells of the CA1 segment, which in turn projects back to neurons in the entorhinal 
cortex. Additionally, CA3 neurons send their axons outward from the hippocampus 
into other brain regions.
Regulation of movement, posture and balance requires yet another brain area; 
the cerebellum. This brain region combines input received from the cerebral cortex 
and from sensory systems, which respectively initiate and monitor highly skilled and 
complex movements. The resulting output of the cerebellar “integrated circuit” is 
provided by the PCs, which represent some of the largest neurons in the brain. PCs 
possess a typical elaborate dendritic tree that contains numerous synapses through 
which they receive excitatory input from parallel fibers, which originate from granu-
lar cells in the cerebellar cortex. Next to parallel fibers, climbing fibers arising from 
the inferior olivary nucleus innervate the PC at the soma and proximal dendrites. 
Eventually, the information from the cerebellum is transmitted via the deep cerebel-
lar nuclei to the upper motor neurons that coordinate the muscular contractions 
underlying complex voluntary movements. 
To evaluate the impact of PTPRR on brain function and mouse behaviour, PTPRR-
deficient mice have been generated [52]. Ptprr -/- mice appeared healthy, were fertile, 
and overall brain morphology was unaffected. Behavioural functions related to the 
olfactory bulb and hippocampus were not studied at that time in the Ptprr -/- mice, 
but the cerebellar function was evaluated [52]. PTPRR knock-out mice displayed 
a mild disturbance of fine motor coordination and balance skills in comparison to 
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wild type controls. Interestingly, ERK1/2 phosphorylation levels were significantly in-
creased in the cerebella of the Ptprr -/- mice. As mentioned above, brain MAPKs are 
extremely important in neuronal development and synaptic plasticity [53], including 
cerebellar long-term depression (LTD) [54]. 
Cerebellar long-term depression 
Simultaneous activity of the parallel fiber and climbing fiber at the PC synapses 
elicits LTD, a process that mutes the post-synaptic response of the PC to the parallel 
fiber (figure 7) [55, 56]. Active parallel fibers release the neurotransmitter glutamate,
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Figure 7: Signaling mechanism underlying cerebellar long term depression (LTD). 
(A) Glutamate released from parallel fiber presynaptic vesicles induces AMPA receptor acti-
vation. Additionally, glutamate binds and activates metabotropic glutamate receptors, lead-
ing to the production of the second messenger IP3. Simultaneous activation of a climbing 
fiber results in Purkinje cell depolarization and an influx of calcium, which teams up with the 
IP3-induced release of calcium from the ER. This synergy leads to a significant activation of 
calcium-dependent protein kinase (PKC).  (B) Subsequently a positive feedback loop is in-
duced in which PKC phosphorylates RKIP, triggering the release of RKIP from c-Raf, enabling 
the sequential activation of MEK, ERK1/2 and PLA2. Consequently, AA is released that closes 
the positive feedback loop by direct binding and activation of PKC, leading to sustained PKC 
activity. As a result, AMPARs are phosphorylated and internalized, causing the depressed 
Purkinje cell response to the parallel fiber  input that is called LTD. AMPAR = α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor, mGluR = metabotropic glutamate re-
ceptor, IP3 = inositol triphosphate, ER = endoplasmic reticulum, PKC = Protein kinase C, RKIP 
= Raf kinase inhibitor protein, c-Raf = RAF proto-oncogene serine/threonine kinase, MEK = 
Mitogen-Activated Protein Kinase/ Extracellular Signal-Regulated Kinase Kinase, ERK1/2 = 
extracellular signal-regulated kinase, PLA2 = phospholipase A2, AA = arachidonic acid, PF = 
parallel fiber , CF = climbing fiber, PC = Purkinje cell. Adapted from [54, 57, 58].
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which binds to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPARs), ligand-gated sodium channels, on the PC membrane. This, in turn, leads 
to a post-synaptic influx of cations and subsequent brief membrane depolarization 
(figure 7A) [57]. Additionally to this electrical response, glutamate also activates the 
metabotropic glutamate receptor (mGluR). This G protein-coupled receptor switch-
es on the production of second messengers, including inositol triphosphate (IP3). 
Signalling via the mGluR alone is insufficient to induce calcium release from the ER. 
Climbing fiber-induced PC depolarization and consequent calcium influx through 
voltage-gated channels is required as well to sensitize the cell for the mGluR-initiat-
ed IP3 in order to release sufficient calcium from the ER. The resulting increase in 
calcium triggers the activation of Protein kinase C (PKC), inducing a positive feed-
back loop that involves the MAPK signalling cascade (figure 7B). The induction of 
this loop leads to the sustained activity of PKC, which eventually phosphorylates the 
AMPAR and triggers its internalization [54, 58]. Consequently, the PC becomes in-
sensitive for parallel fiber stimulation. PCs form the sole output of the cerebellum 
and LTD is one of the key mechanisms that controls the central communication posi-
tion of PCs and regulates the translation from incoming signals to the output to 
other brain regions. Clearly, LTD, but also other neuronal processes, should be 
tightly controlled to maintain proper cerebellar functioning. Within the cerebellum, 
PTPRR is the only KIM-containing classical PTP that is present and, given the in-
creased phosphorylated ERK levels in this brain region of PTPRR deficient mice [52], 
this raises the question whether PTPRR proteins could be involved in cerebellar LTD.
OUTLINE OF THIS THESIS
As mentioned above, MAPK activity is a key factor in many different signalling pro-
cesses in the brain, including cerebellar LTD and NGF-induced neuronal differentia-
tion. Due to its specific presence in the brain and its potency to inhibit MAPK activity, 
PTPRR is among the important candidates to control these, and other, neuronal pro-
cesses. The finding that Ptprr transcripts are upregulated in NGF-stimulated PC12 
cells further encouraged us to test whether, and if yes how, PTPRR proteins are in-
volved in neuronal differentiation. Using genetically modified PC12 cells we studied 
the interaction of PTPBR7 proteins with ERK1/2 and TrkA and subsequent impact 
on NGF-induced PC12 cell differentiation (chapter 2). To evaluate the potential role 
of PTPRR proteins in cerebellar LTD, we generated cerebellar slices of wild-type and 
Ptprr knockout mice in which we measured LTD induction using electrophysiological 
techniques. Furthermore, we used chemical LTD induction to evaluate whether PT-
PRR deficiency influences the phosphorylation levels of key LTD-implicated proteins 
(chapter 3). Reasoning that lack of PTPRR proteins affects neuronal processes, this 
may be witnessed by perhaps subtle aberrations in specific behaviour of Ptprr mice. 
Cerebellar function has been evaluated previously and it was demonstrated that 
PTPRR deficient mice encounter locomotive problems [52]. Directed by the pres-
ence of PTPRR in brain areas like the olfactory bulb and the hippocampus, among 
other regions where it is present, we tested whether PTPRR affects smell function, 
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learning and memory by subjecting Ptprr knockout mice to a battery of behavioural 
tests (chapter 4). Obviously, all the information on PTPRR protein function that will 
be obtained using cell and animal models may have bearing to human health and 
disease states. Thus far, studies on human PTPRR are scarce and not always consist-
ent. Therefore, we have compiled and studied the current literature and database 
information on human PTPRR and linked this to the information from model systems 
(chapter 5). Finally, the results that we obtained in these studies on the role of PT-
PRR proteins in the control of mouse behaviour, cell differentiation, and neuronal 
connections are discussed in a broader context in chapter 6.
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ABSTRACT
Neuronal differentiation relies on multiple spatio-temporally controlled signalling 
events, including nerve growth factor (NGF)-induced activation of the neurotrophin 
receptor tyrosine kinase TrkA. One of the intracellular signalling pathways that is 
activated through TrkA is controlled by mitogen-activated protein kinases (MAPKs) 
ERK1/2. Protein tyrosine phosphatase receptor type R (PTPRR) isoforms are able to 
bind and dephosphorylate MAPKs and may therefore modulate neurotrophin sig-
nalling. We investigated PTPRR effects on the NGF-induced differentiation of PC12 
cells and found that the transmembrane PTPRR isoform PTPBR7, but not a catalyti-
cally inactive mutant, effectively reduced PC12 cell neurite outgrowth. Interestingly, 
also a PTPBR7 version that is unable to interact with MAPKs attenuated PC12 cell 
neuritogenesis, albeit to a lesser extent than the wild-type protein. PTPBR7 also 
interacted with TrkA directly, catalyzing its dephosphorylation at multiple positions. 
We conclude that PTPBR7 regulates NGF-induced PC12 cell differentiation at mul-
tiple levels within the TrkA signalling cascade.
NGF
TrkA
MAPKKK
MAPKK
MAPK
pY
pY
PTPBR7-wt
Neurite outgrowth
KIM domain
PTP domain
pY
pY
PTPBR7-S/D
PTPPBSγx
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INTRODUCTION 
Neurotrophins modulate many aspects of neuronal development, including cell 
survival, differentiation, synapse formation and plasticity [1, 2]. The first identified 
neurotrophin, nerve growth factor (NGF), interacts with at least two receptors, p75 
neurotrophin receptor (p75NTR) and tropomyosin receptor kinase A (TrkA) [3]. TrkA 
is a heavily glycosylated protein, which is initially synthesized as a 80-kDa core pro-
tein, converted to an immature 110-kDa glycoprotein (p110) [4, 5], and then further 
processed in the Golgi apparatus into the 140-kDa mature form (p140) that ap-
pears at the cell surface [6, 7]. Optional proteolytic shedding of TrkA by metal-
loproteases results in a transmembrane 41-kDa TrkA variant (p41) that lacks the 
ligand-binding ectodomain and is constitutively active [8-10]. Mature TrkA responds 
to NGF-binding by receptor dimerization and autophosphorylation [11], first within 
the catalytic kinase domain (on e.g. residue Y674 and Y675 in human TrkA), leading 
to enhanced activation. Subsequent autophosphorylation of tyrosines outside the 
TrkA kinase domain recruits adapter protein complexes that connect the receptor 
to downstream signalling pathways [11, 12]. Phosphorylation of Y785, for example, 
recruits PLCγ and leads to PKC activation, whereas phosphorylation at Y490 initi-
ates PI3-K/Akt and Ras/ERK signalling cascades. 
Rat pheochromocytoma-derived neuroendocrine PC12 cells represent an el-
egant model to investigate growth factor-induced signalling mechanisms [13]. In 
these cells, signalling by EGF leads to the small G protein Ras-mediated transient 
ERK activation and PC12 cell survival and proliferation [14, 15]. In contrast, PC12 
cell differentiation requires NGF-mediated activation of TrkA as a trigger. Activated 
TrkA is internalized and the resulting signalling endosomes then recruit and acti-
vate the small G-protein Rap1 that initiates the B-Raf/MEK/ERK cascade, leading to 
sustained activation of ERK and eventually involves nuclear translocation [15, 16]. 
In the entire cascade that determines spatio-temporal control of ERK activity, multi-
ple interacting proteins are involved, generating a complex signalling network that 
includes feedback loops and crosstalk with other pathways [17]. Whereas ligand-
induced kinase-dependent ‘on’ switches in PC12 signalling cascades have been 
studied extensively, research on counteracting phosphatases that mediate “off” 
switches is lagging behind. 
The dephosphorylation of specific regulatory residues within the TrkA signalling 
cascade can be performed by serine/threonine-specific protein phosphatases (PPs), 
phosphotyrosine-specific protein tyrosine phosphatases (PTPs) as well as dual-spec-
ificity PTPs [18-20]. Three classical PTPs are specifically tailored to dephosphorylate 
and inactivate ERK proteins: HePTP (PTPN7), STEP (PTPN5) and PTPRR. All three 
contain a kinase interacting motif (KIM) that primes them to bind and dephospho-
rylate mitogen-activated protein kinases (MAPKs) [21, 22], with a preference for 
ERK1/2/5 and p38 over JNK [23-25]. Their inhibition of MAPK activity is based on a 
dual effect, involving both dephosphorylation and physical association, which pre-
vents nuclear translocation of MAPK [23, 26]. Stability of the PTP-MAPK complex is 
regulated through reversible phosphorylation of a conserved serine residue within 
the PTP KIM [26-28]. KIM phosphorylation by PKA blocks complex formation, thus 
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sustaining MAPK activity and allowing its nuclear entry. PKA activity is counteracted 
by PP1-mediated dephosphorylation of the conserved serine within the KIM do-
main of the MAPK-directed PTPs.
In PC12 cells only one of the three KIM-containing classical PTP genes, Ptprr, 
is expressed, giving rise to the rat PCPTP1 protein isoform [29]. PCPTP1 is the or-
thologue of mouse PTPBR7, a transmembrane receptor-type PTP that is present at 
the trans-Golgi network, late endosomal vesicles and the cell membrane [30-32]. In 
other cell types a smaller PTPRR isoform, PTPPBSγ, has been observed that lacks 
the transmembrane domain and resides in the cytosol. Mouse PTPRR isoforms are 
predominantly present in the brain with differential expression patterns during de-
velopment [32-35]. PTPRR deficient mice display impaired cerebellar neuronal con-
nectivity [36] and exhibit motor coordination problems [37], impaired novel object 
recognition and increased exploratory behaviour [38]. Here we have explored the 
regulatory role of PTPRR proteins on neuronal differentiation at the cellular level, us-
ing PC12 cells as a model. NGF stimulation of PC12 cells provokes an upregulation 
of PCPTP1 mRNA levels [39] and PTPBR7 overexpression attenuates NGF-induced 
ERK activation in these cells [40]. We show that PTPBR7 impairs NGF-induced PC12 
cell neurite outgrowth, an effect that partly relies on its interaction with ERK. PTPBR7 
additionally binds and dephosphorylates TrkA itself. Our results establish the ability 
of PTPBR7 to modulate neurotrophin signalling in PC12 cells at multiple levels.
MATERIALS AND METHODS 
Mammalian expression plasmids
Generation of wild-type and mutant PTPBR7-eGFP as well as PTPPBSγ-eGFP ex-
pression constructs in pLenti6.2/V5-DEST using Gateway® cloning (Invitrogen) and 
construction of the VSV-tagged rat TrkA expression plasmid pSG8-TrkA-VSV are de-
scribed in the supplementary information. Constructs pCB7-SX3-myc and pCB7-Tfr-
HA were a kind gift of Dr. M.B.A. ter Beest. For the generation of pLenti6/BLOCK-
iT-shPCPTP1-2377, the H1-promoter-driven shRNA expression cassette from 
pSR-2377 [29] was isolated as an EcoRI-XhoI fragment and cloned into the EcoRI/
XhoI-digested pLenti6/BLOCK-iT™-DEST vector (Invitrogen). The bacterial expres-
sion plasmid pGEX-SL has been described previously [41]. A similar plasmid, except 
coding for a catalytically inactive DA/CS double mutant version, was generated by 
site-directed mutagenesis of residue D553 and C587 (numbering corresponds to 
amino acid positions in PTPBR7; Acc.nr. BAA06696) using the QuickChange pro-
tocol (Stratagene). Primers used for mutagenesis are listed in the supplementary 
information. All constructs generated were verified by sequence analysis.
Cell culture and lentiviral transduction 
PC12 cells [10] were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; In-
vitrogen), containing 4 mM glutamine, 1 mM pyruvate, 6% fetal calf serum (FCS; 
PAA Laboratories), and 6% horse serum (Invitrogen). COS-1 cells were cultured in 
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DMEM, supplemented with 4 mM glutamine, 1 mM pyruvate, and 10% FCS. Both 
cell lines were cultured at 37°C in a humidified atmosphere containing 7.5% CO2. 
For shRNA-mediated knockdown, the BLOCK-iT Lentiviral RNAi Gateway Vector Kit 
(Invitrogen) was used according to manufacturer’s protocol. Briefly, lentivirus was 
produced in 10 cm dishes following overnight transfection of HEK293FT cells with 
the plasmid pLenti6/BLOCK-iT-shPCPTP1-2377 and ViraPower Packaging mix using 
Lipofectamine 2000. Lentivirus-containing medium was collected 72h post-trans-
fection, filtered and stored at -80ºC until further use. PC12 cells were seeded on a 
6-wells plate and the following day cells were incubated for 6h with 0.5 ml lentivirus-
supernatant, 0.5 ml medium and 5 μg/ml polybrene (Sigma). After 48h, medium 
was replaced by medium containing blasticidin (10 μg/ml, Invitrogen) and selection 
was continued for at least two weeks, yielding PC12-shPCPTP1 cells.
Neurite outgrowth assay
PC12-shPCPTP1 cells were seeded on coverslips coated with poly-L-lysine (10 μg/
ml) and collagen (50 μg/ml) at a density of 5x104 cells/well on a 6-wells plate. The 
next day, cells were transfected with mouse GFP-tagged PTPRR expression con-
structs using jetPRIMETM (Polyplus Transfection) according to the manufacturer’s 
protocol. One day following transfection, the medium was replaced by DMEM sup-
plemented with glutamine (4 mM), pyruvate (1 mM), horse serum (0.5%) and NGF 
(10 ng/ml; Sigma Aldrich). After 48h of stimulation, cells were fixed in 2% paraform-
aldehyde and stained with DAPI. Images were acquired by fluorescence micros-
copy. EGFP-positive cells were scored for the number and length of neurites in a 
blinded fashion (figure 1). Neurite extensions smaller than the cell body diameter 
were excluded. 
Co-immunoprecipitations and Western blotting
PC12-shPCPTP1 cells were seeded on poly-L-lysine (10 μg/ml)-coated 10 cm dish-
es. One day later, cells were co-transfected with pSG8-TrkA-VSV and one of the 
PTPRR expression constructs using jetPRIMETM (Polyplus Transfection) according to 
the manufacturer’s protocol. At 48h after transfection, cells were washed twice with 
PBS and harvested in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 1% tri-
ton X-100; 100 mM NaF; 2 mM Na3VO4; 20 mM Na4P2O7; 1 mM PMSF; protease in-
hibitor cocktail, Roche Diagnostics). Lysis was continued on ice for 30 min, followed 
by centrifugation for 15 min at 14.000 rpm at 4ºC to remove cellular debris. The 
supernatant was used in immunoprecipitation and Western blotting experiments. 
Briefly, lysate supernatants (1 ml) were pre-cleared using 40 μl protein A-sepharose 
CL-4B beads (GE Healthcare) for 1 hour at 4ºC, followed by overnight incubation 
at 4ºC with 40 μl beads preloaded with 300 μl mouse monoclonal anti-PTPRR anti-
body 6A6 [33]. Beads were then washed six times with wash buffer (50 mM Tris-HCl, 
pH 7.5; 150 mM NaCl; 1% Triton X-100; 1 mM PMSF; protease inhibitor cocktail) 
and taken up in SDS-PAGE sample buffer, followed by boiling. Proteins released 
from the beads were subjected to SDS-PAGE and analyzed by Western blotting 
using rabbit polyclonal anti-ERK1/2 (1:2000, #9102, Cell Signalling Technology), 
rabbit polyclonal anti-TrkA (1:2000, ab8871, abcam), mouse monoclonal anti-PTPRR 
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(1:500, 6A6 [33]) or rabbit polyclonal anti-PTPRR antiserum (1:2000, α-SL [32]). Goat 
anti-mouse and goat anti-rabbit secondary antibodies conjugated to IRDye680 or 
IRDye800 fluorescent dyes (LI-COR) were used for detection and quantification on 
an Odyssey infrared imaging system (LI-COR).
In vitro TrkA dephosphorylation assay
COS-1 cells were transfected with pSG8-TrkA-VSV using DEAE-dextran [30]. After 
a 30 min treatment with peroxovanadium (BpV(phen)) (40 μg/ml; kindly provided 
by N.P. Möller, Novo Nordisk), cells were washed twice with ice-cold PBS and ly-
sed as described above. Subsequently, TrkA-VSV was immunoprecipitated with the 
anti-VSV-G mouse monoclonal antibody P5D4 [42] coupled to protein G-sepharose 
beads. Following extensive washing with lysis buffer, immunoprecipitated proteins 
were washed once with incubation buffer (25 mM HEPES, pH 7.5; 5 mM EDTA; 
10 mM DTT; 1% Triton X-100). Immunoprecipitates were split in two halves and 
incubated for 1h at 37°C with 600 μl incubation buffer containing 2 μg recombi-
nant GST-SL or GST-SL-DA/CS. Recombinant fusion proteins were generated by 
introduction of plasmid pGEX-SL or its DA/CS double mutant version into E.coli 
BL21(DE3)pLysS and induction of recombinant protein production. Subsequent 
isolation and purification was done as described earlier [41]. After the incubation 
with recombinant PTPs, the beads with immunoprecipitates were washed once with 
incubation buffer and taken up in 30 μl sample buffer. Proteins released from the 
beads were subjected to SDS-PAGE and analysed by Western blotting using mono-
clonal anti-phosphotyrosine (1:1000, PY20, Santa Cruz Technologies) and polyclonal 
anti-VSV-G (1:10,000, A190-131A, ITK Diagnostics) antibodies, respectively. Use of 
secondary antibodies and fluorescence detection was as described above. 
Cellular TrkA dephosphorylation assay
PC12-shPCPTP1 cells were seeded on poly-L-lysine (10 μg/ml)-coated 10 cm dishes. 
One day later, cells were co-transfected with pSG8-TrkA-VSV in combination with 
constructs for wild-type or eGFP-tagged PTPRR variants using jetPRIMETM (Polyplus 
Transfection) according to the manufacturer’s protocol. 48h after transfection, cells 
were serum starved in medium containing only 0.5% horse serum for 6h prior to 
stimulation with NGF (20 ng/ml) for 10 min. Cell lysis and immunoprecipitation of 
VSV-tagged TrkA was performed as described above. Precipitated proteins were 
subjected to SDS-PAGE and analysed by Western blotting using rabbit polyclonal 
anti-phosphoY490-TrkA (1:1000, #9141, Cell Signalling Technology) or rabbit mon-
oclonal anti-phosphoY674/675-TrkA (1:1000, #4621, Cell Signalling Technology), 
rabbit polyclonal anti-VSV-G (1:20000, A190-131A, ITK Diagnostics), mouse mono-
clonal anti-PTPRR (1:500, 6A6, [33]), and rabbit monoclonal anti-GAPDH (1:5000, 
#2118, Cell Signalling Technology). Secondary antibodies and visualization method 
were as described above. Results are expressed as the ratio of the anti-phospho-
TrkA and anti-VSV signal intensities.
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Statistics
All data are presented as means ± SEM. Statistical significance was assessed using 
Student’s t-test for independent samples with the Graphpad Prism 4 software.
RESULTS
PTPBR7 inhibits NGF-induced neurite outgrowth in PC12 cells
To test PTPRR effects on NGF-induced PC12 cell signalling and differentiation, but 
exclude interfering effects from endogenous PCPTP1 in our experiments, we de-
veloped PC12-shPCPTP1 cells in which PCPTP1 protein levels are knocked down 
by the stable expression of a rat PTPRR-specific short hairpin RNA (supplementary 
figure 1). These cells were then transfected with expression constructs for eGFP-
tagged mouse PTPBR7 variants, all insusceptible for the shRNA. Neurites, defined 
as cell protrusions with a length of more than the PC12-shPCPTP1 cell’s diameter 
(figure 1), do not form in the absence of NGF. An NGF treatment for 48h induced 
the formation of prominent protrusions in eGFP-expressing control cells (figure 1). 
Similar results were obtained with regular PC12 cells expressing eGFP. In contrast, 
neurite outgrowth in PTPBR7-eGFP-expressing PC12-shPCPTP1 cells was consider-
ably reduced. We observed a significant decline in both the length and number of 
neurites per cell as compared to the control cells. PC12-shPCPTP1 cells express-
ing a catalytically inactive PTPBR7-C/S-eGFP mutant showed neuritogenesis that 
equaled that of eGFP-expressing cells (figure 1). Thus, catalytically active PTPBR7 
significantly inhibits NGF-induced PC12 cell differentiation.
Inhibition of neurite outgrowth partly relies on the PTPBR7 - ERK interaction 
To determine whether PTPBR7-mediated inhibition of PC12 cell neuritogenesis is 
exclusively exerted via its interaction with ERK, we tested eGFP-tagged PTPBR7-
S/D and S/A mutants in pull down and PC12 cell differentiation assays. Changing 
the regulatory serine within the KIM domain into a negatively charged residue, i.e. 
aspartic acid (S/D substitution), mimics PKA-mediated phosphorylation and pro-
hibits PTPBR7’s interaction with ERK [23, 26]. In contrast, substitution of this serine 
by alanine (S/A substitution) precludes PKA-catalyzed phosphorylation at the KIM. 
We corroborated ERK1/2 binding characteristics of the eGFP-tagged PTPBR7 vari-
ants in lysates of transfected PC12-shPCPTP1 cells (figure 2).  As expected, the S/A 
mutation within the PTPBR7 KIM resulted in a pronounced interaction of the eGFP-
tagged PTP with ERK1/2. In contrast, the S/D mutant displayed strongly diminished 
binding, with signal strength on Western blot that is similar to that of the ERK1/2 
background signal observed for eGFP-expressing cells and presumably reflects 
non-specific binding to the beads. PTPRR isoform PTPPBSγ displayed ERK1/2 bind-
ing that is comparable to that of PTPBR7-S/A. 
We then transiently transfected PC12-shPCPTP1 cells with the eGFP-tagged 
PTPRR variants and monitored NGF-induced neurite outgrowth. In line with our ear-
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lier findings, the length and the number of neurites of cells expressing either eGFP or 
catalytically inactive PTPBR7-C/S were similar (figure 3). Neurite outgrowth was sig-
nificantly attenuated in cells expressing wild-type PTPBR7, PTPBR7-S/A or PTPPBSγ. 
PTPBR7-S/D-expressing cells had significantly longer neurites than PTPBR7 wild-
type-expressing cells, an observation that indicates that the PTPBR7-ERK1/2 inter-
action is contributing to the inhibitory effect of PTPBR7 on NGF-mediated neurite 
outgrowth. However, the extent of differentiation of PTPBR7-S/D expressing cells, 
as assessed by measurement of the neurite length and number, did not reach that of 
the control cells. Furthermore, in comparison with the wild-type PTPBR7, the PTPRR 
variants PTPBR7-S/A and PTPPBSγ differ in ERK binding but show equal inhibition 
of neurite outgrowth. These remarkable observations indicate an additional mecha-
nism by which PTPBR7 interferes with TrkA-mediated neuritogenesis.
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Figure 1: PTPBR7 attenuates nerve growth factor (NGF)-induced neurite outgrowth 
in PC12-shPCPTP1 cells. (A) PC12-shPCPTP1 cells, transiently overexpressing eGFP (-), 
wild-type PTPBR7-eGFP (BR7-wt) or catalytically inactive PTPBR7-C/S-eGFP (BR7-C/S), were 
stimulated with NGF for 48 hours prior to fixation. Fluorescent images were acquired and 
representative images from three independent experiments are shown here. (B) For each 
condition, approximately 50 cells were analyzed. Neurites were defined as cell extensions 
longer than the cell body diameter (average of the two blue lines). Per cell, the length (pink 
lines) and number of the neurites (pink numbers) were determined. (C) Quantification of the 
neurite length in pixels (1 pixel = 0.45 µm) of cells as described under (A) and (B). Significant 
difference between the PTPBR7-eGFP-expressing (BR7-wt) and eGFP-expressing control (-) 
cells is indicated by **p<0.006. (D) Quantification of the number of neurites per cell as de-
scribed under (A) and (B). Significant difference between the PTPBR7-eGFP-expressing (BR7-
wt) and eGFP-expressing control (-) cells is indicated by *p<0.02.
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Figure 2: Interaction with ERK1/2 is abolished for the phospho-mimicking mutant PTPBR7-S/D. 
(A) PC12-shPCPTP1 cells were transfected with eGFP, PTPPBSγ-eGFP (PBSγ), wild-type (BR7-
wt) or mutant PTPBR7-eGFP (BR7-C/S, BR7-S/A, BR7-S/D) proteins. PTPRR variants were im-
munoprecipitated using monoclonal anti-PTPRR antibody (IP PTPRR). Immunoprecipitates 
were analysed on Western blots using monoclonal anti-PTPRR (PTPRR) and polyclonal anti-
ERK1/2 (ERK1/2) antibodies. Input reflects a fraction of the total cell lysate before immuno-
precipitation. Post-translational modifications and short-lived nature of PTPRR proteins [43] 
explain the multiple bands on the immunoblots. (B) Quantitative representation of ERK1/2 
over PTPRR levels (arbitrary units) in immunoprecipitates of PC12-shPCPTP1 cells as deter-
mined under (A). Results are presented as mean values relative to the BR7-wt sample and 
error bars indicate SEM from three independent experiments with significant differences in-
dicated by *p<0.05 and **p<0.01 (Student’s t-test).
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TrkA is an in vitro PTPRR substrate
In addition to ERK1/2, PTPBR7  may target additional components in the NGF-in-
duced signalling cascade with the NGF-receptor itself as an important candidate. To 
investigate whether the TrkA serves as an interacting substrate for PTPRR, we used 
lysates of PC12-shPCPTP1 cells transiently expressing TrkA-VSV in combination with 
eGFP-tagged PTPRR variants for co-immunoprecipitation experiments. PTPBR7 in-
teracted with both the immature p110 and mature p140 TrkA (figure 4). KIM S/A 
and S/D mutations did not affect the binding of PTPBR7 with TrkA (figure 4B). Nota-
bly, significantly more TrkA was bound by PTPBR7-C/S, reminiscent of a substrate-
trapping effect. In contrast, the level of co-immunoprecipitated TrkA using PTPPBSγ 
was significantly less as compared to wild-type PTPBR7. Transmembrane proteins 
syntaxin 3 and transferrin receptor served as negative controls, and did not interact 
with PTPBR7 (data not shown). 
To evaluate whether TrkA can be dephosphorylated by PTPBR7, we immuno-
precipitated tyrosine-phosphorylated TrkA-VSV from lysates of transfected and 
BpV(phen)-treated COS-1 cells. Subsequently, bacterially produced recombinant 
GST-fusion protein containing the PTPBR7 phosphatase domain [41] was added 
to one half of the precipitated TrkA-VSV, while the other half was incubated with a 
catalytically inactive version of the PTP. Addition of the active, but not the inactive, 
recombinant PTPBR7 catalytic domain led to complete dephosphorylation of p110 
and p140 TrkA (figure 5). In fact, we observed also the dephosphorylation of the p41 
shedding variant of TrkA. Thus, TrkA represents an additional PTPBR7 target within 
the NGF-induced signalling cascade.
Figure 3: PTPBR7-mediated inhibition of PC12 cell differentiation is partly independent 
of the PTPBR7-ERK1/2 interaction. PC12-shPCPTP1 cells were transfected with eGFP (-), 
PTPPBSγ-eGFP (PBSγ), wild-type PTPBR7-eGFP (BR7-wt), or mutant PTPBR7-eGFP (BR7-C/S, 
BR7-S/A, BR7-S/D) constructs. Cells were then treated with NGF for 48 hours and subse-
quently fixed, after which (A) neurite lengths in pixels (1 pixel = 0.45 µm) and (B) neurite 
numbers were measured (summary of three independent experiments, with each 50 cells). 
Significant differences are reflected by   * p<0.05, ** p<0.01, *** p <0.001 (Student’s t test).
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Figure 4: PTPRR proteins interact with TrkA. (A) Lysates of PC12-shPCPTP1 cells co-trans-
fected with eGFP-tagged PTPRR proteins (PBSγ, BR7-wt, BR7-C/S, BR7-S/A, BR7-S/D) and 
VSV-tagged TrkA were used for immunoprecipitation using a monoclonal anti-PTPRR anti-
body (IP PTPRR). Co-precipitating proteins were detected on Western blot using polyclonal 
anti-TrkA antibody (TrkA) together with a monoclonal anti-PTPRR antibody (PTPRR). An aliquot 
of the total lysate before immunoprecipitation was used as input control. Post-translational 
modifications of PTPRR proteins are indicated by multiple bands and additional bands on 
the blot representing the immunoprecipitates are due to PTPBR7 and PTPPBS degradation 
products [43]. (B) Quantitative representation of co-immunoprecipitated TrkA over immuno-
precipitated PTPRR levels (arbitrary units, relative to the BR7-wt sample) as determined under 
(A). Results are presented as mean values and error bars indicate SEM from four independent 
experiments. Significant differences are indicated by *p<0.05 (Student’s t-test).
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PTPBR7 mediates dephosphorylation of residues Y490 and Y674/Y675 in TrkA
We next investigated the effect of PTPBR7 on phosphorylation levels of the TrkA 
cytosolic residues Y674/Y675 and Y490, which are involved in auto-activation and 
serve as docking sites for further downstream signalling, respectively [11, 44, 45]. 
PC12-shPCPTP1 cells were co-transfected with expression constructs for TrkA-VSV 
and wild-type or mutant PTPRR isoforms, and two days later the cells were treated 
for 10 min with NGF. Subsequently, TrkA was immunoprecipitated and probed for 
its phosphotyrosine content on Western blots (figure 6a). Wild-type PTPBR7 ex-
pression significantly reduced the phosphorylation levels on positions Y490 and 
Y674/675 in p110/p140 as well as p41 TrkA, as compared to eGFP-expressing con-
trols (figure 6b). In contrast, the catalytically inactive PTPBR7-C/S did not reduce 
relative TrkA phosphotyrosine levels. Also PTPPBSγ did not affect phospho-TrkA 
levels, despite its relatively high expression levels and moderate capacity to bind 
TrkA. S/A and S/D KIM domain mutants appear to outperform wild-type PTPBR7 in 
reducing phospho-TrkA levels, and for pY490 in p41-TrkA this even reaches signifi-
cance (p<0.05, Student’s t-test). We cannot exclude, however, that this is due to the 
higher expression levels for PTPBR7-S/A and PTPBR7-S/D (figure 6). Irrespective, in 
addition to a direct inhibitory effect on ERK1/2 activity, PTPBR7 reduces Y490 and 
Y674/Y675 phosphorylation levels in the upstream receptor TrkA, providing multi-
target control on NGF-induced differentiation of PC12 cells.
Figure 5: The PTPRR catalytic domain dephos-
phorylates TrkA in vitro. (A) COS-1 cells express-
ing TrkA-VSV were treated with BpV(phen) before 
being lysed. VSV-tagged proteins were immuno-
precipitated using monoclonal anti-VSV antibody 
(IP VSV) and incubated with active (WT) or inactive 
(DA/CS) recombinant GST-PTPRR phosphatase do-
main fusion proteins and then analyzed on Western 
blots with monoclonal anti-phosphotyrosine (pY) and 
polyclonal anti-VSV (VSV) antibodies. Arrows depict 
the immature p110, mature p140 full-length and the 
cleaved p41 TrkA species. In the bottom panel the 
tyrosine non-phosphorylated and phosphorylated 
forms of p41 TrkA are indicated by the lower and up-
per arrow, respectively. (B) Purified recombinant GST 
fusion proteins that were used as input in (A), con-
taining the catalytically active (WT) or mutant (DA/CS) 
PTPRR domains, were analyzed on Western blot with 
a polyclonal anti-PTPRR antibody (PTPRR).
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Figure 6: PTPBR7 mediates dephosphorylation 
of TrkA residues Y490 and Y674/Y675. (A) PC12-
shPCPTP1 cells expressing either eGFP (-) or eGFP-
tagged PTPRR variants (PBSγ, BR7-wt, BR7-C/S, BR7-
S/A, BR7-S/D) in combination with VSV-tagged TrkA 
were treated for 10 minutes with nerve growth factor 
prior to lysis. VSV-tagged TrkA, immunoprecipitated 
using monoclonal anti-VSV antibody (IP VSV) was de-
tected on Western blot with polyclonal anti-VSV antibody (VSV). Site-specific phosphoryla-
tion levels of p41, p110 and p140 TrkA were monitored using either pY490 or pY674/675 
phosphospecific antibodies. A fraction of the total lysate before immunoprecipitation was 
used for the detection of PTPRR proteins with a polyclonal anti-PTPRR antiserum (PTPRR). 
Multiple bands indicate post-translational modifications of the PTPRR proteins [43]. Protein 
loading was determined using anti-GAPDH antibodies (GAPDH). (B-E) Quantitative represen-
tation of the proportion of immunoprecipitated TrkA that is phosphorylated (arbitrary units)
PTPRR inhibits PC12 cell neuritogenesis at TrkA receptor and MAP kinase levels
41
2 2
DISCUSSION 
In order to differentiate, PC12 cells need NGF-induced, TrkA-mediated, sustained 
ERK1/2 activation and nuclear translocation [14]. PTPRR proteins are well-known 
inactivators of ERK1/2 [23, 37, 46], which are key players within growth factor signal-
ling pathways. We studied the functional implication of the receptor-type isoform 
PTPBR7 for NGF-induced PC12 cell differentiation and found that PTPBR7 attenu-
ates neurite outgrowth at two distinct levels; upstream in the signalling pathway, 
by reverting TrkA phosphotyrosine levels, and more downstream, through a KIM-
mediated binding of ERK1/2.    
In previous experiments using NGF-stimulated PC12 cells we did not observe 
effects of PTPBR7 overexpression or knock-down directly on ERK1/2 phosphoryla-
tion levels [29]. At that time, PTPBR7 mutants were not evaluated. In a different 
study, Ogata and co-workers did note an inhibitory effect of a truncated version of 
PTPBR7 on NGF-induced activity of the ERK substrate Elk in PC12 cells [40]. The ap-
parent discrepancy may be caused by differences in timing and read-out between 
the former studies (determining pERK levels over a period of 60 min following NGF 
addition versus Elk-luciferase reporter assays performed after 5 h of NGF stimula-
tion, respectively). Additionally, differences in the PTPRR variants that were used, 
i.e. wild-type membrane-bound PTPBR7 versus cytosolic truncated PTPBR7, could 
play a role. In our current set of experiments, the PTPPBSγ cytosolic variant turned 
out to be a much more effective ERK binder than wild-type PTPBR7. Likely, non-
transmembrane PTPRR proteins in the cytoplasm have an increased probability for 
engagement with ERK1/2. Furthermore, a difference in ERK1/2 binding capacity 
may be explained by differential PKA-mediated phosphorylation on the regulatory 
serine in the KIM domain of PTPBR7 and PTPPBSγ. Indeed, we previously found 
that ectopic expressed PTPBR7 molecules were maximally phosphorylated on this 
serine residue in PC12 cells, whereas a substantial portion of the ectopic expressed 
PTPPBSγ proteins remained non-phosphorylated [29]. 
Here, we demonstrate that the PTPBR7-ERK interaction accounts only partly for 
the PTPBR7-mediated attenuation of PC12 cell differentiation and reveal TrkA as a 
novel target for PTPBR7. PTPPBSγ interacted much weaker with TrkA than PTPBR7 
did and had no effect on TrkA phosphotyrosine levels, exluding TrkA as a main 
substrate for PTPPBSγ in the NGF-signalling cascade. Thus, PTPBR7 and PTPPBSγ 
both inhibited neuritogenesis, but do so by slightly distinct mechanisms. Unlike 
PTPPBSγ, PTPBR7 uniquely manifests dual behaviour in terms of binding to both 
ERK1/2 and TrkA. Of note, the rat orthologue of PTPBR7 is the only PTPRR isoform 
expressed in PC12 cells and it is well feasible that PTPBR7 and PTPPBSγ exhibit dif-
ferent functions in vivo. 
as determined under (A), with pY490-levels of p110 and p140 (B), pY490 levels of p41 (C), 
pY674/675 levels of p110 and p140 (D), and pY674/675 levels of p41 (E). Results are pre-
sented as mean values relative to the eGFP-expressing control condition. Error bars indicate 
SEM from at least three independent experiments. Significant differences are reflected by 
*p<0.05, **p<0.01 and ***p<0.001 (Student’s t-test).
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Our notion that TrkA binding by PTPPBSγ was strongly reduced in comparison with 
PTPBR7 suggests that the transmembrane (TM) and/or extracellular domain in PT-
PBR7 is important for binding. This contention is supported by preliminary results 
in COS-1 cells that show that a PTPBR7 mutant lacking the cytosolic segment [47] 
still associated with TrkA (our unpublished data). Also mouse PTPRR isoform PTP-
SL, which lacks most of the extracellular domain in PTPBR7, interacted with TrkA in 
those experiments. PTPBR7 and PTP-SL, but not PTPPBSγ, are able to form homo- 
and heterodimers [47]. Together, these observations provide evidence that the TM 
region of the PTPRR isoforms instead of the extracellular domain is the TrkA inter-
acting motif. A role for TM domains in interaction with TrkA is not unprecedented; 
for ankyrin-rich membrane-spanning (ARMS) protein [48], p75NTR neurotrophin 
receptor [49] and the receptor-type PTP RPTPσ [50] binding, the respective TM 
domains turned out to be essential. 
TrkA dimerization-induced autophosphorylation at residue Y674/675 is one of 
the initial effects of NGF-binding and enhances catalytic activity [44, 45]. Subse-
quent phosphorylation on Y490 serves as a docking site for the adaptor protein 
Shc, eventually initiating the MAPK cascade [12]. PTPBR7 mediates dephospho-
rylation of TrkA residues Y674/Y675 and Y490, thus counterbalancing TrkA trans-
activation as well as signalling towards downstream targets. Following activation of 
TrkA at the plasma membrane, the NGF-TrkA complex is rapidly internalized and 
the resulting signalling endosomes are retrogradely transported to the cell body 
to regulate differentiation [51]. PTPBR7 is present at the plasma membrane and in 
endosomal structures [30-32] and therefore may dephosphorylate TrkA immediately 
after activation at the cell surface as well as during its journey through the endocytic 
pathway. Ultimately, the NGF-induced differentiation signal in PC12 cells will lead 
to altered gene expression, including an upregulation of PTPRR transcript levels. As 
yet, it has not been investigated to which extent PTPRR-mediated attenuation of 
TrkA signalling will affect expression levels of NGF-responsive genes in PC12 cells. 
Other PTPs (PTP1B, Shp1, LAR, PTPσ and PTPRZ) also counteract TrkA kinase ac-
tivity and inhibit PC12 cell differentiation [50, 52-55]. PTPBR7 appears ideally suited 
to do so at multiple positions in the downstream pathway; during activation and ret-
rograde transport of TrkA and, more downstream, at the level of activated MAPKs.
PTPRR transcripts are found in the developing brain during mouse embryogen-
esis as well as in the mature brain [32]. Interestingly, mice deficient for PTPRR dis-
play disturbed motor and memory behaviour [37, 38], aspects of brain functioning 
to which also TrkA has been linked [56-59]. Furthermore, TrkA, ERK1/2 and PTPRR 
proteins all contribute to neuronal communication [36, 60-63], hence it would be 
intriguing to study their spatiotemporal dynamics and elucidate whether they share 
specific signalling routes. Our finding that PTPRR represents a multi-level modulator 
of NGF-induced signalling impacting on both ERK1/2 and TrkA, urges for an open 
mind when studying further roles for this PTP in brain development and signal-
ling.        
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SUPPLEMENTARY INFORMATION
Additional materials and methods
Generation of PTPRR variant-containing constructs 
To obtain pENTR-PTPBR7-eGFP, a SalI-NotI fragment from pPTPBR7-EGFP [1] 
was subcloned into pENTR/NotI-XhoII [2]. The mutants pENTR-PTPBR7-C/S-eGFP 
(amino acid position 587 corresponding to Acc.nr. BAA06696), and pENTR-PTP-
BR7-S/D-eGFP and pENTR-PTPBR7-S/A-eGFP (both on amino acid position 338) 
were produced according to the instructions in the QuikChange® Site-Directed 
Mutagenesis protocol (Stratagene), using pENTR-PTPBR7-eGFP as template and 
appropriate sense and antisense primer pairs (listed in supplementary table 1). To 
obtain pENTR-PTPPBSγ, we used pLXSN-PTPPBSγ-IRES-eGFP [3] as template in 
a PCR reaction with primers pLXSN-g+_XhoI sense in combination with pLXSN-
g+_HindIII antisense. The PCR fragment was subsequently XhoI/HindIII-digested 
and subcloned in the corresponding sites in pENTR/NotI-XhoI. Then, to generate 
an eGFP-tagged version of PTPPBSγ, a ScaI-ClaI fragment of pENTR-PTPBR7-eGFP, 
representing the eGFP-tagged C-terminal part of PTPBR7, was subcloned into the 
ScaI-ClaI-digested pENTR-PTPPBSγ. All PTPBR7 and PTPPBSγ-containing con-
structs were transferred from the pENTR vector into the destination vector pLen-
ti6.2/V5-DEST (Invitrogen) by site-specific recombination using the LR ClonaseTM 
II enzyme mix.  
Plasmid pSG8-TrkA-VSV was generated by PCR from a pCDNA3-based plasmid 
containing rat TrkA cDNA [4] using primers CMV sense and TRKA antisense. The 
amplified fragment was digested with EcoRI and XhoI and subcloned into an ap-
proptiate pSG8-VSV-stop vector [5].
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Supplementary figure 1: PTPRR expres-
sion levels in PC12-derived cell lines. 
Lysates of PC12 cells, PC12 cells overex-
pressing PTPBR7, and PC12-shPCPTP1 
cells were used for immunoprecipitation 
using monoclonal anti-PTPRR antibody 
(IP PTPRR). Precipitated proteins were vis-
ualized on Western blot using polyclonal 
anti-PTPRR. Multiple bands indicate post-
translational modifications of the PTPBR7 
protein.
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Supplementary table 1: Primers used during cloning.
Name Sequence (5’ Æ 3’)
C/S sense CCTGTGGTTGTCCACTCCAGTGCGGGGATTGGG
C/S antisense CCCAATCCCCGCACTGGAGTGGACAACCACAGG
S/D sense CCAGGAGCGACGAGGTGACAATGTATCTCTTACGCTG
S/D antisense CAGCGTAAGAGATACATTGTCACCTCGTCGCTCCTGG
S/A sense CCAGGAGCGACGAGGTGCCAATGTATCTCTTACGCTG
S/A antisense CAGCGTAAGAGATACATTGGCACCTCGTCGCTCCTGG
pLXSN-g+_XhoI sense GTTAACTCGAGGATCTGGAG
pLXSN-g+_HindIII antisense GTAAAGCTTCGGAGTCACTC
CMV sense primer GAGGTCTATATAAGCAGAGC
TrkA antisense AGACTCGAGGCCCAGAACGTCCAGGTAACT
D/A sense GTACACTTCATGGCCGGCTCATAAGACTCCAGACAG
D/A antisense CTGTCTGGAGTCTTATGAGCCGGCCATGAAGTGTAC
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ABSTRACT 
Background
Regulation of synaptic connectivity, including long-term depression (LTD), allows 
proper tuning of cellular signalling processes within brain circuitry. In the cerebel-
lum, a key centre for motor coordination, a positive feedback loop that includes 
mitogen-activated protein kinases (MAPKs) is required for proper temporal control 
of LTD at cerebellar Purkinje cell synapses. Here we report that the tyrosine-specific 
MAPK-phosphatase PTPRR plays a role in coordinating the activity of this regulatory 
loop. 
Results
LTD in the cerebellum of Ptprr -/- mice is strongly impeded, in vitro and in vivo. Com-
parison of basal phospho-MAPK levels between wild-type and PTPRR deficient cer-
ebellar slices revealed increased levels in mutants. This high basal phospho-MAPK 
level attenuated further increases in phospho-MAPK during chemical induction of 
LTD, essentially disrupting the positive feedback loop and preventing α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) phosphorylation and 
endocytosis. 
Conclusions
Our findings indicate an important role for PTPRR in maintaining low basal MAPK 
activity in Purkinje cells. This creates an optimal ‘window’ to boost MAPK activity 
following signals that induce LTD, which can then propagate through feed-forward 
signals to cause AMPAR internalization and LTD.
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INTRODUCTION
Neuronal signalling in the brain depends on dynamic changes in the strength 
of synaptic transmission. One of the major mechanisms that regulate synap-
tic strength involves the regulated trafficking of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) into and out of synapses. Increases in 
synaptic AMPARs result in long-term potentiation of synaptic strength and AMPAR 
removal in long-term depression (LTD) [1, 2]. In the cerebellum, Purkinje cells (PCs) 
represent the key output cells that respond to excitatory synaptic signals coming 
from both parallel fibers (PFs) and climbing fibers (CFs) [3, 4]. LTD at the PC syn-
apse occurs upon simultaneous firing of PF and CF [5, 6]. CF activity causes a Ca2+ 
influx through voltage-gated ion channels and sensitizes the PC for the IP3 that is 
produced due to PF stimuli. Collectively, the PF and CF signals lead to Ca2+ release 
from the ER of PCs [7-12]. The transient change in local Ca2+ concentration activates 
a positive feedback loop that transforms the initial transient signal into a long-term 
response that can last for hours or longer [13]. Computational predictions [14, 15] 
and recent experimental studies in cerebellar slices [13, 16] have established the 
key molecular players within this feedback loop (figure 1). 
Simultaneous 
PF and CF activity
PLA2
ERK1/2
RKIP
c-Raf
LTDAMPARPKCCa
MEK1/2
AA
x
2+
PTPRR
Briefly, the Ca2+ levels that occur during LTD induction activate protein kinase C 
(PKC), which in turn phosphorylates the Raf kinase inhibitory protein (RKIP). In the 
unphosphorylated state, RKIP sequesters c-Raf thereby preventing its interaction 
Figure 1: Positive feedback loop model underlying cerebellar LTD. Abbreviations are 
explained in the text. Adapted from [13].
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with and activation of MEK (Mitogen-Activated Protein Kinase / Extracellular Signal-
Regulated Kinase Kinase) [17, 18]. PKC-mediated RKIP phosphorylation thus trig-
gers the sequential activation of the kinase MEK and its downstream target, the 
MAPK ERK. This leads to phospholipase A2 (PLA2) activation [19] and subsequent 
arachidonic acid (AA) release [20], which closes the positive feedback loop by direct 
binding and activation of PKC [21, 22]. The resulting sustained activation of PKC at 
the cell membrane translates into phosphorylation of AMPARs and their subsequent 
internalization [23], effectively causing the depressed PC response to PF input that 
is known as LTD. Aberrations in the above signalling steps or in the control of intra-
cellular Ca2+ levels would be expected to impair LTD regulation and malfunction of 
PC output. Indeed, deficiencies in calcium-binding proteins - such as calretinin, cal-
bindin, and parvalbumin - disturb PC firing and impair LTD [24]. However, our knowl-
edge of the molecular players that regulate the components of the signalling feed-
back loop that leads to AMPAR internalization and cerebellar LTD is still limited. 
One of the key players within the LTD feedback loop is ERK1/2, which is acti-
vated by dual phosphorylation on a specific pair of threonine (Thr-202) and tyrosine 
(Tyr-204) residues within the activation loop [25]. MAPK inhibition can be mediated 
by phosphatases that dephosphorylate specifically phosphoserine and/or phospho-
threonine residues [26, 27]. Some of these phosphatases  [28, 29] are especially 
suited to selectively bind and inactivate MAPKs because of the presence of a ki-
nase interaction motif (KIM) just N-terminal of their phosphatase domain [30]. This 
KIM-mediated interaction not only results in MAPK dephosphorylation and inactiva-
tion, it also mediates sequestration of the MAPK, hence preventing its translocation 
to other cellular compartments [31-34]. Notably, the protein tyrosine phosphatase 
receptor-type R (PTPRR) has been linked to cerebellar function [35]. PTPRR expres-
sion levels are highest in PCs [36] and PTPRR-deficient mice exhibit cerebellum-
associated defects in fine motor coordination and balance skills [37] as well as an 
altered exploratory behaviour [38]. PTPRR preferentially interacts with ERK1/2 [32, 
39-41] and PTPRR-deficient mice have increased ERK1/2 phosphorylation in their 
brain tissue [37].
We hypothesized that PTPRR may be involved in regulating cerebellar LTD in the 
way depicted by the dashed line in figure 1. To test this hypothesis, we examined 
the electrophysiological and molecular consequences of PTPRR deficiency for the 
process of LTD in vitro and in vivo. In cerebellar slices from Ptprr -/- mice we ob-
served significantly elevated ERK1/2 phospholevels under basal conditions, and 
the absence of LTD associated with loss of the increase in phosphorylated ERK1/2 
and AMPAR normally associated with LTD induction. In addition, cerebellar LTD 
was strongly impeded when measured in awake Ptprr -/- mice. We conclude that 
PTPRR allows optimal functioning of the positive feedback loop by maintaining low 
basal ERK1/2 phosphorylation levels, thereby yielding PC responsiveness to LTD-
inducing stimuli. 
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MATERIAL AND METHODS
Solutions, chemicals and antibodies
The following solutions were used (chemicals were obtained from Sigma or Wako, 
unless otherwise specified). Standard Artificial Cerebrospinal Fluid (ACSF): 125 
mM NaCl, 20 mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 2 mM CaCl2, 1.3 mM 
Mg2Cl, and 26 mM NaHCO3; ACSF-PTX: standard ACSF containing 0.1 mM pic-
rotoxin (PTX); K-Glu solution: ACSF-PTX containing 50 mM K+ and 100 μM gluta-
mate; pipette solution: 130 mM potassium gluconate, 2 mM NaCl, 4 mM MgCl2, 
4 mM Na2-ATP, 0.4 mM Na-GTP, 20 mM HEPES (pH 7.2), and 0.25 mM EGTA; lysis 
buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% triton X-100, 100 mM NaF, 2 mM 
Na3VO4, 20 mM Na4P2O7, 1 mM PMSF and protease inhibitor cocktail (Roche Diag-
nostics). For some experiments, the patch pipette solution additionally contained 
10 µM PP1 analog (4-amino-1-tert-butyl-3-(1’-naphthyl)pyrazolo[3,4-d]pyrimidine, 
Merck Millipore).
Primary antibodies (all from Cell Signalling Technology, unless otherwise speci-
fied) were rabbit polyclonal anti-ERK1/2 (#9102), mouse monoclonal anti-pT202/
Y204-ERK1/2 (#9106), mouse monoclonal anti-MEK1/2 (#4694), rabbit monoclonal 
anti-pS217/S221-MEK1/2 (#9154), mouse monoclonal anti-GluA2 (MAB397, Merck 
Millipore), rabbit polyclonal anti-pS880-GluA2 (ab52180, Abcam), rabbit polyclonal 
anti-pY869/Y873/Y876-GluA2 (#3921), rabbit monoclonal anti-Src (#2109), rabbit 
monoclonal anti-pY416-Src (#6943), and rabbit monoclonal anti-GAPDH (#2118). 
For secondary antibodies, goat anti-mouse and goat anti-rabbit antibodies conju-
gated to IRDye680 or IRDye800 fluorescent dyes (LI-COR) were used.
Mice
The generation of Ptprr knockout mice, using 129/Ola ES cells, has been described 
previously [37]. Founder heterozygous male mice have been backcrossed with 
C57BL/6N females for 11 generations. The resulting heterozygous offspring was 
subsequently used for intercrossing, giving rise to Ptprr+/+ (referred to as wild-type), 
Ptprr+/- (heterozygous) and Ptprr -/- mice. Ptprr+/+ mice were intercrossed to produce 
wild-type litters and Ptprr -/- mouse crosses delivered knockout litters, which were 
used for the electrophysiology recordings in cerebellar slices and whole animals. 
The mice used for the immunoblotting experiments were established in the same 
fashion, but after five additional backcrosses, yielding heterozygous offspring that 
was intercrossed to give rise to wild-type and Ptprr -/- litters. For patch clamp record-
ings and immunoblotting experiments, mice 14 to 21 days of age were used.
Mice were housed in a standard room with an artificial 12h light-dark cycle (lights 
on at 7:00h, lights off at 19:00h) in Macrolon type III cages with sawdust bedding, a 
mouse igloo, and nest building material. Food and water were available ad libitum 
and room temperature was 21 °C with controlled humidity. All procedures involving 
animals were approved by the Animal Care Committee of the Radboud University 
Medical Centre, The Netherlands, conforming to the guidelines of the Dutch Coun-
cil for Animal Care and the European Communities Council Directive 2010/63/EU. 
PTPRR is required for Purkinje cell responsiveness in cerebellar long-term depression
57
3 3
Patch clamp recording
Whole-cell patch clamp recordings were made from PCs as described previously 
[13]. Sagittal slices (200 μm thickness) of cerebella from either wild-type or Ptprr-/- 
mice were bathed in standard ACSF containing 0.01 mM bicuculline methochloride 
(Tocris). Patch pipettes (resistance 5-6 MΩ) were filled with pipette solution. Ex-
citatory postsynaptic currents (EPSCs) were evoked in PCs (holding potential of -70 
mV) by activating PFs with a glass stimulating electrode on the surface of the mo-
lecular layer (PF-EPSCs). PF-EPSCs were acquired and analyzed using LTP software 
(W.W. Anderson, Univ. Bristol, UK; [34]) or pClamp software (Molecular Devices). 
To evoke LTD by electrical stimulation (PF&ΔV), PF stimuli were paired with PC de-
polarization (0 mV, 200 ms) 300 times at 1 Hz. For the experiments where the PP1 
analog was included in the patch pipette, LTD stimulation was applied 20-30 min 
after whole-patch clamp was made [46]. Data were accepted if the series resistance 
changed less than 20%, input resistance was greater than 80 MΩ, and holding cur-
rent changed less than 10% during the recording. PF-EPSC decay time constant was 
calculated by fitting with a single exponential decay function.
Immunoblotting
Sagittal slices (200 μm) of cerebella from wild-type or Ptprr -/- mice were bathed at 
37 °C for 30 min and subsequently 1 h at RT in standard ACSF. After incubation 
for 20 min in ACSF-PTX, the slices were transferred to K-Glu solution for 5 min to 
chemically induce LTD, and if required washed with ACSF-PTX for 10 or 20 min. 
Slices (2 per condition) were subsequently homogenized in 100 μl lysisbuffer. Lysis 
was continued on ice for 30 min, followed by centrifugation for 15 min at 14.000 
rpm and 4 °C. Finally, the supernatant fraction was subjected to SDS-PAGE and im-
munoblotting according to standard procedures. Detection and quantification were 
performed using an Odyssey infrared imaging system (LI-COR) and accompanying 
software, respectively.
Electrophysiology in alert mouse
Animals were prepared for chronic recordings of LFP [22]. Mice were anesthetized 
with xylidodihydrothiazin and ketamine. Animals were administered an additional 
dose of xylido-dihydrothiazin (3 mg/kg) and ketamine (30 mg/kg) when they dem-
onstrated agitation or marked increases in respiration or heart rate during the pro-
cedure. In addition, local anesthesia (0.5 mL of 20 mg/mL lidocaine and adrenaline) 
was administered subcutaneously during the soft tissue removal. During surgery, 
two small bolts were cemented perpendicular to the skull to immobilize the head 
during the recording sessions, and a silver reference electrode was placed on the 
surface of the parietal cortex. To allow access to the Crus I and II areas in the cer-
ebellum, an acrylic recording chamber was constructed around a posterior crani-
otomy and covered with a thin layer of bone wax. 
Whisker regions were electrically stimulated with a pair of small cutaneous nee-
dles inserted under the skin (inter-electrode distance 3–4 mm; figure 6A). Electrical 
stimulation consisted of a single square pulse, 0.2 ms in duration and 2 mA current 
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intensity, delivered by an isolation unit (Isoflex, AMPI, Israel) connected to an analog 
pulse generator (Master 8, AMPI, Israel). The amplitude of the current was adjusted 
to avoid overt movements and animal discomfort. LFPs close to the PC layer and PC 
single-unit activity were recorded in response to single electrical stimuli delivered 
at semi-random intervals of 1063 s in the whisker region. An experimental session 
consisted of a 15-min control situation in which single electrical stimuli were given 
at intervals of 10±3 s in the whisker region. This period was immediately followed 
by 10 min of 8-Hz stimulation and then by 30 min of control during which the same 
single stimuli were applied at the same frequency as in the control situation.
Twenty-four hours after anesthesia, alert mice were restrained for the recording 
session. The dura was removed over the cerebellum to expose the tissue in the 
recording chamber. Recordings were performed in the Crus I or II area, and the 
depths of the electrodes were noted. To avoid unnecessary stress for the animals 
and movement artifacts, recording sessions were performed in a quiet room when 
animals were awake and calm. LFP and unitary recordings were performed using 
quartz-insulated, platinum-tungsten fiber microelectrodes with outer and shaft di-
ameters of 80 mm and 25 mm, respectively (Eckhorn system, Thomas Recordings©). 
LFP were filtered at 100 Hz high-pass and 10 kHz low-pass and were stored digitally 
on a computer after conversion with an analog–digital converter (Power 1401, CED©, 
Cambridge, UK). The recorded data were digitized continuously at 20 kHz. Off-line 
analysis and illustrations were performed with Spike2 CED software (CED©, Cam-
bridge, UK). Electrophysiological responses to electrical stimulation in the whisker 
region were assessed by both the configuration of the LFP (which must show P1-N1-
N2-P2-N3 components, figure 6B) and by the identification of appropriate PC firing 
(modulated by spontaneous whisker movements and electrical stimulation).
Statistical analysis
All data are presented as mean values ± SEM. The statistical significance (set at 
p<0.05) of differences between groups was assessed using the independent sam-
ples Student’s t-test or ANOVA repeated measures. When normality could not be 
assumed, Mann-Whitney non parametrical test were used. Statistical procedures 
were performed using GraphPad Prism 4 software package or OriginPro 8.1 soft-
ware. 
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RESULTS
LTD in cerebellar slices is regulated by PTPRR 
To test the involvement of PTPRR in cerebellar LTD, we recorded excitatory postsyn-
aptic currents from PCs in wild-type and Ptprr -/- cerebellar slices while stimulating 
PF synapses (PF-EPSC). While pairing electrical stimulation of PFs together with 
PC depolarization at 1 Hz for 5 min (PF&ΔV) did induce LTD in the wild-type PCs, 
PF&ΔV failed to do so in Ptprr -/- PCs (figure 2A, B). The reduction of PF-EPSC cal-
culated at 30-40 min after PF&ΔV was significantly smaller in the Ptprr -/- PCs than 
that in the wild-type PCs (wild-type: 28.3 ± 6.3% (n=9), Ptprr -/-: 1.6 ± 7.2% (n=9), p 
< 0.05, Student’s t-test).
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Figure 2: The impairment of cerebellar LTD at synapses between parallel fiber and 
Purkinje cells in Ptprr -/- mice. (A) Superimposed PF-EPSCs recorded before (gray line) and 
20 min after (black line) PF&ΔV in PCs of wild-type or Ptprr -/- cerebellar slices. (B) Aver-
aged time course of LTD triggered by PF&ΔV. The LTD was recorded from PCs in wild-type 
(n=9) or Ptprr -/- (n=9) cerebellar slices. PF-EPSC amplitudes are normalized to their mean 
prestimulation level. (C) Amplitudes of PF-EPSCs elicited by PF stimuli of increasing intensity. 
(D) PPF ratios of PF-EPSCs elicited by a pair of PF stimuli with different intervals. (E) Decay 
time constant of PF-EPSC. Error bars represent SEM.
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The PTPRR deficiency may have elevated basal MAPK activity [37] in PCs, there-
by reducing PF-induced EPSCs and preventing PF&ΔV from triggering LTD in the 
Ptprr-/- slices. To consider this possibility, we measured basal PF-EPSCs in PCs of wild-
type and Ptprr -/- cerebellar slices at different stimulus intensities. The relationship be-
tween PF-EPSC amplitude and stimulus intensity was linear and not significantly dif-
ferent between wild-type and Ptprr -/- PCs (figure 2C; p=0.36, two-way ANOVA; n=10 
for wild-type, n=12 for Ptprr -/-). This indicates that loss of PTPRR caused no change 
in the basal amplitude of PF-EPSCs. The paired-pulse facilitation (PPF) ratios were 
also unaltered in Ptprr -/- PCs compared with wild-type PCs (figure 2D; p=0.1, two-
way ANOVA; n=14 for wild-type, n=12 for Ptprr -/-), indicating that the probability of 
glutamate release from presynaptic PF terminals is not affected in Ptprr -/- mice. Fur-
thermore, we determined the PF-EPSC decay time constant in wild-type and  Ptprr -/- 
slices as a measure of AMPAR functional properties [42]. EPSC decay was found to 
be identical in wild-type and Ptprr -/- PCs (figure 2E; p=0.88, Student’s t-test; n=10 
for wild-type, n=12 for Ptprr -/-), suggesting that AMPAR composition is unaltered 
in Ptprr -/- slices. Thus, while the efficacy of basal synaptic transmission and AMPAR 
performance is unaltered in the PCs lacking PTPRR, expression of LTD is impaired. 
These findings suggest a specific role for PTPRR in the regulation of cerebellar LTD. 
PTPRR determines the dynamic range of ERK phosphorylation during 
cerebellar LTD
To determine whether the ability of PTPRR to inhibit MAPK activity [37] is indeed 
relevant for cerebellar LTD, we assessed ERK1/2 activity levels before and after LTD 
in wild-type and Ptprr -/- cerebellar slices (figure 3A). We used a chemical method to 
induce LTD [13, 43-45]: this involved treating cerebellar slices with a solution contain-
ing high K+ and glutamate (K-Glu) to mimic the simultaneous CF-induced membrane 
depolarization and intracellular increase of Ca2+ and the PF-induced mGluR activa-
tion that underlies LTD. This step was followed by subsequent washes of 10 or 20 
minutes to evaluate the effect of removal of the LTD-inducing agent. 
In wild-type cerebellar slices, K-Glu treatment elevated phospho-ERK1/2 levels, 
which returned to basal levels after washout of the chemical stimulants (figure 3A-C). 
Under basal conditions, phospho-ERK1/2 levels were significantly elevated in the 
cerebellar slices of Ptprr -/- mice as compared to wild-type slices (p<0.03, Student’s 
t-test, n=5; figure 3B), which is in line with earlier observations in total cerebella of 
these mice [37]. Elevated phospho-ERK1/2 levels were also detected in the K-Glu-
treated Ptprr -/- slices after subsequent washes (10 min wash: p<0.004, 20 min wash: 
p<0.04, Student’s t-test, n=5). Directly after the K-Glu treatment, however, phospho-
ERK1/2 levels were comparable in wild-type and Ptprr -/- cerebellar slices. This indi-
cates that the net increase in ERK1/2 activity is much lower in Ptprr -/- slices than in 
wild-type slices following chemical induction of LTD. 
To visualize this more directly, the ratio of phospho-ERK1/2 over total ERK1/2 was 
determined and normalized to the ratio under basal conditions (figure 3C). K-Glu 
treatment resulted in a two-fold increase in phospho-ERK1/2 levels in wild-type slices 
(p<0.02, one sample t-test, n=5), which returned to basal levels after wash out of the 
K-Glu solution. 
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Figure 3: ERK and MEK phosphorylation profiles following LTD induction in wild-type 
and Ptprr -/- cerebellar slices. (A) Immunoblot detecting phospho-ERK1/2 (upper panel) and 
total ERK1/2 (lower panel) in cerebellar slices of wild-type and Ptprr -/- mice under basal condi-
tions, after a 5-min stimulation with K-Glu to induce LTD, and following subsequent 10 or 20 
min washing out of K-Glu. Representative images are shown. (B) Quantitative representation 
of phospho-ERK1/2 over total ERK1/2 levels (arbitrary units) in lysates of cerebellar slices as 
determined under (A). Results are presented as mean values and error bars indicate SEM from 
five independent experiments (Student’s t-test, *p<0.05). (C) An alternative quantitative rep-
resentation of the data determined under (A) showing the fold increase of phospho-ERK1/2-
total ERK1/2 ratios in the different samples as compared to the ratio under basal conditions. 
Results are presented as mean values and error bars indicate SEM from five independent 
experiments (Student’s t-test, *p<0.05). (D) Immunoblot detecting phospho-MEK1/2 (upper 
panel) and total MEK1/2 (lower panel) in cerebellar slices of wild-type and Ptprr -/- mice under 
basal conditions, stimulated with K-Glu to induce LTD, or after subsequent wash out of K-Glu 
for 10 or 20 min. Representative images out of five independent experiments are shown. 
(E) Quantification of the ratio of phospho-MEK1/2 over total MEK1/2 levels (arbitrary units) 
from the cerebellar slice lysates as described under (D). Results are presented as mean values 
and error bars indicate SEM from five independent experiments. (F) Quantitative representa-
tion of the fold increase of relative phospho-MEK1/2 levels compared to the relative levels 
under basal conditions as determined in the cerebellar slice lysates described under (D). 
Results are presented as mean values and error bars indicate SEM from five independent 
experiments (Student’s t-test, **p<0.01).
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The net effect of K-Glu treatment of Ptprr -/- slices on phospho-ERK1/2 increase was 
significantly less compared with wild-type slices (p<0.05, Student’s t-test, n=5) and, 
importantly, was not significantly different compared to basal levels. Based on these 
findings, we propose that high basal phospho-ERK1/2 levels in Ptprr -/- cerebellar 
slices occlude a significant increase of ERK1/2 activity upon LTD induction. Thus, in 
wild-type conditions PTPRR serves to provide an optimal window for ERK activation 
by ensuring low basal phosphorylation of ERK1/2.
 
PTPRR does not affect events upstream of MAPK in the positive feedback loop 
To determine whether PTPRR deficiency causes additional deregulation in the posi-
tive feedback cycle that controls cerebellar LTD, we next evaluated MEK1/2 activity 
levels in K-Glu-treated Ptprr -/- and wild-type cerebellar slices. MEK1/2 is an upstream 
activator of ERK1/2 (figure 1) and is activated when phosphorylated at residues Ser-
218 and Ser-222. In contrast to what was found for ERK1/2, PTPRR deficiency had 
no effect on phospho-MEK1/2 levels in the cerebellar slices. Under all conditions 
tested, phospho-MEK1/2 levels were equal in Ptprr -/- and wild-type slices and in 
both cases a significant increase in phospho-MEK levels was discernible upon LTD 
induction (wild-type: p<0.008, Ptprr -/-: p<0.003, one sample t-test, n=5). Phospho-
MEK levels returned to basal levels after washing out the LTD-inducing solution 
(figure 3D-F). These results are in line with PTPRR acting at the level of MAPK in the 
regulatory signalling network, rather than at upstream targets. We thus hypothesize 
that the absence of LTD in PTPRR-deficient cerebellar slices results from the inability 
to translate increased MEK1/2 activity into further activation of the LTD regulatory 
loop, due to insufficient increases in ERK1/2 phosphorylation. As a consequence, 
AMPAR internalization and thus the induction of LTD will be precluded. 
 
PTPRR is required for GluA2-S880 phosphorylation during LTD induction
PKC-mediated phosphorylation of the S880 residue on the GluA2 subunit is known 
to be a critical event during LTD induction, triggering AMPAR internalization by en-
docytosis to depress synaptic transmission [23]. To test whether PTPRR deficiency 
affects this process, we measured phospho-GluA2-S880 levels in cerebellar slices 
of wild-type and Ptprr -/- mice. Under basal conditions, phospho-GluA2-S880 levels 
were comparable in cerebellar slices of wild-type and Ptprr -/- mice (figure 4A-B), 
corroborating that basal AMPAR surface levels are not altered in Ptprr -/- cerebellar 
slices as demonstrated by normal properties of basal PF synaptic transmission in 
PCs from Ptprr -/- mice (figure 2C-E). As expected, chemical LTD induction resulted 
in an increase in GluA2-S880 phosphorylation in wild-type cerebellar slices (p<0.05, 
Student’s t-test, n=5; figure 4B). Importantly, pSer880 levels remained high even 
after removal of the K-Glu solution for 20 min (p<0.05, Student’s t-test, n=5), indi-
cating the expected response to LTD induction. In contrast, phospho-GluA2-S880 
levels in Ptprr -/- slices did not increase during LTD induction and wash out; if any-
thing, they slightly decreased. Compared to wild-type slices, the Ptprr -/- slices con-
sistently demonstrated lower phospho-GluA2-S880 ratios (F(1,8)=5.732, p<0.04, 
ANOVA repeated measures), providing an explanation for the absence of LTD in 
PTPRR deficient PCs.  
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Figure 4: Phosphorylation on GluA2-S880, but not on GluA2- Y869/Y873/Y876, is im-
paired in Ptprr -/- cerebellar slices upon LTD-induction. (A) Immunoblot detecting phos-
pho-S880-GluA2 (upper panel) and total GluA2 (lower panel) in cerebellar slices of wild-type 
and Ptprr -/- mice under basal conditions, stimulated with K-Glu to induce LTD, or after sub-
sequent wash out of K-Glu for 10 or 20 min. (B) Quantitative representation of the relative 
phospho-GluA2 levels, calculated as the ratio of phospho-GluA2 over total GluA2 levels 
(arbitrary units) from the different cerebellar slice lysates as described under (A). Results are 
presented as mean values and error bars indicate SEM from five independent experiments 
(ANOVA repeated measures, *p<0.05). (C) Phospho-Y869/Y873/Y876-GluA2 (upper panel) 
and GAPDH (lower panel) immunoblot detection in wild-type and Ptprr -/-  cerebellar slices un-
der basal conditions, stimulated with K-Glu to induce LTD, or after subsequent washes of 10 
or 20 min. (D) Quantitative representation of the relative p3Y-GluA2 levels, normalized over 
GAPDH levels (arbitrary units) from the different cerebellar slice lysates as described under 
(C). Results are presented as mean values and error bars indicate SEM from four independent 
experiments (ANOVA repeated measures, *p<0.02).
PTPRR impacts LTD via routes other than Src-mediated GluA2 phosphorylation
Src-mediated tyrosine phosphorylation of residue 876 in GluA2 prevents subse-
quent S880 phosphorylation and, thereby, AMPAR endocytosis [46]. We therefore 
asked whether PTPRR deficiency prevents LTD by enhancing phosphorylation of the 
triple-tyrosine motif (3Y; positions 869, 873 and 876) in GluA2. Under basal condi-
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tions, phospho-GluA2-3Y levels in wild-type and Ptprr -/- cerebellar slices were the 
same (figure 4C-D). In wild-type slices, chemical induction of LTD decreased GluA2-
3Y phosphorylation, which is in line with the enhanced GluA2-S880 phosphorylation 
and subsequent LTD. Interestingly, GluA2-3Y dephosphorylation in response to K-
Glu treatment was much more efficient in PTPRR deficient slices (p<0.02, Student’s 
t-test, n=4). This argues against augmented GluA2-3Y phosphorylation as the cause 
for LTD impairment in PTPRR knockout slices.
To further substantiate this notion, we asked whether intracellular application of 
a specific Src family kinase inhibitor, a PP1 analog, would restore LTD in Ptprr -/- cer-
ebellar slices. In line with published observations [46, 47], including the PP1 analog 
in the patch pipette solution did not affect LTD in wild-type slices (figure 5A). The 
reduction of PF-EPSC was 43.6 ± 4.5%, which is not significantly different from the 
reduction observed in the absence of this inhibitor (figure 2B). However, the LTD 
impairment observed in PTPRR-null slices was not rescued by the PP1 analog (figure 
5A, 1.4 ± 2.0%). To further exclude the contribution of aberrant Src signalling to 
the impairment of LTD observed in PTPRR-deficient slices, we examined phospho-
rylation of the autoactivating tyrosine-418 residue in Src, the mouse equivalent of 
chicken Src-Y416. Phospho-Y416 immunostaining declined in wild-type cerebellar 
slices after chemical induction of LTD (figure 5B), in line with a previous report [48]. 
Basal pY416-Src levels in PTPRR deficient slices appeared mildly attenuated (figure 
5B) but this trend did not reach significance. As in wild-type samples, chemical LTD 
induction resulted in a decrease of pY416-Src signal, further excluding Src hyperac-
tivity as a cause for the LTD impairment in Ptprr -/- slices.
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Figure 5: Impairment of cerebellar LTD in Ptprr -/- Purkinje cells does not result from 
Src-family kinase hyperactivity. (A) Averaged time course of PF-EPSC amplitudes trig-
gered by PF&ΔV and normalized to their mean prestimulation level, recorded from PCs in 
wild-type (n=3) or Ptprr -/- (n=3) cerebellar slices while including a Src family kinase inhibi-
tor (PP1 analog) in the patch pipet. (B) Wild-type and Ptprr -/- cerebellar slices under basal 
conditions,stimulated with K-Glu to induce LTD or after subsequent washes of 10 or 20 min 
were used for immunoblot analysis of Src kinase activity, using phospho-Y416-Src (upper 
panel set) and total Src (lower panel set) antibodies. GAPDH immunostaining (lower panel in 
each set) was used for normalization purposes. Representative images out of four independ-
ent experiments are shown.
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Collectively, our findings suggest a disturbed window of ERK1/2 signalling in Ptprr-/- 
mouse brain that leads to failure of proper downstream signalling in the positive 
feedback loop, yielding a reduction in GluA2-S880 phosphorylation. This would 
be predicted to prevent AMPAR internalization from the PC surface, providing a 
mechanism for the impaired LTD observed in the Ptprr -/- mouse cerebellum. 
Abnormal LTD in vivo in alert Ptprr -/- mice
Lastly, we wanted to assess whether the LTD abnormalities observed in cerebellar 
slices also occur in vivo. Therefore we applied a recently developed LTD protocol 
to alert Ptprr -/- animals [49, 50]. We investigated local field potential (LFP) plasticity 
in the PC layer in response to electrical stimulation of the whisker pad before and 
after conditioning trains of stimulation (figure 6A). LFP responses in alert wild-type 
and mutant mice demonstrated the classical P1-N1-N2-P2-N3 components, where 
P1-N1 reflects presynaptic input and N2 and N3 reflect the postsynaptic response 
at the recording site (figure 6B, gray traces). Following 10 min of 8 Hz stimulation, 
the latencies of the N2 and N3 peaks increased in wild-type mice (horizontal arrows 
in figure 6B). Furthermore, a marked decrease in the amplitude of the N3 compo-
nent was observed (see # in figure 6B upper trace). This effect was maximal just after 
conditioning (~50% amplitude decrease) and lasted for over 30 min. In contrast, no 
significant change in N1 or N2 amplitude was observed upon conditioning. The 
long-term alteration of N3 amplitude and latency thus represent read-outs of LTD in 
the cerebellum of alert animals [49, 50]. 
In Ptprr -/- mice, there were striking abnormalities in these signals. As compared 
to wild-type controls, the conditioning protocol had much smaller ability to attenu-
ate the amplitude of the N3 component (see # at bottom trace in figure 6B) and 
the conditioning-induced shifts in the latency of the N2 and N3 components were 
absent in mutant animals (figure 6B). Mean LFP amplitude (figure 6C-E) and latency 
changes (figure 6F-H) were quantified for each of the LFP components (N1, N2 and 
N3) in 6 wild-type and 6 Ptprr -/- animals by comparing averages over each 5 min 
interval before and after 8 Hz stimulation. These analyses revealed reduced changes 
in the amplitude of the N3 component and the complete absence of N2 and N3 
latency shifts. Collectively, these data implicate PTPRR as a physiological regulator 
of PC LTD in alert animals. 
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Figure 6: Experimental design 
and LFP response to electrical 
stimulation of mouse whiskers 
and changes of cerebellar LTD 
in alert mutant mice. (A) Facial 
dermatomes of the whisker re-
gion were electrically stimulated 
with a pair of needles under the 
skin. Sensory information comes 
into the Crus II area from the 
trigeminal nucleus (Tn) in the 
brainstem, which receives affer-
ent signals from the trigeminal 
ganglion (Tg). (B) Early response 
associated with sensory input in 
the cerebellum via the trigeminal 
nucleus is characterized by P1-
N1-N2-P2-N3 components. Av-
eraged superimposed traces of 
the evoked field potential com-
ponents before 8-Hz stimulation 
protocol, (black trace) and 30 
min after 8-Hz stimulation pro-
tocol (gray trace) in control (top) 
and in mutant mice (bottom). Ar-
rowheads indicate shifted laten-
cies of postsynaptic components 
after 8-Hz stimulation. (C-H) 
Time course of N1, N2 and N3 
amplitude (C-E) and latency (F-H) 
changes before (negative time 
periods) and after (positive time 
periods) the 8-Hz stimulation 
protocol (not shown) in 6 Ptprr-/- 
mice and in 6 control mice. Mean 
normalized data represent the 
peak amplitude of the different 
components (C-E) and the time 
difference at peak latency (F-
H) between each 5-min interval 
and the mean value measured 
in control conditions. Significant 
differences between mutant 
and control mice are indicated 
with asterisks (Student’s t-test,
* p<0.05; ** p<0.01; *** p<0.001).
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DISCUSSION 
Cerebellar LTD requires a positive feedback loop (figure 1) that includes MAPK as 
one of its key components [13]. Previous observations that Ptprr -/- mice show in-
creased levels of cerebellar phospho-ERK and exhibit motor coordination deficits 
[37] prompted us to study the role of PTPRR in cerebellar LTD. Our experiments, 
both in alert mice and in ex vivo cerebellar slices, reveal that PTPRR is required for 
cerebellar LTD. This requirement most likely arises from PTPRR keeping basal ERK 
phosphorylation levels low, thereby priming PC responsiveness to LTD-inducing 
stimuli.
Under basal conditions, the amount of postsynaptic AMPARs on the surface of 
PCs is determined by the steady-state activities of exocytotic and endocytotic trans-
port routes [51]. Activity of PFs and CFs results in the net internalization of AMPAR 
from the PC surface, yielding LTD [5, 6]. This effect on AMPARs is ensured by the 
arrangement of several key signalling molecules in a positive feedback loop, includ-
ing the release of RKIP from Raf-1, resulting in the sequential activation of Raf-1, 
MEK, ERK1/2 and PLA2, and consequent AA production [13, 16]. Elimination of an 
ERK1/2 negative regulator, such as PTPRR [32, 37, 40, 41], should augment both 
ERK1/2 activity and AMPAR internalization. Indeed, PTPRR deficiency resulted in an 
increase in basal ERK1/2 activity, which would be expected to alter levels of AMPAR 
at the cell surface. However, our measurements revealed that basal PF-EPSC ampli-
tudes, PPF ratios and PF-EPSC decay time constants were equal for Ptprr -/- and wild-
type PCs, indicating normal levels of synaptic AMPAR and normal synaptic transmis-
sion. Moreover, basal phosphorylation of both the endocytosis-preventing tyrosine 
and the endocytosis-enabling serine in the C-terminus of the GluA2 AMPAR subunit 
was unaffected in Ptprr -/- cerebellar slices, indicating that AMPAR turnover occurs 
normally under basal conditions.      
Rather than determining the basal properties of AMPARs, PTPRR appears to par-
ticipate selectively in the signalling mechanism that leads to LTD induction. Despite 
the fact that basal ERK1/2 phosphorylation is increased in Ptprr -/- slices, this does 
not lead to stronger AMPAR internalization or LTD. Rather, there is an absence of 
LTD in PTPRR-deficient PCs. Although a direct comparison between in vitro and 
in vivo LTD measurements is challenging, it is likely that we are studying the same 
synapses (parallel fiber to PC) in both experimental preparations. One advantage 
of the 8 Hz LTD-inducing protocol is that a single type of sensory input, arising from 
the whisker pad, produces a clear simple spike response in PCs at the latency of N3 
LFP components and this is followed by a complex spike response [50]. During 8 Hz 
stimulation the 2 types of PC input (mossy and climbing fibers) are significantly in-
creased [50], mimicking to some extent the in vitro LTD-inducing stimuli used in the 
present work. The close relationship between PC firing and the N3 components, the 
polarity inversion of this component at the PC layer level and the amplitude reduc-
tion of the N3 component by an antidromic volley applied to the parallel fiber beam 
strongly support the contribution of the parallel fiber-PC synapse to in vivo LTD [50].
 Our electrophysiology data establish absence of LTD in PTPRR deficient PCs. 
Concurrent with these findings, GluA2-S880 phosphorylation, which triggers AM-
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PAR internalization, could not be induced in Ptprr -/- cerebellar slices. Likewise, the 
increased basal ERK1/2 phosphorylation levels in Ptprr -/- cerebellar slices could not 
be further elevated by LTD-inducing conditions: phospho-ERK1/2 levels in Ptprr-/- 
and wild-type slices were identical at this point. Presumably the increased basal 
phospho-ERK1/2 levels reduce the range of phosphorylation that is available for 
maximizing ERK1/2 activity. We hypothesize that it is not the actual ERK1/2 activity 
levels but rather the net increase in activity levels that determines the responsive-
ness of PCs to LTD induction. Indeed it has been reported that enhanced ERK sig-
nalling beyond basal activity levels is required to effectively trigger LTD in cerebellar 
PCs [45]. Furthermore, a requirement for an increase in ERK activity - rather than the 
absolute level of ERK activity - to induce LTD would be consistent with the “leaky 
integrator” model for cerebellar LTD proposed several years ago [52]. Our current 
findings support and extend these notions.
In several other cell signalling studies such an ‘activity increase window’ has been 
proposed to explain surprising results [53, 54]. For instance, neutrophils derived 
from rheumatoid arthritis patients show increased basal MAPK activity levels, but 
cytokine stimulation does not lead to a further increase in MAPK activity and this 
fails to elicit a physiological response [54]. The mechanism by which elevated basal 
MAPK activity could impair induction of effects in which they normally participate 
remains to be uncovered, but some understanding may come from studies in hu-
man muscle cells isolated from diabetic individuals [53]. Normally, insulin adminis-
tration effectively triggers PI3K-dependent tyrosine-phosphorylation of IRS1 in mus-
cle cells, but in cells from diabetic patients a much lower sensitivity was observed. 
Due to increased basal MAPK activity, a considerable portion of IRS1 was phospho-
rylated on its MAPK target site and this reduced its ability to be activated by PI3K 
[53]. Translating this to our current study, it may be that in PTPRR-deficient PCs 
the MAPK hyperactivity under basal conditions has directly or indirectly resulted in 
phosphorylation – i.e. desensitization or inactivation – of components required for 
AMPAR internalization. Alternatively, because PTPRR is able to dephosphorylate 
proteins other than MAPKs (Erkens and Hendriks, unpublished data), the absence 
of PTPRR activity may also impair the AMPAR regulatory machinery via increased 
phosphotyrosine levels of involved proteins. PTPRR has been implicated in the for-
mation and transport of adaptin-coated vesicles in neuronal cells [55], motivating 
further identification of PTPRR substrates in PCs.
Could GluA2 itself be a PTPRR substrate? Efficient AMPAR endocytosis is pre-
vented by tyrosine phosphorylation of the GluA2 subunit by Src-family tyrosine ki-
nases [48]. An elegant study recently showed that GluD2-meditated recruitment of 
the protein tyrosine phosphatase PTPMEG is necessary to dephosphorylate tyrosine 
876 in GluA2 and to allow subsequent serine-880 phosphorylation by activated PKC 
[46]. PTPMEG-null mice display impaired LTD in cerebellar PCs [56]. However, our 
finding of impaired LTD in Ptprr -/- animals argues against a similar role for PTPRR. 
Instead, the absence of Src overactivity and GluA2-Y876 hyperphosphorylation in 
PTPRR-deficient PCs points to a decreased ability to serine-phosphorylate GluA2. 
In addition to its role in regulating LTD induction, PTPRR may also be involved in 
the long-term maintenance of LTD. The observation that inhibition of MAPK activa-
tion completely blocks LTD induced by the PKC-activator TPA [13] suggests that 
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MAPK signalling has an additional role that is independent of PKC. To maintain 
the late phase of LTD (> 60 min after LTD-induction) the synthesis of new proteins 
is required [57]. It is feasible that MAPK, in addition to its central role in the posi-
tive feedback loop, also participates in signalling between active synapses and the 
nucleus. By entering the nucleus and phosphorylating transcription factors, such as 
CREB, that are required for the late phase of LTD [58], MAPK may alter the tran-
scriptional program of the PC. By its capacity to not only dephosphorylate ERK1/2 
but also to prevent its traveling to the nucleus [31, 32], PTPRR thus may be able to 
modulate both the initial and late phases of LTD.
Despite its clear role in cerebellar LTD, it would be too simple to correlate our cur-
rent findings to the disturbed motor locomotive phenotype observed in an earlier 
study [37].  There are indications that LTD is not essential for cerebellar learning and 
motor performance [59]. Moreover, backcrossing our Ptprr -/- mice to the C57BL/6N 
genetic background resulted in the loss of the overt motor defects phenotype that 
we previously observed in Ptprr -/- mice on a mixed 129/C57BL/6 background (our 
unpublished observations), an apparent discrepancy that is more often encountered 
[60]. Genetic background differences also impact the behavioural phenotypes ob-
served in these mice [37, 38]. 
Plasticity in brain regions other than the cerebellum is also determined by pro-
cesses such as long-term potentiation and LTD and these processes also rely on 
MAPK signalling cascades [61, 62]. PTPRR is expressed in brain regions outside the 
cerebellum, most notably hippocampus and olfactory bulb, albeit at much lower 
levels [36, 37, 63-65]. Recently hippocampal defects were observed in Ptprr -/- mice, 
including impaired novel object recognition memory [38]. In other cerebral areas, 
especially in the striatum, a close homolog of PTPRR, STEP, may compensate in 
Ptprr -/- mice. STEP also has MAPKs as substrates [40, 41, 66, 67] and regulates sev-
eral key players involved in synaptic plasticity processes, including the AMPAR [68] 
within the hippocampus. The close functional similarity between PTPRR and STEP 
and their partly overlapping expression pattern in the brain is suggestive of partial 
redundancy of both PTPs in synaptic plasticity signalling processes, and warrants 
further investigation.
Conclusions
We observed a significant impairment of LTD in Ptprr -/- cerebellar PCs, both in vitro 
and in vivo, pointing to an essential role for the MAPK phosphatase PTPRR in neu-
ronal responsiveness and connectivity. PTPRR activity is required for maintaining 
low basal ERK1/2 phosphorylation levels so that proper synaptic signals can trigger 
a substantial increase in MAPK activity and consequent AMPAR internalization and 
LTD initiation. Our findings show that PTPRR-mediated tight control of phosphoryla-
tion-mediated signalling is crucial for normal PC responsiveness. This is an example 
of the intricate molecular machinery that is required to fine-tune neuronal connec-
tivity and thereby maintain proper brain function.
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ABSTRACT
Mouse gene Ptprr encodes multiple protein tyrosine phosphatase receptor type R 
(PTPRR) isoforms that negatively regulate mitogen-activated protein kinase (MAPK) 
signalling pathways. In the mouse brain, PTPRR proteins are expressed in cerebel-
lum, olfactory bulb, hippocampus, amygdala and perirhinal cortex but their precise 
role in these regions remains to be determined. Here, we evaluated phenotypic 
consequences of loss of PTPRR activity and found that basal smell was normal for 
Ptprr -/- mice. Also, spatial learning and fear-associated contextual learning were un-
affected. PTPRR deficiency, however, resulted in impaired novel object recognition 
and a striking increase in exploratory activity in a new environment. The data cor-
roborate the importance of proper control of MAPK signalling in cerebral functions 
and put forward PTPRR as a novel target to modulate synaptic processes.
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INTRODUCTION
Brain functions, such as olfactory bulb-associated smell, hippocampus-dependent 
learning, and cerebellum-related locomotion require proper cellular signalling 
through reversible phosphorylation exerted by kinases and phosphatases. Whereas 
the role of kinases in the brain has been thoroughly studied, insight in the role of 
phosphatases is lagging behind. 
One of the key signalling pathways that are active throughout the entire brain is 
the mitogen-activated protein kinase (MAPK) cascade, which mediates the trans-
duction of extracellular signals to cytoplasmic and nuclear effectors that are impor-
tant in neuronal development and synaptic plasticity [1]. In the olfactory bulb, neu-
rogenesis still occurs in adult life and here odor-induced MAPK activation promotes 
olfaction sensory neuron survival [2]. Long term potentiation and long term depres-
sion, key mechanisms to modulate synaptic responsiveness, in the hippocampus [3, 
4] and cerebellum [5] also rely heavily on MAPK signalling cascades. MAPK’s promi-
nent role in the functioning of whole brain regions is furthermore best illustrated 
by its involvement in olfactory learning [6] and hippocampal memory formation [7]. 
MAPK activation requires phosphorylation on both the threonine and the tyrosine 
residue in its activation loop [8], performed by dual specific MAPK kinases (MAP-
KKs). Therefore, phosphatases specific for serine/threonine (PP phosphatases), for 
tyrosine (classical PTPs), or dual specificity phosphatases (DUSPs) are able to ter-
minate MAPK signalling [9, 10]. In humans, eleven DUSPs [11] and three classical 
PTPs [12] contain a kinase interaction motif (KIM) that enables selective binding 
to dephosphorylate MAPKs [13]. The KIM-mediated interaction not only enables 
dephosphorylation, but also prevents translocation of the MAPK to the nucleus [14-
17]. PTPRR, one of the three KIM-containing PTPs, is specifically enriched in the 
brain and targets the p38, JNK and preferably ERK1/2/5 MAPKs [15, 18-20]. In line 
with this role, increased ERK1/2 phosphorylation levels were found in brain tissue of 
Ptprr -/- mice [21]. While PTPRR transcripts peak in the cerebellum, it is additionally 
expressed at lower levels throughout the rest of the brain, including the olfactory 
bulb, hippocampus, amygdala and perirhinal cortex [22-25]. Earlier, we showed cer-
ebellum-associated defects in fine motor coordination and balance skills for Ptprr 
-/- mice [21]. However, properties linked to the other PTPRR-expressing brain regions 
have not been evaluated thus far. Here, we examined whether PTPRR regulates 
olfactory bulb-associated smell and learning and memory-related tasks that require 
proper functioning of the hippocampus, amygdala and perirhinal cortex. The results 
obtained from a wide range of behavioural tests point at a role for PTPRR in novel 
object recognition memory and exploratory behaviour.
ANIMALS, MATERIALS AND METHODS
Animals and housing
The generation of Ptprr knockout mice, using 129/Ola ES cells, has been described 
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previously [21]. F1 heterozygous male mice have been backcrossed with C57BL/6N 
females for 11 generations. Resulting F12 heterozygous offspring was subsequently 
used for intercrossing, giving rise to Ptprr+/+ (referred to as wild type), Ptprr+/- (het-
erozygous) and Ptprr -/- mice. To establish the F13 (cohorts 1 and 2) mice used for 
behavioural phenotyping, these Ptprr+/+ mice were intercrossed to produce wild 
type litters, and Ptprr -/- mouse crosses delivered knockout litters. Thus, for the F13 
animals included in the experiments the grandparents were all heterozygous litter-
mates. Cohort 3 was established in the same fashion but after four additional back-
crosses, yielding F16 heterozygous offspring and a subsequent F17 population.
Mice were housed in a standard room with an artificial 12h light-dark cycle (lights 
on at 7:00h, lights off at 19:00h) in Macrolon type III cages, 2-4 animals per cage, 
with sawdust bedding, a mouse igloo, and nest building material. Food and water 
were available ad libitum and room temperature was 21 °C with controlled humidity. 
Behavioural tests were performed with wild type and Ptprr -/- male and female 
mice, in an age range between 4-16 months (see supplementary table 1 and sup-
plementary figure 1), and sex- and age-matched per test. Test room conditions had 
a constant luminance of 50 lux. Behavioural scoring occurred between 8:00h and 
16:00h, and was done in a blinded fashion, with the observer in close proximity of 
the animals. The animals were allowed to habituate to the test room at least 30 
minutes prior to the experiment. Following each mouse observation, devices were 
cleaned thoroughly with tap water. All tests have been recorded via camera on DVD.
All procedures involving animals were approved by the Animal Care Committee 
of the Radboud University Medical Centre, The Netherlands, conforming to the 
guidelines of the Dutch Council for Animal Care and the European Communities 
Council Directive 2010/63/EU. 
Behavioural analyses
Smell function
Buried food test – The buried food test [26] was performed in a Macrolon type III 
cage, containing 3 cm sawdust and a honey loop (Kellog’s, the Netherlands) that 
was located in a corner 1 cm from the wall and 1.5 cm under the bedding. Each 
mouse was placed individually in the opposing corner facing the wall and the la-
tency (s) to find the loop was recorded with a time limit of 15 min.  Prior to the test, 
the mice were acquainted with the honey loops by placing one per mouse in the 
home cage for three consecutive days, followed by an overnight fasting period of 
18 hours.   
Olfactory habituation/dishabituation – During the olfactory habituation/dishabita-
tion test [26] each mouse was placed individually in a Macrolon type II cage with a 
layer of sawdust and a flat grid on top. With an inter-trial interval of 1 minute, each 
odor was presented three times for 2 minutes by separate cotton swabs, which were 
enclosed by a cylindrical shaped gauze and placed 4 cm above the bottom. The 
time the mice spent sniffing (s) was recorded and was defined as directing the nose 
to the tip on a distance of 2 cm or closer. Leaning against or climbing in the gauze 
was not considered as exploration. Scent presentation order was as follows: water, 
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almond, banana, social odor 1, and social odor 2. Non-social odors (bought in a 
fishing items store) were freshly prepared by dipping the cotton tip for 5 seconds 
in distilled water or in a solution of almond or banana aroma (1 mg/L). Social odors 
were generated by sweeping the cotton tip for 5 seconds through used cage bed-
ding of 2 distinct cages, housing 2 male mice. The swabs were stored separately in 
airtight bags and kept outside the testing room until use. 
Prior to the experiment, the mice were habituated for 30 minutes in a cage identi-
cal to the test set-up with a dry cotton swab. 
Learning, memory and anxiety function
Morris water maze I – Mice were placed individually in a black pool (120 cm diam-
eter) filled with water (21-22 °C; made opaque by the addition of milk powder), at 
different starting positions and were supposed to find the submerged platform by 
using distant visual cues in the room [27]. The spatial cues were present on the four 
walls in the test room at a distance of ~0.5 m as described earlier [27]. All trials and 
probe tests were recorded on DVD and to facilitate video camera tracing of the 
mouse, a strip of white tape (width 10 cm) was taped along the top/inside perim-
eter of the pool to prevent dark reflection. The 8 cm-diameter round platform was 
placed in the middle of the SE quadrant, submerged 1 cm below the water surface, 
and the latency (s) to find the platform was determined manually. During all trials the 
observer was present and always located in the same position in the room. 
Each mouse performed four acquisition trials (maximal swimming time 120 sec-
onds; 30 seconds on the platform; inter-trial interval 60 minutes) on day 1 and day 
2, followed by 5 trials on day 3. Starting positions were S, N, W, and E. After the trial 
the mice were placed back in their home cage, containing a paper towel for drying. 
A single probe test was performed, directly after the last trial on day 3, with the plat-
form was removed from the swimming pool. Each mouse was individually placed 
in the swimming pool at the N position and allowed to swim for 120 seconds. The 
time spent swimming in the four different quadrants (NE, SE, SW, NW) was deter-
mined, using EthoVision® video tracking software (Noldus Information Technology, 
The Netherlands).
Morris water maze II – In a different variant of the Morris water maze (MWMII), the 
mice received 4 trials (maximal swimming time 120 seconds; 30 seconds on the 
platform; inter-trial interval 60 minutes) on day 1 and 2, 5 trials on day 3 and 2 trials 
on day 4. Per day the platform location was alternated between the NW and the 
NE quadrant. Starting positions were S, N, W, and E. After the trial the mice were 
placed back in their home cage, containing a paper towel for drying. For the probe 
test, which was performed directly after the last trial on day 4, the platform was re-
moved from the swimming pool and, with S as starting position, each mouse was al-
lowed to swim for 120 seconds. Subsequently, the time spent swimming in the four 
different quadrants (NE, SE, SW, NW) was determined. Additionally, the swimming 
tracks (see supplementary figure 2), speed and total path length, were determined 
using EthoVision® video tracking software.
PTPRR deficient mice exhibit increased exploration in a new environment and impaired novel object recognition memory
83
4 4
Fear-associated context learning – The StartFear system (Panlab, S.L.U. Barcelona, 
Spain) with accompanying software was used. The set-up consisted of a sound at-
tenuating cubicle in which a second box  (W 25 cm, L 25 cm, H 25 cm) was placed 
with black methacrylate walls, a transparent front door, and a grid on the floor. The 
grid, delivering the shock, was located on a high sensitivity weight transducer plat-
form, enabling the recording of mouse movements. Footshock, background noise, 
box light and tone were all controlled by Freezing software (v1.3.04 Panlab, S.L.U., 
Barcelona, Spain). The gain of the weight transducer was set at 5000x, the AC filter 
at 0.5 Hz and the gain to the computer at 16x. Freezing, defined as mouse activity 
that is at least 1500 ms below a threshold of 5.5 (arbitrary units), was determined 
automatically using the software. All trials were recorded on DVD. During all ses-
sions the light was on and the speaker delivered 60 dB white noise. 
The protocol, adapted from Balemans et al. [28], consisted of an acquisition trial, 
followed by the context test 24h later and extinction tests 48h and 96h later. In 
the acquisition trial, each mouse was placed individually in the box and allowed to 
explore for 2.5 minutes after which a footshock of 0.75 mA was provided during 2 
seconds. The mouse was removed from the box after 30 seconds and placed back 
in its home cage. During the context and extinction tests, each mouse was placed 
individually in the same set-up for 5 minutes, but no footshock was applied. In all 
trials, freezing was automatically monitored by the software. Prior to the acquisition, 
mice were handled for 7 days. 
Mirrored chamber – The mirrored chamber [29] consisted of 5 mirrored sides (3 
sides, one top and one floor, L 30 cm, W 30 cm, H 30 cm) and one open side, 
forming a box that was placed in a second box, leaving a 5 cm surrounding corridor. 
A sixth mirror was placed on the wall of the second box, facing the open side of the 
mirrored chamber. The walls of the outer box were opaque black and the floor of 
the corridor was white. Luminance was 250 lux in the corridor and 30 lux within the 
mirrored chamber. Each mouse was placed individually in the corner far left from 
the entrance of the mirrored box and was observed for 30 min. The time spent (s) in 
the front and in the back of the mirrored chamber was scored as well as the latency 
to enter (s).
Novel object recognition test – The novel object recognition test [30, 31] was per-
formed in a square open field  (L 50 cm, W 50 cm, H 40 cm) with white plastic walls. 
During trial 1, two identical objects (X1 and X2) were placed in opposite corners at 
approximately 10 cm distance from the wall. Each mouse was placed individually 
in the third corner, facing the wall, and was allowed to explore for 5 minutes. After 
an inter-trial interval (ITI) of 5, 15, 40, or 100 minutes, the mouse was reintroduced 
in the set-up for trial 2 with one similar object (X) and one dissimilar object (Y) as 
compared to trial 1. Again the mouse was allowed to explore for 5 minutes.
Objects used were a grassed glass tea-candleholder (diameter bottom 6.0 cm, 
diameter top 4.5 cm, height 4.5 cm) standing upside down, a grey plastic tube with 
a lid on top (diameter bottom 4.5 cm, diameter top 6.5 cm, height 5.5 cm) filled with 
plaster bandage, a grassed silver bowl (diameter 7.5 cm, height 4.5 cm) standing 
upside down and filled with marbles, and a glass bottle (diameter 2.5 cm, height 8.0 
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cm) filled with sand. The objects were available in triplicate to avoid olfactory trails. 
Object combination, mouse order, ITI and location of the objects were randomized.
Object exploration was defined as directing the nose to the object at a distance 
smaller than 2 cm and/or touching the object with the nose. Sitting on the object 
was not considered as explorative behaviour. Exploration time of object X1 (X1), 
X2 (X2), X (X) and Y (Y) was determined. The total object exploration time during 
trial 1 (e1) and trial 2 (e2) was defined as e1=X1+X2 and e2=X+Y, respectively. The 
discrimination index was calculated using the formula (Y-X)/(X+Y) [31]. 
Explorative and habituation behaviour
Open field – Each mouse was placed individually in a square open field box (L 50 cm, 
W 50 cm, H 40 cm) with white plastic walls for 30 minutes and scored for the time (s) 
spent walking, wall leaning, rearing, sitting, and grooming. These  parameters were 
defined as follows: walking, movement of hind and forepaws with a minimal dis-
tance of 1 cm; wall leaning, standing on hind legs with one or two forepaws against 
the wall; rearing, standing upright on the hind legs, while the forepaws are not 
touching any surface; sitting, no movements of the hind and forepaws; grooming, 
washing (parts of) its body.
Phenotyper cage – Each mouse was individually housed for 3 consecutive days in 
a PhenoTyper® cage (L 45 cm, W 45 cm, H 55 cm; Noldus Information Technology, 
The Netherlands), containing transparent walls, air holes, sawdust as bedding, and 
an immobile shelter. Each cage contained a top unit with a digital video camera and 
infrared lights. With 8 phenotyper cages in the test room, 8 mice (4 of each geno-
type group) could be observed individually at the same time. The distance moved 
(cm) per hour was acquired by EthoVision® video tracking software.
Statistics 
All data are presented as means ± SEM. Data were assembled using three differ-
ent cohorts and the order of behavioural tests, the age at the time of testing, and 
the corresponding paragraph in the Results section are included in supplementary 
figure 1 and supplementary table 1. When mice with different age and/or sex re-
vealed comparable results per test and per genotype group, the data of the dis-
tinct cohorts were pooled. The statistical significance (set at p<0.05) of differences 
between groups was assessed using the independent samples Student’s t-test, one 
sample Student’s t-test, or ANOVA repeated measures test for (multiple) factorial 
analyses. Statistical procedures were performed using GraphPad Prism 4 and the 
SPSS statistics 20 software package. 
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RESULTS 
Ptprr -/- mice display normal smell function in the buried food test
To evaluate global olfactory bulb function in Ptprr -/- mice, general smell ability was 
assessed with the buried food test [26]. Wild type mice (n=10) found the hidden 
treat within 61.79 ± 14.38 s. The latency of Ptprr -/- mice (n=10) to find the treat 
was 70.44 ± 19.04 s, revealing no significant difference between the two genotype 
groups, indicating that general smell function and scent-associated exploration is 
unaffected in Ptprr-/- mice. 
Ptprr -/- mice exhibit the ability to discriminate odors in the olfactory 
habituation/dishabituation test 
Then, to study olfactory discriminative functions in Ptprr -/- mice, we performed 
the olfactory habituation/dishabituation test [26]. Wild type (n=9) and Ptprr -/- 
(n=9) mice demonstrate active sniffing during the entire 2 min presentation 
of a cotton swab saturated with water, almond scent or banana scent (figure 1). 
Upon repeated presentation of the same scent, these mice demonstrated re-
duced sniffing activity (water: F(1,16)=86.629, p<0.001; almond: F(1,16)=32.144, 
p<0.001, ANOVA repeated measures, effect of odor trial), illustrating habituation. 
 
Figure 1: Olfactory habituation/dishabituation test. Habituation and discrimination be-
tween familiar and novel odors, respectively, was tested by sequential 2 min presentations 
of three non-social odors (water, almond, banana) and two social odors (wipes from two dif-
ferent cages) to wild type (+/+, n=9) and Ptprr  -/- (-/-, n=9) mice. The time spent sniffing (s) 
was recorded for each individual mouse. For both genotype groups, a significant decline or 
increase is indicated by a p<0.003 or b p<0.02, respectively.
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Each time a new odor was presented, a significant increase in sniffing was observed 
(almond: F(1,16)=39.443, p<0.001; banana: F(1,16)=7.183, p<0.02, ANOVA repeat-
ed measures, effect of odor trial), a phenomenon that we interpret as dishabitu-
ation. Compared with the sniffing behaviour towards the three non-social odors, 
both genotype groups displayed a strong increase in sniffing towards social odor 1 
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(cage bedding scent of a foreign cage; F(1,16)=26.502, p<0.001, ANOVA repeated 
measures, effect of odor trial). Again, repeated odor presentation resulted in habitu-
ation (social 1: F(1,16)=27.978, p<0.001; social 2: F(1,16)=12.039, p<0.003, ANO-
VA repeated measures, effect of odor trial) and introduction of social odor 2 (cage 
bedding scent of second foreign cage) in dishabituation (F(1,16)=11.578, p<0.004, 
ANOVA repeated measures, effect of odor trial), as shown in figure 1. 
This test revealed similar results for Ptprr -/- and wild type mice, illustrating that 
 Ptprr -/- mice are able to distinguish different odors, further proving that general 
smell function is not affected in these animals.  
 
Ptprr -/- mice show normal spatial learning in the Morris water maze
To address hippocampus-associated spatial learning, we subjected wild type and 
Ptprr -/- mice to the classical Morris water maze [32], here named Morris water maze 
I (MWMI). During the acquisition, both genotype groups (wild type: n=30, Ptprr -/-: 
n=31) showed a similar and significant decline in escape latency (F(1, 59)=196.629, 
p<0.001, ANOVA repeated measures, effect of time) upon repeated trials to find 
the submerged platform (figure 2A), illustrating that both wild type and Ptprr -/- mice 
learned the platform location. This was further emphasized by the subsequent 
MWMI probe test, in which wild type (n=19) and Ptprr -/- mice (n=20) performed 
equally in showing a significantly increased swimming time in the target quadrant 
when compared to the 25% chance level (p<0.01, one sample t-test; figure 2C).  
To challenge hippocampus function, we used a Morris water maze variant (MW-
MII) in which the platform location was alternated between the NW and NE quad-
rant every day. Both wild type (n=29) and Ptprr -/- (n=30) mice showed similar learn-
ing curves at day 1 and 2 and an overall reduced escape latency at day 3 and 4 of 
the acquisition (Trial 1-15: F(1, 57)=40.215, p<0.001, ANOVA repeated measures, 
effect of time; figure 2B). Also in the MWMII probe test, wild type and Ptprr -/- mice 
(n=29 per genotype group) performed equally and exhibited a significant prefer-
ence for the NE target quadrant (p<0.01, one sample t-test; figure 2D), which was 
the last acquisition platform location. In addition, wild type animals also preferen-
tially visited the NW quadrant (p<0.05; figure 2D). During the 2 minutes of the MW-
MII probe test, both genotype groups swam an equal distance (wild type: 2665 ± 
85 cm,  Ptprr -/-: 2661 ± 64 cm) and with similar velocity (wild type: 22.3 ± 0.71 cm/s, 
Ptprr -/-: 22.2 ± 0.53 cm/s), as was evaluated for the wild type (n=10) and Ptprr -/- 
(n=10) mice of cohort 3. Representative examples of swim tracks during the MWMII 
probe are shown for both genotype groups (n=9) from cohort 3 in Supplementary 
figure 2. No obvious thigmotaxis, nor differences in used search strategies, were 
observed in either genotype group. 
In conclusion, these results demonstrate that hippocampus-involved spatial 
learning is not altered in Ptprr -/- mice using the applied MWM repetitive paradigm. 
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Figure 2: Morris water maze I and II. (A) Escape latency (s) to find a submerged platform 
in the SE quadrant was measured for wild type (+/+, n=30) and Ptprr  -/- (-/-, n=31) mice in the 
classical Morris water maze I  during 3 consecutive days (4 or 5 trials per day). (B) Latency was 
also measured in the Morris water maze II variant (+/+ n=29, -/- n=30) in which the platform 
location was alternated between the NW and NE quadrant, during 4 consecutive days (2, 
4, or 5 trials per day). (C,D) In the probe test following MWM I (+/+ n=19, -/- n=20; C) and 
MWM II (+/+ n=29, -/- n=29; D), the platform was removed and the fraction of time spent 
swimming in each of the four quadrants was determined. Black and grey arrow indicates for-
mer and former last platform location, respectively. Performances significantly above chance 
level (25%) are indicated with asterisks (* p<0.05; ** p<0.01; *** p<0.001).
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Ptprr -/- mice exhibited fear-associated learning with increased context-
induced freezing, but normal extinction behaviour
Fear-associated context learning, which requires proper amygdala and hippocam-
pus function [33, 34], was addressed by means of a fear conditioning test [28]. At 
the start of the acquisition trial, general freezing behaviour is low in both wild type 
and Ptprr -/- mice (figure 3A). Just one footshock was sufficient for the mice to learn 
the association between the context and the aversive stimulus. During the acquisi-
tion trial, wild type mice demonstrated freezing for 47.9 ± 5.9 % and Ptprr -/- mice 
for 43.0 ± 5.3 % of the 30 seconds time period directly following the footshock, 
after which the animals were placed back in the home cage. Wild type mice also 
demonstrated elevated freezing behaviour during a 5 min context test, performed 
24h later, when compared with their basal pre-shock freezing levels (20.9 ± 4.02 % 
versus 1.4 ± 0.46 %, p<0.001, students t-test; figure 3A). Freezing diminished in the 
extinction tests at 48h and 96h after the acquisition, down to ~11 % of total time. 
Ptprr -/- mice, like wild type animals, showed significant freezing behaviour in the 
context test 24h after the single foot shock (38.0 ± 6.4 % compared to 1.9 ± 0.34 
%, p<0.001, students t-test) and also displayed extinction of freezing behaviour at 
48h and 96h (down to ~8 % of total time). Surprisingly, the fraction of time spent 
 freezing during the 24h context test by the Ptprr -/- mice was significantly exceeding 
that of wild type mice (p<0.04, students t-test; figure 3A). The 24h freezing level 
data, when presented as five subsequent 1-min scoring intervals, revealed that all 
animals show less freezing in the first interval as compared to the following four 
intervals (figure 3B; effect of time F(4,76)=4.226, p<0.004). 
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Figure 3: Fear- associated context learning. (A) During the acquisition at day 1, wild type 
(+/+, n=10) and Ptprr -/- (-/-, n=11) mice received one single footshock. Fear-associated con-
text memory was tested 24h later by introducing the animals in the same context without 
footshock. Fear extinction was evaluated 48h and 96h later. In all trials, the fraction of time 
freezing (% of total time) was determined. Post-shock values were significantly different from 
baseline pre-shock freezing levels (p<0.001, as indicated by “a”). Asterisk indicates that con-
text test freezing levels of Ptprr  -/- mice differed significantly from that of wild type controls 
(p<0.04). (B) The fraction of time freezing (in % of total time) is depicted for five successive 
1-min intervals during the context test. Ptprr -/- mice significantly differ in their freezing levels 
from wild type animals, as indicated by the asterisk (p<0.04).  
PTPRR deficient mice exhibit increased exploration in a new environment and impaired novel object recognition memory
89
4 4
Both groups show a similar freezing slope (genotype x time effect F(4,76)=0.343, 
p<0.848, n.s.). However, a genotype effect is apparent (F(1,19)=4.906, p<0.04, 
ANOVA repeated measures), with Ptprr -/- mice demonstrating significantly higher 
freezing levels than wild type mice during all five 1-min intervals of the 24h context 
test.  
Thus, both genotype groups show fear-associated learning followed by extinc-
tion, with the Ptprr -/- mice having a higher freezing response when exposed to the 
context 24h after the aversive stimulus. 
 
No indications for increased anxiety of Ptprr -/- mice in the mirrored chamber
The increased freezing reaction of Ptprr -/- mice in the fear conditioning context test 
may be due to increased anxiety as compared to wild type controls. We therefore 
used the mirrored chamber as an environment to test anxiety [29]. The total time 
that the mice spent in the mirrored chamber, however, did not differ between wild 
type (n=9) and Ptprr -/- (n=10) mice (figure 4). Furthermore, both genotype groups 
spent equal time in the back of the mirrored chamber, which is considered the most 
anxious region. Also, the finding that the latency to enter the mirrored chamber 
(data not shown) was significantly lower for Ptprr -/- mice (42.4 ± 12.2 s, p<0.001) 
than for wild type animals (144.7 ± 23.6 s) argues against an increased anxiety for 
Ptprr -/- mice.
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Figure 4: Mirror box. Individual wild 
type (+/+, n=9) and Ptprr  -/- (-/-, n=10) 
mice were placed in one corner of the 
alley surrounding the mirrored cham-
ber and the time (s) spent in the front, 
the back, and the total area of the mir-
rored chamber was recorded over a 30 
minute period.
Ptprr -/- mice exhibit impaired novel object recognition memory
To study hippocampus- and partly perirhinal cortex-associated learning without in-
volvement of any aversive stimuli, we performed the novel object recognition test 
[30, 31], which is based on the animal’s intrinsic property to explore a new object 
more than a familiar one. During the 5 minutes of trial 1, wild type (n=30) and Ptprr-/- 
(n=31) mice spent equal time exploring the two identical objects (table 1). For the 
5-minute trial 2, the animals were reintroduced in the set-up after an inter-trial inter-
val (ITI) of 5, 15, 40 or 100 minutes (figure 5A), respectively, and allowed to explore 
one familiar (X) and one novel object (Y). For the 5-minute ITI, both wild type and 
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Ptprr -/- mice displayed a preference, i.e. an exploration time fraction significantly 
larger than 50%, for the novel object Y (p<0.01, one sample t-test; figure 5B). How-
ever, whereas wild type controls still showed significantly more exploration towards 
object Y after ITIs up to 100 minutes, Ptprr -/- mice lost this propensity already after 
an ITI of 15 minutes. Overall, Ptprr -/- mice showed significantly less preference to-
wards the new object Y (ITI 5-100: F(1, 59)=4.788, p<0.03, ANOVA repeated meas-
ures for genotype x ITI). This difference was most pronounced at ITIs 15-100 (F(1, 
59)=7.868, p<0.007, ANOVA repeated measures for genotype x ITI). At an ITI of 40 
minutes, Ptprr -/- mice did spend more time exploring object Y but this preference 
was significantly less than that of wild type animals (p<0.04, students t-test). 
Table 1: Object exploration time in the novel object recognition test.  
Trial 1 Wild type 
(n=30)
Ptprr -/- 
(n=31)
ITIg 
(min)
Trial 2 Wild type 
(n=30)
Ptprr -/-
(n=31)
 X1a (s) 10.7 ± 0.83 8.84 ± 1.1 5  Xc (s) 5.53 ± 0.71 4.91±0.71s
 X2b (s) 8.07±0.81* 7.45 ± 0.91  Yd (s) 9.20±0.91** 9.81± 1.0***
e1e (s) 18.8 ± 1.4 16.3 ± 1.5 e2f (s) 14.7 ± 1.4 14.7 ± 1.3 
 X1a (s) 10.7 ± 0.97 10.6 ± 1.1 15  Xc (s) 7.26 ± 0.80 9.45 ± 0.89 
 X2b (s) 8.41 ± 0.76 8.89 ± 1.1  Yd (s) 11.8± 1.1** 12.2 ± 1.1 
e1e (s) 19.2 ± 1.6 19.5 ±1.9 e2f (s) 19.0 ± 1.6 21.6 ± 1.7 
 X1a (s) 10.9 ± 0.83 10.9 ± 0.88 40  Xc (s) 9.19 ± 1.1 10.2 ± 0.85 
 X2b (s) 10.3 ± 1.1 10.1 ± 0.71  Yd (s) 18.0± 1.6*** 14.1 ± 1.1**
e1e (s) 21.2 ± 1.7 21.0 ± 1.3 e2f (s) 27.1 ± 2.2 24.3 ± 1.6 
 X1a (s) 9.09 ± 1.1 9.41 ± 0.88 100  Xc (s) 7.40 ± 0.67 7.56 ± 0.71 
 X2b (s) 7.85 ± 0.84 7.52 ± 0.79  Yd (s) 10.5± 0.98* 9.78 ± 1.1 
e1e (s) 16.9 ± 1.8 16.9 ± 1.6 e2f (s) 17.9 ± 1.4 17.3 ± 1.5 
a, b, c, d Exploration time in seconds of object X1, X2, X and Y, respectively 
e e1=X1+X2
f e2=X+Y 
g inter-trial interval in minutes
Significant differences within one genotype group between X1 and X2 (trial 1) and between 
X and Y (trial 2) are indicated by * p<0.05, ** p<0.01 and *** p<0.001
The total exploration time (X+Y, e2) was similar between the two genotype groups, 
but differed per ITI (table 1). To correct for e2, the discrimination index was calcu-
lated from the exploration time (s) of object X (X) and Y (Y) during trial 2, using the 
formula (Y-X)/(X+Y) (figure 5C). Whereas the discrimination index was equal for wild 
type and Ptprr -/- mice at an ITI of 5 minutes, it was significantly lower for Ptprr -/- mice 
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at an ITI of 15-100 minutes (F(1,59)=6.856, p<0.011, ANOVA repeated measures, 
genotype x ITI effect). Both the lower object Y exploration time fraction (%) and 
the lower discrimination index indicate an impairment of novel object recognition 
memory for these Ptprr -/- mice.
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Figure 5: Novel object recogni-
tion test. (A) Individual mice were 
allowed to explore two similar 
objects (X1 and X2) for 5 minutes 
(Trial 1). After an inter-trial interval 
(ITI) of 5, 15, 40 or 100 minutes, 
respectively, the mice were re-
introduced in the same environ-
ment and allowed to explore a 
familiar object (X) and a new ob-
ject (Y) for again 5 min (Trial 2). 
Resulting raw data (in seconds) 
are summarized in table 1. (B) The 
time spent exploring object Y (Y) 
as percentage of the total object 
exploration time (e2) is depicted 
for wild type (+/+, n=30) and 
Ptprr -/- (-/-, n=31) mice and for the 
various ITIs. Novel object explo-
ration that significantly (p<0.01) 
exceeded the 50% chance level 
is indicated with “a”. Significant 
differences between wild type 
and Ptprr -/- mice are indicated 
with * (p<0.03), ** (p<0.007), and 
# (p<0.04) signs, respectively. (C) 
The discrimination index, calcu-
lated from the exploration time of 
object X (X) and Y (Y) during Trial 
2 using the formula (Y-X)/(X+Y), is 
plotted against the ITI for the two 
genotype groups. The asterisk 
reflects the significant difference 
between wild type and PTPRR de-
ficient mice (p<0.011).
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Ptprr -/- mice display increased active exploration in the open field
The disability of Ptprr-/- mice to distinguish a new from a familiar object after 15 min-
utes or longer, prompted us to evaluate explorative behaviour for a 30 min period in 
these mice. In the open field, both wild type (n= 20) and Ptprr -/- (n=21) mice spent 
most of their time sitting and walking, and relatively less time on grooming, leaning 
and rearing (figure 6A). Interestingly, when compared to wild type controls, Ptprr -/- 
mice spent significantly more time walking (p<0.006, Student’s t-test) and displayed 
a trend towards more leaning and rearing. Concomitantly, sitting and grooming, be-
haviour associated with habituation was significantly reduced in Ptprr-/- mice (sitting: 
p<0.04, grooming: p<0.03, Student’s t-test). Also when determining the total time 
spent walking, leaning and rearing over three consecutive periods of 10 minutes, 
Ptprr -/- mice spent significantly more time on explorative behaviour than their wild 
type controls (F(1, 39)=7.172, p<0.011, ANOVA repeated measures, genotype x 
time; figure 6B). This illustrated increased explorative activity over long periods of 
time by Ptprr -/- mice when exposed to new environments.   
Figure 6: Open field. (A) The time (s) spent on walking, wall leaning, and rearing (i.e. explo-
ration), as well as sitting and grooming (i.e. habituation) in an open field set-up was scored 
during 30 minutes for individual wild type (+/+, n=20) and Ptprr  -/- (-/-, n=21) mice. Significant 
differences in sitting and grooming (p<0.05) and in walking (p<0.01) behaviour by the two 
genotype groups are indicated with one and two asterisks, respectively. (B) Total exploration 
time (the sum of walking, leaning, and rearing; s) is depicted for the three consecutive peri-
ods of 10 minutes. A significant difference between the genotype groups is indicated with 
an asterisk (p<0.011).
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Ptprr -/- mice demonstrate increased exploration in the phenotyper cage
In the phenotyper cages we studied night and day activity of wild type (n=18) and 
Ptprr -/- (n=19) mice, measured as distance moved per hour, over a period of 3 con-
secutive days. Both groups displayed a clear day/night rhythm as illustrated by high 
activity during the nights (wild type: 3973 ± 852 cm, Ptprr -/-: 4984 ± 1217 cm) and 
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low activity in daytime (wild type: 1236 ± 260 cm, Ptprr -/-: 1615 ± 127 cm). For wild 
type mice activity levels peak during the first hours in the phenotypers, decrease 
over time during the first night, and decrease further during the second and third 
night (figure 7 and inset), illustrating habituation to the new environment. Although 
Ptprr -/- mice displayed a similar trend of gradually decreasing activity over the 
nights 1-3, the animals walked significantly more during the three nights (p<0.004, 
F(1,35)=9.261, ANOVA repeated measures, genotype x night; inset figure 7). Note 
that Ptprr -/- mice walked significantly longer distances during the whole first (F(1, 
35)=6.588, p<0.015), the whole second (F(1, 35)=7.361, p<0.01) and the whole 
third (F(1, 35)=7.168, p<0.011) night, as determined by ANOVA repeated measures 
(genotype x time effect; figure 7). This further strengthens the notion that Ptprr -/- 
mice exhibit lasting increased exploration in a new environment.  
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Figure 7: Phenotyper cages. Day (white area) and night (dark area) activity, depicted as 
distance moved per hour (in cm), was recorded during 62 hours for wild type (+/+, n=18) 
and Ptprr -/- (-/-, n=19) mice using individual phenotyper cages. Inset shows the average night 
activity (average distance moved per hour, in cm) during 3 consecutive nights. For each night 
(p<0.02) and for the total three-night period (p<0.004) the significant difference between 
wild type and Ptprr -/- mice is indicated by one and two asterisks, respectively.
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DISCUSSION 
PTPRR expression in the hippocampus, amygdala, perirhinal cortex and the olfactory 
bulb prompted us to study behaviour related to these brain regions in Ptprr -/- mice. 
Here we report that these animals demonstrate normal olfactory bulb-related sense 
of smell but display impaired novel object recognition memory and an increased 
exploration of new environments. 
The hippocampus is one of the major players in distinct memory- and learning-
related tasks including exploration of, and habituation to, a new environment [35], 
spatial learning [32], fear-associated contextual learning [33, 34], and novel object 
recognition [36, 37]. When examining adaptive and explorative behaviour of Ptprr 
-/- mice in the phenotyper cage, they displayed high locomotion activity during the 
nocturnal period and low activity during the day as has been shown for C57BL/6 wild 
type mice [28], indicating that PTPRR deficiency does not influence circadian rhythm. 
Strikingly however, PTPRR knockout led to endured elevated activity levels. This 
phenomenon was also observed in the open field test, in which Ptprr -/- mice explore 
the new environment more persistently than wild type controls. 
Previously, no significant difference was found in open field exploration between 
Ptprr -/- mice and their wild type controls, while in an activity cage reduced basal night 
activity for Ptprr -/- mice was reported [21]. This apparent discrepancy with the current 
results may be explained by the different genetic backgrounds of the cohorts that 
were tested [38]. In the current study, the mice were on an almost pure C57BL/6N 
background as a result of at least 11 backcrossings, whereas the previously tested 
mice were generation F3 animals, which still carried a considerable mouse 129/Ola 
genetic contribution and presumably therefore behaved more passively [39].
Lack of PTPRR expression in the hippocampus did not result in deficits in spatial 
learning as assessed using the classical MWMI or the MWMII variant. Other studies 
do link hippocampus-associated spatial learning to protein tyrosine phosphatases, 
including LAR [27], PTP1B [40], RPTPζ [41], PTPδ [42] and STEP [43]. Of these PTPs, 
STEP is the closest homolog of PTPRR, with also the MAPKs as target [18, 20, 44]. 
STEP expression levels are highest in striatum [45, 46], moderate in other brain re-
gions [47], but is absent from the cerebellum. Because both PTPRR and STEP are 
expressed in the hippocampus it could be that partial redundancy accounts for the 
rather mild spatial learning effect in STEP deficient mice [43] and the absence of 
such a phenotypic effect in Ptprr -/- mice. Furthermore, KIM-containing dual specific-
ity phosphatases expressed in the hippocampus may also act compensatory and 
attenuate functional consequences [11, 22].
Fear-associated contextual learning is mainly mediated by the hippocampus, cor-
tex and amygdala [33, 34]. These three areas do express PTPRR, but the Ptprr -/- mice 
are well capable of fear-associated contextual learning and subsequent extinction of 
this memory. This may be due to compensatory actions of STEP. Interestingly, STEP 
knockout mice showed a mild improvement of fear associated learning [48, 49]. 
Remarkably, Ptprr -/- mice displayed elevated freezing behaviour in the context test. 
While for other mouse models such increased freezing behaviour in the context test 
could be linked to anxious behaviour [28, 50, 51], Ptprr -/- mice did not show elevated 
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anxiety in the mirrored chamber as compared to wild type mice. 
The novel object recognition task is dependent on well-functioning of the PTPRR-
containing brain regions hippocampus and perirhinal cortex [36, 37, 52]. This test 
is based on the animal’s innate preference for novelty and is used to study recogni-
tion memory [30]. Notably, this particular test was based on real-time object sniffing 
 during 5 min periods, therefore exploration behaviour of the entire environment was 
not evaluated. Our recognition study demonstrated that Ptprr -/- mice were ham-
pered in novel object recognition when using ITIs from 15 to 100 minutes. These 
results suggest an impaired memory function in Ptprr -/- mice and point toward dis-
turbed hippocampus functioning.  
Collectively, a role for PTPRR proteins in adaptation to and recognition of new 
objects and environments was demonstrated in many of the behavioural tests per-
formed. Through which mechanism can PTPRR isoforms contribute to these specific 
brain functions? Could the observed phenotype be attributed to the influence of 
PTPRR on MAPK signalling? PTPRR variants interact with and dephosphorylate the 
MAPKs ERK1 and ERK2, and to a lesser extent p38, JNK, and ERK5 [15, 18-20]. In 
line, both ERK1 and ERK2 are hyperphosphorylated in the brains of mice deficient 
for PTPRR [21]. Interestingly, some of the findings we obtained with Ptprr -/- mice 
were reminiscent of those in ERK1 knockout mice. ERK1 deficient animals did not 
show any deficits in fear-associated learning but were more active in the open field 
[53]. Homozygous knockout of ERK2 is embryonic lethal but a knockdown of ERK2 
did result in viable mice that presented with clear memory defects but a normal 
explorative behaviour [54]. A mouse model with a conditional knockout of ERK5 in 
neural stem cells during development revealed a normal basal smell function, but 
these mice were hampered in their ability to distinguish between structurally similar 
odors [55]. PTPRR deficient mice also displayed normal basal smell but extensive 
testing of odor discrimination capacity has not been performed. Finally, mice de-
ficient for ASK-1, a MAPK kinase kinase family member that acts upstream of JNK 
and p38, also exhibited hyperactivity in a novel environment and impairment of 
novelty preference [56]. Thus indeed, altered MAPK signalling cascades in PTPRR 
mice might underlie the observed hippocampus-dependent exploration and mem-
ory function deficits. 
In conclusion, our data disclose a distinct role for PTPRR in recognition memory 
and exploration of a new environment. Contributory roles in regulating neuronal 
processes in other brain areas may well be masked due to redundancy with other 
MAPK phosphatases, most notably STEP. More detailed cellular and animal stud-
ies using combined knock-out or knock-down of multiple MAPK phosphatases are 
therefore eagerly awaited.
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 SUPPLEMENTARY INFORMATION
Additional animals, materials and methods
Supplementary table 1: Experimental setup   
Test Cohort gender Age 
(months)
Wild type 
(n)
Ptprr -/- (n)
Buried food test 2 ♀ 14 10 10
OHT 2 ♀ 15 9 9
MWMI acquisi-
tion
1
2
3
♂
♀
♂
5
13
4
10
10
10
10
10
11
MWMI probe 1
2
♂
♀
5
13
10
9
10
10
MWMII acquisi-
tion
1
2
3
♂
♀
♂
8
13
4
10
9
10
10
10
10
MWMII probe 1
2
3
♂
♀
♂
8
13
4
10
9
10
9
10
10
Fear-associated 
context learning
3 ♂ 10 10 11
Mirrored cham-
ber
1 ♂ 9 9 10
NOR 1
2
3
♂
♀
♂
11
14
6
10
10
10
10
10
11
Open field 1
3
♂
♂
10
5
10
10
10
11
Phenotyper cage 1
2
3
♂
♀
♂
6
16
4-7
8
4
6
8
4
7
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Supplementary figure 1: Experimental design. The order of behavioural tests (indicated at 
arrows) for cohort 1 (males), cohort 2 (females), and cohort 3 (males). The age of the mice at 
time of testing is depicted in months. 
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SUPPLEMENTARY DATA
Supplementary figure 2: 
Swim tracks of Morris wa-
ter maze II probe. Swim 
tracks were recorded dur-
ing the MWMII probe in 
which mice were allowed 
to swim for 2 minutes, while 
no platform was available. 
Track images from 9 wild 
type (upper part) and 9 
Ptprr-/- (lower half) mice of 
one cohort are shown. Dur-
ing the preceding MWMII 
acquisition, the platform 
location was alternated 
between the NW and NE 
quadrant, with the latter as 
final position. 
PTPRR deficient mice exhibit increased exploration in a new environment and impaired novel object recognition memory
103
4 4

Human PTPRR 
(Protein Tyrosine Phosphatase Receptor Type R)
Chapter 5
Mirthe Erkens*, Hubertus Kremer◊, Rafael Pulido‡, Wiljan Hendriks*
* Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Rad-
boud University Nijmegen Medical Centre, Nijmegen, The Netherlands 
◊ Department of Neurology, University Medical Center Groningen, The Nether-
lands 
 ‡ IKERBASQUE, Basque Foundation for Science, Bilbao, Spain; BioCruces Health 
Research Institute, Barakaldo, Spain 
Atlas of Genetics and Cytogenetics in Oncology and Haematology 2013
Chapter 5
106
5 5
Human PTPRR (Protein Tyrosine Phosphatase Receptor Type R)
107
5 5
IDENTITY
Gene name:   PTPRR 
Alias:             EC-PTP; PCPTP1; PTP-SL; PTPBR7; PTPPBS; Ch-1PTPase; NC-PTPCOM1 
Hugo name:   PTPRR
Location:        12q15
DNA/RNA 
Description
Like its mouse ortholog [1], the human gene PTPRR represents a very complex locus 
as revealed by BLAST searches [2] using the collection of deposited PTPRR cDNA 
query sequences (figure 1). Differentially regulated promoters drive transcription 
from at least four different sites within the 285 kilobasepair-spanning genomic re-
gion and at five positions alternative splicing may occur. Part of the resulting al-
ternative transcripts make up the NCBI-annotated isoforms #1 through #5 in the 
nucleotide database (NM_002849, NM_130846, NM_001207015, NM_001207016 
and NR_073474, respectively). Furthermore, one of the alternative exons resides 
within a region that in the reverse transcriptional orientation is annotated as a fu-
marylacetoacetate hydrolase domain-containing protein 2 (FAHD2) pseudogene. 
Thus, transcripts including this PTPRR exon – i.e. the isoform #5 types – carry FAHD2 
antisense sequences that may have a regulatory impact on transcripts from the func-
tional genes FAHD2A and FAHD2B that reside on chromosome 2q11. 
Use of the most upstream promoter results in a ~4 kilobase-long transcript variant, 
isoform #1, encoding what Augustine and co-workers termed the human PTPPBSα 
isoform [3]. This protein is equivalent to mouse PTPBR7, a canonical receptor-type 
transmembrane PTP. The human PTPPBSα transcript is built from sequences derived 
of 14 exons. This build-up was determined back in 2001 by Bektas and co-workers 
[4] and recently confirmed and extended with isoform #2-specific exonic parts [5]. 
Within the distal region of the very large intron 2, a second alternative promoter 
is residing that leads to the human PTPPBSβ isoform (#3), which equals the mouse 
PTP-SL transcript. Although initially this variant was not encountered in human 
cDNA libraries [3], the presence of four expressed sequence tags and two inde-
pendent cDNA deposits (NM_001207015, AK295951) in public libraries underscore 
the existence of this transcript isoform in human tissue. 
Then, within intron 4 - just proximal of exon 5 - a third alternative transcriptional 
start site is present that appears as the origin of the PTPPBSγ (#2) and PTPPBSδ(#4) 
variants [3]. Initially, it was thought that perhaps two different transcription start sites 
at close distance were used; an upstream one rendering isoform #4 and a second 
one, that would yield isoform #2, just some 200 base pairs downstream and within 
the part that is spliced out in transcript #4. However, multiple cDNA reads in the 
public database (most notably BX571751) disclose that transcription initiation of 
isoform #2 type mRNAs in fact occurs at the more upstream alternative promoter as 
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well. Thus, in- or exclusion of a single sequence stretch just proximal of the canoni-
cal exon 5 appears the discriminating factor between isoforms #2 and #4. Mining 
the non-redundant nucleotide database did not provide entries that would back up 
the PBSγ and PBSδ “+/-“ additional alternatives that were suggested more than a 
decade ago [3].
RNA variants represented by isoform #5 (acc. NR_073474) and database entry 
BC072386 also result from the use of the PBSγ/δ type promoter. These variants are 
unique, however, due to the splicing out of exon 7 and the inclusion of two alterna-
tive exons that reside in introns 10 and 13, respectively. Since exon 7 contributes 
187 nucleotides, its exclusion alters the PTPRR reading frame and results in the 
incorporation of three exon 8-encoded missense amino acids followed by a prema-
ture stop. Thus, although isoform #5 is annotated as a noncoding RNA, truncated 
proteins that span the first 91 or 130 amino acids of PBSγ or PBSδ, respectively, and 
then end with KYQ* may exist.
The above-discussed alternative exon within intron 10 is the one that overlaps 
with pseudogene FAHD2P1 that is annotated on the complementary strand. Per-
haps due to remnants of transcriptional sequence elements that relate to the pseu-
dogene, a bit more downstream in intron 11 there may be a potential promoter 
driving transcription of the last four PTPRR exons only. Evidence for this comes from 
nucleotide database entries AK091647 (#9), AL711271 and most notably CR749836 
(#8). The resulting transcript, with inclusion of a few hundred nucleotides contribut-
ing its poly-A tail, may well represent the ~3 kilobase-sized mRNA that has been 
detected in Northern blot analyses [3]. An open reading frame that constitutes the 
C-terminal 87 amino acids of the PTPRR PTP domain, hence representing an enzy-
matically inactive N-terminal truncation mutant, is discernible. It remains to be in-
vestigated whether the intron 11 transcription start is indeed genuine and whether 
the resulting RNAs have coding potential. 
The cDNA in entry AK091647 (#9) yields one more surprise for the human PTPRR 
locus; 110 additional nucleotides directly upstream of exon 12 are retained within 
this clone. These additional bases were also found in AK304672 (#7),  demonstrating 
that an alternative splice acceptor site for the exon 12 5’ start exists. Usually, the 
distal site is used and exon 12 donates 158 bases to the maturing transcript. In 
the cases just mentioned, the proximal site was used and the elongated exon 12 
contributes 268 bases. If this occurs in transcripts originating from the upstream 
promoters, the PTPRR reading frame will dictate the addition of a single lysine to 
the protein before a stop codon is encountered. Hence, the resulting protein will 
lack the 121 C-terminal residues of the catalytic domain and will be enzymatically 
inactive. The predicted open reading frame within the transcripts dictated by the 
fourth, intron 11-residing promoter, however, is not altered by the exon 12 splice ac-
ceptor choice since the AUG start codon is contributed by the shared exon 12 part.
It is of note that directly downstream of PTPRR, in a head-to-tail fashion, yet an-
other receptor-type PTP gene is located: PTPRB. At first sight, the expression pat-
tern in mouse brain is distinct from that of PTPRR [6, 7] and future research will have 
to unveil whether both genes share transcriptional regulatory elements.
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Figure 1: Schematic depiction of human gene PTPRR (upper panel), derived alternative 
transcripts (middle panel) and corresponding protein isoforms (lower panel). Arrows 
in the upper panel indicate the four distinct transcriptional start sites within the 285 kBp 
PTPRR locus on chromosome 12q15. Exon numbers according to transcript isoform #1 (acc.
nr. NM_002849) are indicated above the corresponding, green boxes. Crimson boxes re-
flect the alternative first exons produced from the three distal promoters. Alternative spliced 
exonic parts are in dark-blue. The sky-blue area within intron 11 reflects the position of a 
pseudogene in the opposite transcriptional orientation. In the middle panel the build-up of 
the nine different PTPRR transcripts, deduced based on cDNA deposits in public databases, 
is depicted. The respective exon-derived sequence blocks are colour-coded as indicated 
above and are depicted unfused, to facilitate comparison with the gene build-up. See text for 
more details. The accession numbers for the major database entries defining the transcript 
variants #6 to #9 are given. The first five mRNAs correspond to annotated reference se-
quences (accession numbers are mentioned in the text). In the lower panel, again to facilitate 
comparison with gene and transcript build-up, the exon-encoded protein contributions are 
depicted unfused. Moreover, flanking the open reading frames (thick boxes) the non-coding 
mRNA parts are shown as thin white bars. The N-terminal, salmon protein domain reflects the 
signal peptide (SP). The transmembrane spanning region (TM) in PTPPBSα and PTPPBSβ is 
shown in turquoise and the kinase-interacting motif (KIM) and protein tyrosine phosphatase 
catalytic domain (PTP) are coloured purple and orange, respectively. The asterisks indicate 
a conserved furin-like cleavage site and the black dot in the exon 13-derived amino acid se-
quence represents the essential catalytic site cysteine. A dashed pink box indicates the 30 aa 
open reading frame that is predicted based on database entry BX571751. Black arrows point 
to the position of methionines that may be functional as alternative starts upon PTPPBSγ/δ 
translation. Drawings are to scale (except for exon sizes in the top panel) and size bars are 
indicated.
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Expression
Isoform-specific expression studies on human samples are limited to RT-PCR 
analyses [3] which in general point to expression patterns that are quite similar to 
mouse [3, 8] and rat [9]. Human PTPPBSα is expressed exclusively in brain and the 
PTPPBSγ/δ-type transcripts are also detectable in various other tissues, most nota-
bly uterus and intestine [3]. PTPPBSβ isoform expression was not addressed in that 
study. Given that both in mouse and in rat a developmental promoter switch occurs 
in cerebellar Purkinje cells (PCs), favouring PTP-SL-type expression in mature PCs, it 
seems likely that also in human cerebellum the promoter within PTPRR intron-2 will 
drive postnatal expression of PTPPBSβ isoforms. The notion that PTPPBSγ/δ-type 
isoforms are detectable outside brain is of importance for recent studies that impli-
cate PTPRR in carcinogenic processes in cervix and colon [5, 10].
DNA - Pseudogene
There are no pseudogenes detectable for gene PTPRR in the human genome. Its 
closest relatives are the other two genes within the “R7” subclass of classical PTPs 
[11], PTPN5 and PTPN7, which encode for STEP and HePTP, respectively.
PROTEIN
Description
From the above it is clear that human PTPRR encodes many different PTPRR protein 
isoforms (figure 1). The longest one is a 657 single-pass transmembrane receptor-
type PTP by virtue of its N-terminal signal peptide (SP). Removal of the SP from 
the precursor protein will yield a 71 kDa mature protein of the PTPBR7 type (see 
table 1 for nomenclature). This human PTPRR isoform #1 may additionally be post-
translationally cleaved at an evolutionary conserved furin-like site, in analogy with 
the mouse ortholog [14], rendering a 59 kDa protein spanning 519 residues. This 
processing site is also present in the 545 amino acid long isoform #3 that has PTP-
SL as its ortholog in mouse. It may well be that it is actually the second AUG codon 
that is being used for the start of translation, as it was found in mouse [1]. In that 
case, the PTPPBSβ open reading frame would be 30 nucleotides shorter, and a 535 
residue-spanning protein of 60 kDa would be synthesised. Although isoform #3 
lacks an obvious signal peptide preceding the transmembrane segment, one may 
expect that like PTP-SL [15] it will behave as a type III transmembrane molecule [16]. 
Human PTPRR transcript type #4 displays an open reading frame that predicts the 
synthesis of a 451 aa PTPRR isoform, coined PTPPBSδ [3], that has a unique three 
amino acid N-terminus before it proceeds with the exon 5-encoded PTPRR read. 
Consequently, this predicted 51 kDa protein contains the TM segment and may be 
topologically similar to the PTPPBSβ protein isoform #3. The original PTPRR tran-
script #2 was thought to have its coding region starting exactly three nucleotides 
before exon 6-derived sequences, hence resulting in a 46 kDa cytosolic protein 
that spans 412 residues and is lacking any meaningful hydrophobic part. Multiple 
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cDNAs now argue in favour of extending the 5’ end of the type #2 transcript and 
by doing so the (more) full-length cDNA then only displays a rather short, 30 aa 
protein-encoding ORF due to a stop codon in the part that is spliced out in isoform 
#4-type transcripts. 
Adding to the complexity is that in mouse PTPPBSγ mRNA it is not the first but 
rather the second and third AUG codon that is used by the translational machinery 
[1]. If the same holds true in human, then the PTPPBSγ/δ-type transcripts would 
yield 42 and 37 kDa sized cytosolic PTPs independent of the in- or exclusion of the 
283 nucleotide intron preceding exon 5. 
Table 1: PTPRR isoforms nomenclature 
Homo sapiens Mus musculus
PTPPBSα (#1) PTPBR7
PTPPBSβ (#3) PTP-SL
PTPPBSγ (#2)* PTPPBSγ-42
PTPPBSδ (#4)* PTPPBSγ-37
*Homology depending on the start codon used
There are two domains that are present in all PTPRR proteins encoded by transcript 
isoforms #1 through #4; a so-called kinase interaction motif (KIM) and, of course, the 
catalytic PTP domain [17]. This classical, strictly phosphotyrosine-specific catalytic 
PTP segment spans some 280 conserved amino acids and includes the active site 
cysteine that is essential for the nucleophile attack on the phosphorus of the phos-
photyrosine in the substrate protein [18]. Overall, the three-dimensional structure of 
PTP domains shows only minor differences in the core elements. For instance, the 
structure of the catalytic segment in the “R7” PTP subfamily (that is comprised of 
PTPRR, STEP and HePTP [11]) displays a short β sheet consisting of the N-terminal 
βx and C-terminal βy strands (figure 2)[12] that is not encountered in the founding 
PTP1B structure [19]. Also, this R7-type PTP domain structure contains several heli-
ces [12, 20, 21] that are additional to the canonical structure in other PTPs [22]. Most 
notably, PTPRR, STEP and HePTP have an additional N-terminal helix (termed “α0”) 
that is stabilized by hydrophobic interactions with helix α5 and the loop following 
helix α2’ [12, 20, 21]. This results in a hydrophobic cavity of ~16Å depth that may be 
instrumental in the regulation of enzyme activity and substrate specificity [21]. Helix 
α0 is located 15 residues downstream of the KIM motif, a 16 amino acid sequence 
that is essential for PTPRR’s interaction with the MAP kinases ERK1, ERK2, ERK5 
and p38 [17, 23-25]. Thus, helix α0 may facilitate proper positioning of the KIM to 
ensue interactions with the docking groove in MAP kinases [26]. As a consequence 
not only the regulatory tyrosine in the MAP kinase’s activation loop is dephosphory-
lated, causing its inactivation [17], but additionally the physical interaction prevents 
MAP kinase translocation to the nucleus [23, 27]. Vice versa, the association of a 
KIM-containing PTP with an active MAP kinase triggers specific phosphorylation of 
a threonine residue within the PTP’s α0 helix [17, 24]. The consequence of this phos-
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phorylation event, however, remains to be investigated. Quite opposite, the effect 
of protein kinase A (PKA)-mediated phosphorylation of a conserved serine residue 
within the KIM motif is well studied since it abolishes the binding and subsequent 
dephosphorylation of MAP kinases by KIM-containing PTPs [27-29].
A B
Cys588
WPD loop
hydrophobic
cavitySer375
Thr655
α2’
βx βy
α5
The predicted proteins that may result from translation of the PTPRR messenger 
types #5 through #9 will be enzymatically dead. The transcript #5 and #6 derived 
types will lack all PTP domain residues and also the KIM segment is far from com-
plete, all due to a reading frame change that is caused by exon 7 skipping. Depend-
ing on the AUG choice, a small protein that would contain the TM domain might be 
produced, which could theoretically influence the multimerization behaviour of the 
PTPBR7 and PTP-SL type isoforms [15]. PTPRR splice forms that manage to maintain 
the long version of exon 12 (e.g. the  #7 type), however, will produce protein vari-
ants that only lack the C-terminal 121 amino acids. Such truncated, KIM-contain-
ing proteins would be enzymatically inactive but may compete with endogenous 
full-length PTPRR isoforms for binding to MAP kinases or other PTPRR-associating 
biomolecules. Any regulatory impact of the hypothetical 87 amino acid long pro-
tein that corresponds to the ORF in transcript versions #8 and #9 would be purely 
speculative.
Localization
No detailed studies on the subcellular localization of human PTPRR protein isoforms 
have been performed and, again, only inference from mouse and rat data [8, 15, 
30-34] remains. Based on this, it seems reasonable to postulate that isoform #1 will 
display a PTPBR7-like cell surface expression and that isoform #3 may reside on the 
trans-Golgi network and multivesicular bodies or sorting endosomes, like mouse 
Figure 2: Ribbon (A) and surface (B) type representation of the three-dimensional struc-
ture of the PTP domain in human PTPRR, as determined by X-ray crystallograpy (PDB 
code: 2A8B; [12]). Numbers are according to PTPPBSα protein isoform #1. Relevant struc-
tural elements, mentioned in the text, are indicated. The KIM domain and the α0 helix that 
was observed in the mouse PTPRR structure (PDB code: 1JLN) are N-terminal of Ser375 
and were absent in the human recombinant protein part used for crystallization. Blue parts 
represent alpha helices and red domains symbolize beta strands. Yellow portions indicate 
310 helices and the green parts represent ramdom coil segments. Molecular graphics were 
created with YASARA [13].
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PTP-SL does. Depending on the translational start site choice, the other isoforms 
produce either PTP-SL-like vesicle-associated versions or, more likely, cytosolic 
proteins that resemble murine PTPPBSγ. Intriguingly, the mouse transmembrane 
PTPRR isoforms form multimeric complexes and their relative PTP activity is signifi-
cantly lower than that of the cytosolic PTPPBSγ type [15]. This predicts regulatory 
potential for any biomolecule that would bind to the PTPBR7 and/or PTP-SL parts 
that are N-terminal of the transmembrane segment. Identification of receptor-type 
PTP ligands is a cumbersome process [35, 36] and although mouse PTPBR7 extra-
cellular domain displayed a clear affinity for highly myelinated brain regions [37] the 
corresponding PTPRR ligands still await proper identification.
Function
The localization of the two transmembrane mouse PTPRR isoforms on anterograde 
as well as retrograde endocytic vesicles [34] suggests either a role in the regulation 
of vesicle transport or a fate as cargo in these compartments. In line with the first 
option, protein interaction and transfection studies pointed at a potential functional 
interaction with β4-adaptin, an AP-4 complex subunit that participates in vesicle 
sorting [32]. Further studies are needed to corroborate this finding and it remains to 
be established whether this holds for human PTPRR as well. On the contrary, ample 
evidence now supports a regulatory impact for PTPRR isoforms on MAP kinase sig-
nalling. After the initial ectopic overexpression experiments that disclosed the KIM-
dependent and PKA-regulated PTPRR-MAP kinase interactions [17, 27, 31] it was 
surprising to find that endogenous PTPRR apparently was dispensable for proper 
EGF- and NGF-induced MAP kinase activity in rat PC12 cells [15]. Findings in PTPN7 
deficient mice, however, had suggested that KIM-containing PTP impact on MAP 
kinase cascades might be very subtle [38]. Furthermore, pharmacological inhibition 
[39, 40] and mouse knock-out studies also proved PTPN5 to be a  physiological 
regulator of MAP kinase cascades [41]. Indeed, also Ptprr knock-out mice displayed 
MAP kinase hyperphosphorylation in relevant tissues [42]. 
PTPRR’s closest homolog, the PTPN5-encoded protein STEP, is additionally ca-
pable of dephosphorylating the cytosolic tyrosine kinase Fyn, Pyk2, and subunits 
of AMPA and NMDA receptors in neuronal cells, implicating KIM-containing PTPs 
in neuronal functions like synaptic transmission [43, 44]. There is even evidence 
that PTPN5 is linked to the pathophysiology of diverse neuropsychiatric disorders 
in man, including Schizophrenia and Alzheimer’s disease [45, 46]. Although direct 
evidence for an impact of PTPRR on Src-family kinase or AMPA and NMDA receptor 
subunit phosphorylation levels has not yet been obtained, it remains an interesting 
possibility in view of the phenotypic consequences of PTPRR deficiency in mice [42] 
and the proposed links with some human (neuro)pathological conditions (below).
IMPLICATIONS
The mapping of a novel type 2 diabetes susceptibility locus on chromosome loca-
tion 12q15, back in the former century, early on triggered the testing of PTPRR as a 
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candidate risk gene. Although the subsequent study provided a first snapshot of the 
gene and also yielded multiple polymorphisms, none of the identified mutations 
did segregate with diabetes [4]. Thus PTPRR is excluded as a risk gene at the type 
2 diabetes locus on chromosome 12q15. 
In prefrontal cortex and hippocampal areas in brains of depressed suicide sub-
jects a significant reduction of MAP kinase transcript levels and increased amounts 
of a dual-specificity MAP kinase phosphatase have been noted [47]. Intriguingly, 
transcriptome-wide micro-array expression studies on postmortem orbitofrontal 
cortex tissue from violent suicide victims subsequently revealed a 1.5-fold upregula-
tion of PTPRR mRNA levels when compared to controls [48]. This suggests a picture 
in which the reduction of MAP kinase signals in distinct brain areas - for example 
due to PTPRR aberrancies - may ultimately lead to profound mood distortions with 
eventual violent or deadly consequences. Such mood disorders are quite hard to 
study in mouse models and also the subtleties in brain expression patterns will se-
verely hamper reductionistic studies on the psychopathophysiological relevance of 
these findings.
Recently, however, an additional correlative finding aids in building a case for 
involvement of PTPRR in psychoneuropathologies. It is currently well accepted that 
genetic components are contributing to major depressive disorder (MDD), a chronic 
and rather common mental disease. Given that reduced MAP kinase activity has 
been noted in MDD pathogenesis [49, 50] and that PTPRR proteins inhibit this sig-
nalling pathway, it made sense to test whether PTPRR perhaps represents an MDD 
risk gene. By monitoring the distribution of 16 single nucleotide polymorphisms 
(SNPs) at the PTPRR locus in a Chinese Han population indeed one (rs1513105) 
demonstrated allelic association with an increased risk for MDD, but primarily in the 
female subjects [51]. Replication in additional cohorts will be the next step. 
Like for MDD, the heterogeneous etiology of alcohol use disorders (AUD) pre-
dicts a complex interplay of environmental and heritable factors and the latter may 
include impaired MAP kinase signalling circuits. By combining genome wide as-
sociation studies (GWAS) and gene set enrichment analyses (GSEA) on subjects 
characterized for alcohol response level phenotypes, a set of 173 genes that appear 
relevant for the disorder, among which PTPRR, could be extracted [52]. Several had 
a reported involvement in alcohol response and addiction, and a specific enrich-
ment for neuronal signalling genes - especially the ones impacting on glutamate 
signalling - was apparent [52]. Analogous to STEP [43], PTPRR may modulate AMPA 
and NMDA receptor levels and as such is an appealing genetic component for the 
modulation of alcohol’s effects.
An inv(12)(p13q13) translocation detected in an acute myelogenous leukemia 
was found to result in multiple fusion transcripts spanning the first three or four 
exons of gene TEL in combination with the final five to eight exons of PTPRR [53]. 
Only a single chimeric TEL/PTPRR fusion transcript, however, dictates an open read-
ing frame that would be in-frame with PTPRR sequences. This fusion transcript joins 
the fourth TEL exon with the ninth of PTPRR and results in a protein that lacks the 
first (exon 8-encoded) thirty-odd residues of the PTP catalytic domain and thus will 
be enzymatically activity. It therefore seems more likely that an altered  functionality 
of the TEL transcriptional repressor part in the chimeric protein is instrumental in 
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the disease. Recent findings, however, more directly support a role for PTPRR in 
cancer etiology. RNA expression studies in mice highlighted PTPRR isoform expres-
sion in the epithelial linings of the intestine [3]. Gene expression profile analyses 
revealed that PTPRR transcription was markedly downregulated in colorectal tumors 
as compared to normal mucosa [54]. The decreased expression in precancerous and 
cancerous colorectal tumors resulted from epigenetic changes, both at the level of 
CpG island DNA methylation and histone-tail modification, that were also observed 
in colon cancer cell lines and were maintained in metastases [5]. The finding was 
recently confirmed in an independent study on colon carcinomas [55] and can now 
be extended to cervix cancer on the basis of a study that concentrated on the con-
sequences of DNA methyltransferases 3B (DNMT3B) hyperactivity in invasive cervi-
cal cancer [10]. It turned out that PTPRR was silenced through DNMT3B-mediated 
methylation. Given the impact of the RAS/RAF/MAPK signalling axis in cancer cell 
proliferation, it is not difficult to envision that PTPRR down-regulation would aid 
constitutive activation of this key pathway. Furthermore, PTPRR re-expression was 
shown to inhibit the expression of the oncogenic human papillomavirus E6/E7 pro-
teins [10], providing yet another advantage for HPV-positive cells to downregulate 
this PTP gene. 
PTPRR is normally not only expressed in the cervix but also in endometrial tissue. 
By comparing mRNA levels throughout the menstrual cycle, PTPRR was found to 
be increased some fifty-fold from the proliferative to the secretory phase in endo-
metrial tissue [56]. Furthermore, PTPRR expression appeared an additional four-fold 
higher in late secretory phase tissue of women with endometriosis as compared to 
controls, which suggests that PTPRR may prevent normal endometrial differentia-
tion and could represent a predisposing factor in the aetiology of endometriosis 
[56].
The most recent addition to the list of disease associations for PTPRR is that 
of nearsightedness, or myopia [57]. For this common ocular genetic disease over 
20 candidate genomic loci have been put forward, including one on chromosome 
12q21–23 that links to high-grade myopia. Subsequent genetic association studies 
using hundreds of SNPs within the linkage region yielded several that significantly 
associated with the disease, including rs3803036 that represents a Lys>Arg mis-
sense mutation in PTPRR [57]. Microarray analyses revealed that PTPRR is differen-
tially expressed in fetal and adult ocular tissue, warranting further studies on its role 
in myopic development.
TO BE NOTED
Ptprr knockout mice display mild, ataxia-like, locomotive impairment [42] but the 
gene’s location in human does not match with the various ataxia loci that have been 
mapped thus far and that still await identification of the underlying gene defects 
[58].
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GENERAL DISCUSSION 
Proper brain functioning depends on a high degree of organization of cellular and 
molecular contacts to warrant an efficient, fast and reliable information flow [1]. At 
the same time tremendous structural and functional flexibility of these signalling 
circuits is necessary to enable learning and adaptation. For acquisition and mainte-
nance of these very complex and even somewhat paradoxal characteristics of the 
brain, neuronal differentiation and synaptic plasticity have to be heavily controlled. 
This involves regulation of proper cell fate specification, spatiotemporal control of 
transcriptional programs of the multiple different cell types that are formed, and 
use of irreversible and reversible post-translational protein modifications, including 
tyrosine phosphorylation. The concerted action of protein tyrosine kinases and pro-
tein tyrosine phosphatases (PTPs) determines the level of phosphorylated tyrosine 
residues by catalyzing the addition and removal of phosphate groups, respective-
ly. The classical PTP family consists of enzymes that are strictly phosphotyrosine-
specific. Another subfamily of PTPs, made up by the dual-specificity phosphatases 
(DUSPs), have a broader substrate specificity [2, 3]. Protein tyrosine phosphatase 
receptor type R (PTPRR) is a receptor-like transmembrane member of the classical 
PTP family. In mice, the Ptprr gene gives rise to multiple transcripts and protein 
isoforms that are preferentially present in the brain, but are additionally found in the 
stomach, intestine, uterus, placenta and weakly in the prostate [4]. First indications 
on potential physiological roles for PTPRR isoforms came from in vitro studies using 
mammalian cell models. PTPRR proteins specifically interact with and dephospho-
rylate mitogen activated protein kinases (MAPKs) [5-8], which are involved in many 
fundamental cellular processes, including proliferation, differentiation, migration, 
metabolism, survival, and plasticity [9, 10]. A glimpse on in vivo PTPRR protein func-
tion came from studies in mice, revealing a role for this phosphatase in the control 
of motor coordination [11]. The research described in this thesis adds significant 
new insight into the involvement of PTPRR proteins in the control of mouse beha-
viour, cell differentiation, neuronal connections, and molecular signalling pathways. 
At the molecular level, we disclosed that the transmembrane PTPRR variant ef-
ficiently counteracts neuronal differentiation signals that are mediated via the nerve 
growth factor (NGF)-induced signalling cascade, by dephosphorylating both the 
responsible cell surface receptor and the downstream MAP kinase in rat PC12 cells 
(chapter 2). In chapter 3 it is described that PTPRR proteins also are required for the 
proper facilitation of long-term depression (LTD), an essential process of Purkinje 
cell synaptic plasticity within the cerebellum [12]. Furthermore, we have determined 
the impact of PTPRR isoforms on mouse behaviour and found that PTPRR defi-
ciency leads to impaired novel object recognition and elevated exploratory behav-
iour (chapter 4) [13]. The obtained information on PTPRR functioning in mouse and 
rat model systems is supplemented with a discussion on structural and functional 
aspects of human PTPRR in chapter 5. Here, the obtained results from the various 
chapters will be merged and placed into a broader perspective. 
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Impact of PTPRR on molecular signalling pathways 
Growth factors that steer neuronal cell proliferation and differentiation mostly act 
through cell surface receptor tyrosine kinases that phosphorylate themselves and 
other specific intracellular target proteins on tyrosines. As a result, monomeric 
 GTPases of the RAS family are activated that subsequently pass on the signal to a 
three-protein module that is known as the MAPK signalling pathway, a sequential 
cascade of MAP kinase kinase kinase (MAPKKK), MAP kinase kinase (MAPKK), and 
MAP kinase (MAPK) [14]. The classic MAPKs contain the extracellular signal-regulat-
ed kinases 1/ 2 and 5 (ERK1/2 and ERK5), the c-Jun amino-terminal kinases (JNK1, 
2 and 3) and the p38 proteins (p38α/β/γ/δ). Activated by dual phosphorylation on 
a conserved threonine and tyrosine residue, MAPKs phosphorylate multiple cyto-
solic and nuclear targets, hence regulating cytosolic as well as gene transcriptional 
processes. MAPK activation can thus be terminated in multiple ways; by dephos-
phorylation of the threonine or tyrosine residue or by dephosphorylation of both. 
A subclass of protein tyrosine phosphatases (PTPs), consisting of PTPRR, striatal-
enriched protein tyrosine phosphatase (STEP) and hematopoietic tyrosine phos-
phatase (HePTP), is specifically designed to bind and dephosphorylate the classic 
MAPKs [5-8]. Following the determination of the crystal structures of these PTPs 
[15, 16], more recent studies are now refining the molecular details that determine 
the substrate specificity and differential interaction strengths towards the distinct 
MAPKs. In these studies sophisticated techniques such as matrix assisted laser de-
sorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry, isothermal titra-
tion calorimetry, nuclear magnetic resonance (NMR), small angle X-ray scattering, 
and molecular modelling [17-22] are being used. PTPRR, STEP and HePTP proteins 
harbour a kinase interaction motif (KIM) and a kinase specificity sequence (KIS) [8] 
that, together with specific residues in the catalytic PTP domain, are of great impor-
tance in substrate recognition [17, 19]. A very elegant study used a combination of 
molecular and enzymologic methods to pinpoint specific residues in the highly con-
served KIM and catalytic domain of STEP that mediate ERK recognition [23]. Using a 
similar approach, it should become feasible to reveal the specific residues in PTPRR 
proteins that determine the interaction with specific MAPKs. ERK1/2 is the preferred 
substrate for PTPRR proteins. In consonance with this property, increased ERK1/2 
phosphorylation levels were found in brain tissue of Ptprr knockout mice [11]. In this 
thesis, we shed light on the role of PTPRR isoforms in two paradigm neuronal signal-
ling pathways that depend on proper ERK1/2 activity, i.e. the NGF-indcued TrkA-
mediated signalling cascade that drives neuronal differentiation (chapter 2) and the 
positive feedback loop in Purkinje cells that underlies cerebellar LTD (chapter 3), 
which we will discuss below.
Multiple forms of TrkA exist due to glycosylation and optional proteolytic clea-
vage, including the immature p110, mature p140 and cleaved p41 forms [24-30]. 
Binding of NGF to mature TrkA on the cell surface of PC12 cells, which are derived 
from a pheochromocytoma of the rat adrenal medulla and represent an elegant 
model for neuronal differentiation [31], will trigger a signalling cascade that includes 
the MAPK pathway. We found that PTPRR proteins counterbalance NGF-induced 
PC12 cell differentiation by inhibition of both ERK1/2 and TrkA activities (figure 
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1; chapter 2). In fact, in addition to its impact on mature p140 TrkA, PTPRR pro-
teins efficiently dephosphorylate the p41 TrkA variant that lacks the ectodomain 
and is constitutively active. PTPBR7-mediated dephosphorylation of TrkA at posi-
tion Y674/675 (human TrkA residue numbering) and Y490 predictably precludes 
receptor trans-activation and signalling towards the PI3-K/Akt and Ras/ERK cas-
cades, respectively [32-34]. Phosphorylation of TrkA on Y785 recruits PLCγ, lead-
ing to the activation of the PKC pathway [34]. Future research, using antibodies 
directed against Y785, may help to reveal whether PTPRR proteins are involved in 
Y785 dephosphorylation as well. 
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TrkA
cytosolic
targets nuclear targets
RAF
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ERK1/2
PTPRR
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In turn, PTPRR-mediated inhibition of TrkA signalling can be counteracted as well. 
The PTPRR-ERK1/2 interaction is fine-tunable via protein kinase A (PKA) and protein 
phosphatase 1 (PP1) [35]. PKA phosphorylates a conserved serine residue within 
the KIM domein in PTPRR, thereby preventing the binding of the phosphatase to 
its substrate ERK1/2. This action is reversed by PP1, re-enabling the PTPRR-ERK1/2 
interaction and facilitating PTPRR-mediated dephosphorylation of the MAPK and 
its retention in the cytoplasm. The notion that PC12 cells require NGF-mediated 
protein kinase A (PKA) activation for sustained ERK1/2 activity and ERK1/2 nuclear 
translocation [36, 37], together with the observation that NGF-sensitive PC12 cells 
contained high levels of KIM-phosphorylated PTPRR [38] support a model in which a 
PTPRR-mediated brake on NGF-induced signalling is suppressed by PKA (figure 1). 
Figure 1: Schematic over-
view of the role of PTPRR 
in the NGF-induced TrkA 
signalling pathway. Bind-
ing of NGF to TrkA induces 
the activation of the RAF - 
MEK1/2 - ERK1/2 signalling 
unit, leading to the phos-
phorylation of cytosolic and 
nuclear targets involved in 
PC12 cell differentiation. 
Furthermore, NGF induces 
Ptprr mRNA transcription 
and subsequent PTPRR 
protein synthesis via as yet 
undefined routes. PTPRR 
proteins inhibits the TrkA 
signalling cascade by bind-
ing and dephosphorylation 
of TrkA and ERK1/2. PTPRR-
ERK1/2 binding is potentially 
inhibited by the TrkA-medi-
ated activation of PKA and 
the inhibition of PP1. Arrows 
and bars indicate stimulatory 
and inhibitory interactions, 
respectively. Abbreviations 
are explained in the text. 
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The observation that upon NGF signalling the catalytic subunit in PP1 is inactivated, 
and that this inactivation occurs through phosphorylation by cyclin-dependent pro-
tein kinase 5 (Cdk5), is consistent with this model and explains how this signalling 
cascade can further promote the differentiation of NGF-treated PC12 cells [39]. To 
make it even more elaborate, NGF stimulation of PC12 cells provokes the upregula-
tion of PTPRR at the transcriptional level [40]. In this way a well-controlled feedback 
mechanism is provided in which ultimately elevated PTPRR protein levels will impair 
the TrkA-initiated cell signalling (figure 1). 
Picturing PTPRR proteins solely as negative regulators of TrkA signalling might 
be too simple, however. Preliminary experiments using COS-1 cells indicated that 
catalytically active transmembrane PTPRR isoforms stimulate TrkA maturation and 
cell surface expression. These results are in analogy with the finding that inactive 
receptor tyrosine kinases mature much more efficiently than constitutively active 
mutants [41, 42]. Although we did not find an altered p140/p110 TrkA ratio when 
PTPRR proteins were co-expressed in PC12 cells, one should keep an open mind 
towards such a potential helper function of PTPRR proteins in TrkA biosynthesis.  
The presence of PTPRR transcripts and proteins in mature mouse brains [4, 11, 
43-45], indicates that these PTP isoforms also perform functions in nerve cells af-
ter differentiation has completed. In this thesis, we show that PTPRR proteins are 
involved in signalling processes underlying synaptic plasticity (chapter 3). A key 
regulatory mechanism in synaptic plasticity is the transport of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPARs) and N-methyl D-aspartate re-
ceptors (NMDARs) to and from the postsynaptic membrane [46]. The major output 
in the mouse cerebellum is generated by Purkinje cells (PCs), which receive and pro-
cess the signals coming from the parallel fibers and climbing fibers. Simultaneous 
stimulation of the PC by both fiber types induces a rise in intracellular Ca2+ levels, 
which - in turn - leads to the activation of a positive feedback loop that includes the 
Raf - MEK1/2 - ERK1/2 cascade. This feedback loop results in sustained activation 
of protein kinase C (PKC) at the cell membrane and subsequent AMPAR phospho-
rylation and internalization, causing LTD at the PC synapse (figure 2A)[47, 48]. To 
our surprise, an hyper-phosphorylated ERK1/2 level in the cerebellum of PTPRR 
deficient mice was found to hamper the PC responsiveness to LTD-inducing signals, 
indicating a critical role for PTPRR proteins in controlling the positive feedback loop 
that underlies cerebellar LTD (figure 2A; chapter 3). One should bear in mind that 
PTPRR proteins may well be involved in the dephosphorylation of other, non-MAPK, 
proteins involved in this process. One such candidate substrate may be the protein 
tyrosine kinase Src. Src-mediated tyrosine phosphorylation of the AMPAR precludes 
PKC-mediated phosphorylation and AMPAR internalization [49], and thus a hyper-
activation of Src due to PTPRR deficiency could well explain the absence of LTD in 
Ptprr knockout mice. However, our application of phospho-specific antibodies in 
the immunoblot analyses of cerebellar lysates ruled out Src-family kinases as poten-
tial substrates for PTPRR proteins in the LTD process [12]. 
To obtain clues on additional PTPRR substrates, we may learn from STEP, the 
closest homolog of PTPRR and encoded by gene PTPN5. Similar to PTPRR proteins, 
STEP binds and dephosphorylates MAPKS [6, 8, 23, 50]. Additionally, STEP has 
a diverse range of other substrates that are involved in synaptic plasticity within 
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the hippocampus and amygdala (figure 2B)[51-57]. STEP directly dephosphorylates 
the AMPAR and NMDAR, controlling their trafficking to and from the postsynaptic 
membranes [51, 52, 54, 57]. Furthermore, STEP regulates NMDAR surface expres-
sion also indirectly, by dephosphorylation and inhibition of the focal adhesion ki-
nase family kinase Pyk2 [58] and the Src-family tyrosine kinase Fyn [59], which act 
upstream of NMDAR phosphorylation and internalization.
 
NMDARAMPAR AMPAR
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Pyk2
STEP
MAPK
PTPRR
?
A B
MEK1/2
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?
Figure 2: Schematic overview of PTPRR and STEP involvement in AMPAR and/or 
 NMDAR trafficking at the postsynaptic membrane. (A) PTPRR inhibits the activity of 
ERK1/2, which is a key component of the positive feedback loop that underlies PKC-medi-
ated  AMPAR internalization, resulting in long-term depression of Purkinje cells. (B) STEP is 
involved in LTD in the hippocampus and amygdala. STEP stimulates AMPAR and NMDAR 
endocytosis by dephosphorylation of the receptors itself and of the regulatory proteins Fyn, 
Pyk2 and MAPKs. Arrows and bars indicate stimulatory and inhibitory interactions, respec-
tively. Abbreviations are explained in the text. 
The level of STEP expression in the striatum [60, 61] is much higher than in other 
brain areas [62], and STEP is absent from the cerebellum. This leaves the possibil-
ity that signalling networks similar to those observed in the striatum are modu-
lated by PTPRR proteins in the cerebellum. In fact, since PTPRR transcript levels 
are found throughout the rest of the brain as well [4, 11, 43-45], a role for PTPRR 
proteins in other neuronal signalling pathways is anticipated and may be hidden in 
STEP-expressing brain areas due to redundancy. Initial mass spectrometry studies 
have been performed to search for PTPRR binding proteins in mouse brain lysates 
[63]. This approach revealed CamKII, Gαo, and Neurotrimin as putative candidates, 
exhibiting roles in calcium ion-regulated events and cell-cell adhesion. Future ex-
periments should reveal whether these proteins provide additional links between 
 PTPRR proteins and neuronal development and plasticity. Furthermore, an inter-
action of the PTPRR phosphatase domain with β4-adaptin, a subunit of the AP-4 
complex, was noted in a yeast two-hybrid system [64]. Co-localization with this com-
plex was observed for the transmembrane PTPRR isoforms at the Golgi apparatus 
and on endosomes in neuronal cells, [64, 65]. The AP-4 complex mediates vesicle 
transport from the trans-Golgi network to endosomes and the cell surface [66-68]. 
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Intriguingly, the role of the AP-4 complex has been linked to the specific distribution 
of AMPARs to the somatodendritic domain of Purkinje cells [69]. The connection be-
tween the PTPRR transmembrane isoforms and the AP-4 complex therefore encour-
ages further research to clarify whether PTPRR proteins are implicated in transport 
of AMPAR-containing vesicles.    
Thus far, approaches to identify PTPRR substrates used (parts of) PTPRR proteins 
as bait. Alternatively, one could think of a phospho-proteomics approach in which 
the phosphotyrosine (pY)-containing protein content of cells expressing either a 
wild-type or catalytically inactive variant of PTPRR is isolated by anti-pY antibody 
columns and analyzed by mass spectrometry. This method demonstrated its value 
in identification of novel substrates for protein tyrosine phosphatase non-receptor 
type 14, among others [70]. Still, most methods to identify PTP substrates are based 
on a stable interaction of the PTP under study with its substrate [71]. However, it 
may well be that PTP-substrate interactions display weak and/or transient behaviour 
and therefore will be missed in such approaches. The field thus is in need of com-
plementary methods that are not dependent on the preservation of the complex 
and/or the phosphorylation status of the proteins that interact with a given PTP. 
The recently developed BioID technique fulfils such criteria. In BioID a promiscuous 
biotin ligase is fused to the protein of interest in order to biotinylate proximal pro-
teins, which subsequently can be isolated and further analyzed [72]. This technique 
is able to identify accurately also transient and weak binding partners, as well as the 
proteins that are in close proximity of the protein of interest [73] and thus appears a 
promising tool to further identify substrates of PTPRR proteins.  
Impact of PTPRR proteins on signalling responsiveness  
In the previous section signalling cascades were presented as highly versatile sys-
tems, which constantly undergo change in molecular composition. Almost always a 
change in the molecular assembly of signalling machines also implies a change in 
signalling function. Clearly, these dynamics in signal transduction systems are abso-
lutely crucial for proper brain functioning as the constantly changing environmental 
cues that a cell receives must at all times be reliably translated into intracellular sig-
nals to preserve appropriate decision-making. But how is this reliability and specific-
ity covered, and how is robustness against noise maintained without losing sensitivi-
ty? For this aim, the concentration, activity, modification state, and/or localization of 
signalling mediators should be controlled constantly. To shape the temporal behav-
iour of these molecules, cells are equipped with a range of regulatory mechanisms, 
including spatiotemporal organization, protein-protein interactions and feedback 
motifs, in this way forming complex tangled networks of interconnecting proteins 
and cascades [74-78]. As discussed, ERK1/2 is such a key signalling mediator that 
encapsulates upstream signals and enables processing of signal information in a 
highly dynamic context, thus providing flexibility in the governance of distinct PC12 
cell fates [79-81]. In figure 3A-B I tried to illustrate the principles behind the dynamic 
plasticity in the ERK signalling network. As depicted, transient ERK1/2 activation, 
lasting for minutes, underlies epidermal growth factor (EGF)-induced survival and 
proliferation, whereas sustained ERK1/2 activation, lasting for hours or longer, is 
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Figure 3: Schematic overview of distinct ERK signalling dynamics and pathways that 
underlie EGF- and NGF-induced proliferation and differentiation, respectively. (A) EGF 
induces PC12 cell proliferation, whereas (B) NGF stimulates PC12 cells to differentiate. 
(C) Stimulating PC12 cells with EGF or (D) NGF results in a transient or sustained ERK1/2 
activation, respectively. (E) EGF- or (F) NGF-induced signalling networks that lead to transient 
or sustained ERK1/2 activity, respectively. Arrows and bars indicate stimulatory and inhibitory 
interactions, respectively. Abbreviations are explained in the text. 
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required for NGF-induced differentiation [82, 83]. To understand how these two 
similar, enzyme-linked receptor signalling pathways can trigger such distinct cellular 
decisions while converging on identical MAPKs, one needs to realize that in addi-
tion to overlapping elements in the EGF and NGF signalling, both pathways utilize 
distinct feedback mechanisms, protein-protein interactions, and spatial organiza-
tion (this is illustrated in figure 3C). Both EGF- and NGF-mediated activation of the 
EGF and TrkA receptor, respectively, lead to Ras activation and the consequent 
initiation of the c-Raf - MEK - ERK cascade. Geared by EGF, the cascade displays 
a transient nature due to the presence of a Ras-inhibiting negative feedback loop, 
mediated by ERK1/2 and SOS [84]. NGF signalling, however, escapes from this loop 
through the addition of an alternative route, which uses Rap1 to activate the MAPK 
cascade. Importantly, this route includes a positive feedback loop that flows from 
ERK, via PKC back to Raf, to sustain ERK1/2 activity [83]. An extra layer of ERK1/2 
activity control is represented by scaffold proteins, such as KSR, that form a platform 
to bring the MAPK signalling participants in close proximity, a requirement for time-
ly activation [85]. This ‘hard-wiring’ of signalling nodes via scaffold protein-protein 
interactions further shapes the spatial organization and duration of ERK activation. 
The response of PC12 cells to EGF is switched from proliferation to differentiation 
simply by overexpression of the neuronal isoform of KSR [86]. Finally, an important 
feature of NGF signalling is that it persists after receptor internalization, thus during 
retrograde transport, whereas internalized EGFRs are rapidly degraded [84], further 
adding to the differences in ERK dynamics between the two cascades. 
 Our work demonstrated that PTPRR isoforms add critical points of control during 
the NGF-induced cascade in order to fine-tune ERK1/2 dynamics by manipulat-
ing the activity of the TrkA receptor and of ERK1/2 itself (chapter 2). Additionally, 
PTPRR isoforms affect ERK1/2’s spatial distribution by prohibiting ERK1/2 entry into 
the nucleus [5, 35]. Our interpretation of findings was based on measurements at 
fixed time points and on characterizing whole cell populations. To fully understand 
the impact of PTPRR proteins on the dynamics of NGF-induced signalling, collect-
ing results from individual cells and at different time points or even time scales is 
required. For this, time-lapse and fluorescent (bio-)sensor technology should be 
applied. Recently a biosensor specific for phosphorylated ERK was generated. For 
design of this biosensor an ankyrin repeat protein (DARPin), which consist of con-
secutive homologous structural modules that specifically recognize phosphorylated 
ERK, was combined with a fluorophore that increases fluorescence upon binding of 
the substrate [87]. Together with the development of a biosensor for phosphoryla-
tion of the PTPRR KIM domain, this would provide the required tools to monitor the 
specific intracellular location and timing of the PTPRR-involved signalling events 
following NGF stimuli. 
The above concerned the ERK1/2 dynamics in response to upstream signals, but 
is there any cellular requirement for basic, steady-state signalling via the MAPK cas-
cade? Yes, there is! Basal MAPK activity is in fact widespread in signalling systems 
under physiological conditions. It increases the propensity for activation, enhancing 
cell substrate interactions by enabling faster responses and higher sensitivities to 
external signals [88]. Thus, one may expect that within the cerebellum increased 
phospho-ERK1/2 levels would lead to elevated activity of the positive feedback 
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loop and ultimately to increased induction of LTD. Our results indicate, however, 
that the increased phospho-ERK1/2 levels in PTPRR deficient cerebellum did not 
stimulate, but rather prohibited LTD induction. We therefore hypothesized that el-
evated basal phospho-ERK levels cause a reduction in the dynamic range of phos-
phorylation that can serve to maximize ERK activity. In other words, not the actual 
ERK1/2 activity levels are important, but the net increase in activity levels deter-
mines whether cerebellar Purkinje cells will undergo LTD. 
Does this idea fit with recent ideas about protein kinase signalling processes, 
based on calculations and modelling [77]? Let us consider a simple motif represent-
ing a common element in many signalling cascades [89]. It exists of a kinase, which 
upon a stimulus is activated by phosphorylation and subsequently starts phospho-
rylating its substrate. To make it reversible, this reaction is counterbalanced by a 
phosphatase that dephosphorylates the substrate (model 1; figure 4A). Enhance-
ment of the signal leads to an increase in active kinase levels, which have to exceed 
those of the counterbalancing phosphatase in order to result in a net increase in 
phosphorylated substrate. Ultimately, all substrate proteins will become phospho-
rylated, resulting in a switch-like response curve (figure 4B). In other words, the 
information flow appears binary; it is either on or off. The inclusion of a negative 
feedback signal, for instance by direct inhibition of the kinase by the activated sub-
strate, prevents a binary type of elevation of phospho-substrate levels and rather 
results in a graded response to signal enhancement (model 2; figure 4C) [90-92]. 
Thus, differences in signal strength will be represented by proportional phospho-
substrate levels (figure 4D): ‘grey values’ are added to the previous black-or-white 
situation, introducing tunability of the system. 
Let’s now return to a situation without feedback mechanisms. In a leaky signalling 
system, i.e. when there is low basal kinase activity in absence of an upstream stimulus 
(model 3; figure 4E), the lack of negative feedback would result in a near-flat response 
curve [77]; the signal is permanently ‘on’ (figure 4F). Consequently, the dynamic out-
put range is near zero, prohibiting the discrimination between different values of the 
input signal and, hence, information transfer. Incorporation of a feedback signal in the 
leaky system, however, will yield greater sensitivity and regulatory freedom (model 
4; figure 4G); it will increase the range of signal strengths that can be translated into 
distinct substrate phospho-levels (figure 4H). The leaky basal kinase activity and con-
sequent low levels of phosphorylated substrate in absence of the signal will effectively 
dampen the impact of small changes in kinase activity. Thus, negative feedback in a 
system with low basal signalling activity merges robustness against noise and sensi-
tivity towards a broad range of stimulus strengths. With these simplified models and 
with the information about presence of basal ERK1/2 activity in cerebellar Purkinje 
cells in mind, it makes sense to propose that PTPRR proteins provide the negative 
feedback input that shapes the ERK1/2 activity curve in order to optimize sensitivity, 
as in model 4. PTPRR deficiency would result in a model 3-like situation, with a near-
flat ERK1/2 response curve, hence essentially no sensitivity. In summary, collectively 
our experimental evidence and the theoretical considerations outlined above make 
clear that PTPRR negative feedback signalling may well impinge on MAPKs and up-
stream receptor-type kinases to enhance the output dynamic range, decreasing the 
noise-induced signalling and thus refining and augmenting information transfer. 
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Figure 4: The impact of basal kinase activity and negative feedback in signalling dynam-
ics. (A) Model 1: A signal induces the activation of a kinase, which phosphorylates a substrate. 
The reaction is counterbalanced by a phosphatase that dephosphorylates the substrate. (B) 
Output - signal curve for model 1. (C) Model 2: Enzymatic cycle similar to model 1 with the 
addition of negative feedback (bars). (D) Output - signal curve for model 2. (E) Model 3: En-
zymatic cycle similar to model 1 with the addition of basal kinase activity. (F) Output - signal 
curve for model 3. (G) Model 4: Enzymatic cycle similar to model 3 with the addition of nega-
tive feedback (bars). (H) Output - signal curve for model 4. Figures were adapted from [77].
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Impact of PTPRR proteins in oncogenesis 
Given that MAPKs are ubiquitous regulators of key cellular processes, including 
differentiation, proliferation, and survival, it is not surprising that disturbance of 
ERK1/2 activity is often observed within a variety of human diseases, including can-
cer [93, 94]. Of note, the ERK1/2 hyperactivity that is consistently encountered in 
tumor specimens has never been reported to be due to mutations in ERK1/2 them-
selves, but rather involves mutations of upstream activators or impairment of nega-
tive feedback mechanisms [94]. PTPRR proteins take part in such negative control 
mechanisms. We addressed this point in Chapter 5 of this thesis, where we summa-
rized studies wherein PTPRR transcripts were found suppressed via DNA methyla-
tion in colon and cervical cancers, including tumor metastases [95-99]. Experimental 
re-expression of PTPRR proteins in human cervical cancer cell lines led to reduced 
activity of MAPK pathway components, including ERK1/2 and AP-1 transcription 
factor family members, as well as reduced expression of human papillomavirus 
(HPV) oncogenes [99]. Down-regulation of PTPRR transcripts in colon and cervical 
epithelial cells thus are thought to facilitate hyperactivation of the ERK1/2 path-
way and HPV oncogene expression, hence promote cancer progression. Recently, 
a comparable situation was observed for prostate cancer, of which the onset and 
progression often is driven by androgens that activate signalling via the androgen 
receptor [100]. In advanced prostate cancer, androgen receptor signalling persists 
even in the absence of androgens. In prostate cancer cells, PTPRR expression was 
found to be down-regulated in response to androgens and the loss of PTPRR activ-
ity thus favors activation of the ERK1/2 pathway and cancer progression. Further 
support for a role for gene PTPRR in cancer etiology came from a recent study that 
showed reduced PTPRR, and also PTPRZ1, protein levels in oral high-grade tumor 
tissue as compared to levels in low grade tumors [101]. Moreover, PTPRR expres-
sion correlated with the absence of lymph node metastases, indicating that PTPRR 
proteins may prevent that well-differentiated tumors develop into more aggressive, 
poorly differentiated tumors with the ability to metastasize. 
PTPRR expression is most prominent in the brain, raising the question whether 
PTPRR proteins are involved in brain tumors. Several PTPs are known to play a 
role in glioma, one of the most common brain cancers [102]. PTPRZ1, for example, 
is promoting cell migration and tumor growth [103-105]. However, screening of 
glioma tissue samples of tumors with different grades did not reveal aberrant PTPRR 
mRNA levels (Bourgonje et al., personal communication), although mutations in the 
PTPRR gene cannot be excluded. As discussed, PTPRR proteins may be of clinical 
importance in a wide variety of other cancers and may be valuable as a prognostic 
marker and as target for therapy (chapter 5). For this, a deeper understanding of the 
molecular processes involving PTPRR proteins and the cellular context is required. 
The effect of PTPRR expression on the ERK1/2 pathway in prostate cancer, for ex-
ample, differs per cell line and might depend on PTEN status [100]. Furthermore, 
the impact of loss of PTPRR proteins on tumor growth and metastasis should be 
determined in more detail by assessing cell proliferation and cell migration in vitro 
and in vivo.
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Impact of PTPRR proteins on brain functioning 
PTPRR transcripts are found in the developing as well as the mature brain [31]. In 
adult mice, Ptprr transcript levels peak in the cerebellum [4, 11, 43-45] and we dem-
onstrated disturbed LTD in this brain region in PTPRR deficient animals (chapter 3). 
LTD is thought to have different roles, including neuroprotection against excitotoxic 
cell death [106-108]. For a long time LTD was considered to be essential for mo-
tor performance [109-111]. Initially, while measuring fine motor coordination and 
balance skills in 129-C57BL/6 mixed background Ptprr knockout mice, we noted 
locomotive abnormalities [11]. However, in later studies, using a mouse cohort that 
was backcrossed to the inbred C57BL/6 strain, we were not able to reproduce these 
findings (unpublished data). This suggests a genetic background dependency for 
the original phenotype [112, 113]. Therefore, LTD at the parallel fiber-PC synapse is 
not associated with motor coordination in the mouse cohorts we used. Also other 
mutant mice that display impaired AMPAR internalization and LTD were reported to 
exhibit normal basic motor performance and motor learning [114]. Pharmacologi-
cal inhibition of LTD did not result in locomotor learning deficits in rats either [115], 
further arguing against a universal role for cerebellar LTD in motor learning. Perhaps 
alternative parallel fiber-PC plasticity mechanisms are able to compensate for the 
suppressed LTD in the mutant mice. However, a compensatory change in parallel 
fiber-PC LTP induction or pre-synaptic parallel fiber plasticity was not encountered 
in our Ptprr knockout animals (chapter 3) nor in other LTD-deficient mice [114]. Thus, 
compensatory changes apparently do not occur at the parallel fiber-PC interface, 
but other plasticity mechanisms still have to be evaluated. 
It has been hypothesized that the concerted action of multiple types of cerebellar 
synaptic plasticity, also involving other cerebellar neuronal connections, contribute 
to the process of motor learning [116]. Still, the PCs occupy an integrative position 
in the cerebellar circuitry and represent the sole output neurons of the cerebellar 
cortex. Interestingly, PC firing properties are disturbed in PTPRR deficient mice, 
as illustrated by fast local field potential oscillation and increased PC rhythmicity 
(Cheron et al., personal communication). Furthermore, in wild-type mice a latency 
(time delay) of PC activity upon an LTD-inducing protocol is observed, whereas this 
feature is absent in PTPRR deficient mice (chapter 3). Such fast oscillations were also 
reported for ataxic mouse models upon ablation of calcium binding proteins [117, 
118], or with a lack of calcium-mediated big potassium channels [119], reduced 
levels of ubiquitin protein ligase E3A (as in Angelman syndrome) [120], or induced 
fetal alcohol syndrome [121]. Additionally, the lack of timing plasticity as observed 
in PTPRR deficient mice, was also encountered in mice that lacked big potassium 
channels in their Purkinje cells and in the mouse model for Angelman syndrome 
[122, 123]. The disturbed PC firings may affect transmission to the deep cerebellar 
nuclei and consequently other targets, including the cerebral cortex [123, 124]. The 
exact organization of these firing systems and the consequence of errors therein on 
mouse behaviour, including the potential role of PTPRR proteins in all of this, awaits 
further research. 
Next to expression in the cerebellum, PTPRR transcripts are also present at lower 
levels throughout the rest of the brain, including the olfactory bulb, hippocampus, 
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amygdala and perirhinal cortex [4, 11, 43-45]. This poses potential functions for 
PTPRR proteins in these brain regions as well. Olfaction depends on the proper 
development, functioning and replenishment of a dedicated set of neurons, and 
involves rigidly controlled cellular and molecular processes [125]. It is remarkable, 
therefore, that removal of newly born neurons in the adult brain had no effect on 
basal olfaction [126] although it did lead to impaired olfaction-dependent social be-
haviour, including predator avoidance and sex-specific responses [127]. We showed 
that mice deficient for PTPRR exhibit normal, olfactory bulb-related sense of smell 
(chapter 4). Testing specific smell abilities that are involved in social behaviour in 
our PTPRR deficient mice would further complete our analysis on olfactory bulb 
functioning. We also found that PTPRR deficient mice display impaired novel object 
recognition memory and an increased exploration of new environments (Chapter 
4). Similar findings appeared in studies on mice subjected to a knockout, and even 
knockdown, of key components of the MAPK signalling cascades [128-130]. Also 
TrkA has been linked to memory deficits as illustrated by changes in TrkA expres-
sion in mice and rats that encounter problems with spatial and novel object learning 
[131, 132]. Furthermore, selective TrkA activation did disturb spatial learning and 
memory processes in otherwise wild-type mice [133]. 
Interestingly, impaired novel object recognition was also observed in a mouse 
model for obesity that showed multiple symptoms of attention deficit hyperactivity 
disorder (ADHD) [134]. Hyperactivity, a key symptom of ADHD, is commonly ob-
served in several other neuropsychiatric disorders as well, including bipolar disorder, 
and schizophrenia [135]. Hyperactivity-associated disorders are extremely complex 
and it is much too early to put forward the Ptprr knockout mice as a potential model 
for ADHD. To come to that point, first different pharmacological responses to vali-
dated drugs and additional detailed behavioural tests should be performed [136]. 
Interestingly, several studies point to a correlation between Ptprr expression and 
human mood disorders (discussed in chapter 5), such as major depressive disorder 
and alcohol use disorders [137, 138]. Furthermore, PTPRR transcripts were found to 
be up-regulated in the brains of suicide victims [139]. Obviously, any link between 
PTPRR biology and multifactorial psychoneuropathologies will remain speculative 
for a long time in future as it will be difficult to study, in both humans and in animal 
models. 
The partial overlap in expression of PTPRR and STEP [4, 11, 43-45, 60-62], sug-
gests that their functions in brain may overlap as well. With respect to behaviour, 
STEP deficient mice showed normal exploratory activity, anxiety, general social be-
haviour, and overall normal motor coordination with an increased performance on 
the rotarod [56, 140]. Remarkably, STEP deficient mice exhibited greater dominance 
behaviour compared to wild-type animals [56]. Furthermore, although mice defi-
cient for STEP showed learning abilities similar to wild-type mice in hippocampus-
related memory tests [56, 140], in more complex paradigms the STEP deficient 
mice showed improved performance to accomplish difficult memory tasks and 
fear-associated learning [56, 141]. STEP has been linked to several neuropsychiatric 
disorders, including Alzheimer’s disease, Fragile X syndrome, epilepsy and schizo-
phrenia [142]. However, findings reported on these issues are not always consistent. 
The notion that STEP protein levels are increased in post-mortem schizophrenic 
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cortex [143], for example, could not be reproduced in an independent study [144]. 
Furthermore, impaired pre-pulse inhibition, a finding observed in schizophrenia pa-
tients, was observed also in STEP deficient mice [140], indicating that a lack of STEP 
would be associated with schizophrenia rather than an increase in STEP protein 
levels. Finally, sensitivity of STEP deficient mice to the effects of administration of an 
NMDAR antagonist that induces schizophrenia-like symptoms in mice is inconsist-
ent throughout literature [140, 143]. Discrepancies also exist in the field of epilepsy, 
illustrated by reports that describe either a reduced or an increased susceptibility 
to pharmacological induced seizures in STEP deficient mice [140, 145]. Given the 
above, a functional similarity between STEP and PTPRR proteins may be expected 
but is far from obvious. The mild phenotypes observed in the PTPRR and STEP de-
ficient mice, raise the possibility that a deficiency in either protein can - at least in 
part - be compensated for by the other. In other words, it is well feasible that some 
functional consequences of PTPRR or STEP deficiencies are masked. The genera-
tion of a Ptprr and Step double knockout mouse thus would provide a valuable tool 
to better map the influence of these functionally similar but distinct PTPs on behav-
ioural aspects. 
CONCLUDING REMARKS
PTPRR protein isoforms exhibit versatile roles in diverse cellular signalling processes 
required for adequate neuronal differentiation, synaptic plasticity and mouse be-
haviour. Studies using material derived from human tissue have until now provided 
further valuable information on the function of PTPRR proteins in health and dis-
ease, including neuropsychiatric disorders and cancer. In this regard, PTPRR mutant 
mice may function as a valuable model to study aspects of the etiology and pathol-
ogy of these diseases. PTPRR’s suggested role in cancer progression indicates that 
this PTP may serve as a biomarker or as a potential therapeutic target in the future. 
Ultimately, following further advancement with application of novel techniques, like 
BioID, life cell imaging, electrophysiology on alert animals, computational model-
ling etc., a deeper understanding of PTPRR’s role in different cellular processes and 
its impact on mouse and human brain function is to be expected. 
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SUMMARY
The functioning of our brain is fully dependent on the proper formation of neurons 
and synaptic neuronal contacts that together comprise a highly organized circuit for 
cell-cell communication. During our lifespan this circuit conserves flexibility, allow-
ing the brain to adapt to variability in external triggers and enabling us to learn and 
memorize. Clearly, the processes underlying neuronal differentiation and synaptic 
plasticity require tight control to prevent errors in brain development and func-
tioning. At the cellular level, reversible tyrosine phosphorylation represents one of 
the key regulatory mechanisms for maintenance of this architectural and functional 
flexibility. Spatial and temporal control of protein phosphotyrosine levels is exerted 
by the complementary action of protein tyrosine kinases and protein tyrosine phos-
phatases (PTPs). The studies described in this thesis were aimed at the brain signal-
ling role of one specific group of PTPs, the protein tyrosine phosphates receptor-
type R (PTPRR) protein isoforms. 
PTPRR proteins are known for their interaction with and dephosphorylation of 
mitogen-activated protein kinases (MAPKs), essential components in signalling cas-
cades that for example underlie nerve growth factor (NGF)-induced neuronal differ-
entiation or regulation of synaptic strength of Purkinje cells within the cerebellum. 
The finding that Ptprr transcripts are upregulated in NGF-stimulated neuroendo-
crine PC12 cells of rat, prompted us to study whether PTPRR proteins are involved 
in NGF-induced neuronal differentiation. In chapter 2 we show that the transmem-
brane PTPRR isoform PTPBR7 counteracts NGF-induced signalling in PC12 cells by 
dephosphorylating both the responsible cell surface receptor, TrkA, and its down-
stream MAPKs, the ERK1/2 proteins. 
Previous studies have shown that PTPRR is prominently expressed in cerebellar 
Purkinje cells and that mice lacking PTPRR exhibit impaired cerebellum-related mo-
tor function. To study cerebellar long-term depression (LTD), an essential mecha-
nism of Purkinje cell synaptic plasticity, we generated cerebellar slices of wild-type 
and Ptprr knockout mice. In chapter 3 it is described how we used electrophysi-
ological techniques on these slices and on living wild-type and Ptprr knockout mice 
to demonstrate that PTPRR proteins are required for cerebellar LTD.
In addition to causing cerebellar defects, the disturbance of signalling pathways 
in Ptprr knockout mice affects other brain region-dependent functions as well. In 
chapter 4 we present studies on behavioural aspects that involve brain regions out-
side the cerebellum, including the hippocampus. We show that PTPRR deficiency 
leads to impaired novel object recognition and elevated exploratory behaviour. 
The new insights in PTPRR protein function, obtained from cell and animal  models, 
might be valuable to understand cognate processes in the human brain and may 
also help to reveal mechanisms that make human brain capacity rather unique. In 
chapter 5, therefore, we compared knowledge from rat, mouse and cell model sys-
tems with information on human PTPRR as collected from the current literature and 
databases. Markedly, in addition to the Ptprr transcripts found in mouse and rat, 
the humane gene gives rise to extra transcripts of which the predicted proteins lack 
important domains and presumably have a regulatory role. Furthermore, we discuss 
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reports that point to a link between PTPRR expression and diseases as cancer and 
psychoneuropathologies. 
In the concluding chapter 6 I summarized the results obtained in the different 
studies and placed them in a broader context. 
In conclusion, our findings underscore that PTPRR proteins are of key importance 
for neuronal differentiation and communication in the mammalian brain, and hence 
for learning and behaviour. This thesis and the identification of an increasing number 
of PTPRR abnormalities in human conditions, involving aberrant cell growth and dif-
ferentiation, is therefore indicative for the potential value that in-depth knowledge 
on the role of this protein family has for further study of human health and disease.
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Voor het functioneren van onze hersenen is de correcte ontwikkeling van neuronen 
en het aanleggen van synaptische contacten tussen deze zenuwcellen essentieel. 
Het resultaat van deze twee processen is een zeer complex, maar uiterst goed geor-
ganiseerd cel-cel communicatienetwerk. Tijdens ons leven behoudt dit netwerk de 
nodige flexibiliteit, waardoor ons brein kan reageren op veranderende externe 
stimuli en we in staat zijn om te leren en te herinneren. Uiteraard moeten de pro-
cessen die ten grondslag liggen aan neuronale differentiatie en synaptische plasti-
citeit gecontroleerd plaatsvinden om verstoringen in de ontwikkeling en functie van 
het brein te voorkomen. Op cellulair niveau vormt de reversibele  defosforylering 
van tyrosine-residuen een belangrijk regelmechanisme voor het handhaven van 
deze structurele en functionele flexibiliteit. Plaats- en tijdsgebonden controle van 
eiwit-fosfotyrosine-niveaus wordt uitgevoerd door de complementaire activiteit van 
proteine-tyrosine-kinases en proteine-tyrosine-fosfatases (PTPs). Het onderzoek dat 
wordt beschreven in dit proefschrift richt zich op de signalerende rol in de hersenen 
van een specifieke groep PTPs, de protein-tyrosine-fosfatase-receptor-type R 
( PTPRR) isovormen. 
PTPRR eiwitten staan bekend om hun interactie met en defosforylering van 
mitogeen-geactiveerde-protein-kinases (MAPKs), essentiële componenten in veel 
signaaltransductie-cascades, waaronder de zenuwgroeifactor (NGF)-geïnduceerde 
signalering die leidt tot neuronale differentiatie. Daarnaast zijn MAPKs betrokken bij 
de regulatie van de sterkte van Purkinje cel synapsen in het cerebellum. In neuro-
endocriene PC12 cellen van de rat stimuleert NGF Ptprr transcriptie. Dit gegeven 
moedigde ons aan om te onderzoeken of PTPRR betrokken is bij neuronale differen-
tiatie. In hoofdstuk 2 laten we zien dat de transmembraan PTPRR isovorm PTPBR7 
NGF-geïnduceerde signalering in PC12 cellen tegengaat door defosforylering van 
zowel de NGF-receptor, TrkA, als de MAPKs ERK1/2.  
Eerder onderzoek heeft laten zien dat PTPRR sterk tot expressie komt in cerebel-
laire Purkinje cellen en dat PTPRR-deficiënte muizen verstoorde cerebellum-gerela-
teerde motoriek vertonen. In hoofdstuk 3 hebben we coupes van wildtype en Ptprr 
knockout muizenhersenen gebruikt om cerebellaire lange-termijn depressie (LTD), 
een essentieel mechanisme voor Purkinje cel synaptische plasticiteit, te bestuderen. 
Aan de hand van elektrofysiologische bepalingen in deze cerebellaire coupes en 
in levende muizen konden we aantonen dat PTPRR eiwitten essentieel zijn voor 
cerebellaire LTD. 
Naast het veroorzaken van defecten in het cerebellum, heeft de verstoring van 
signaaltransductie-cascades in Ptprr knockout muizen ook tot gevolg dat functies 
van andere hersengebieden (gedeeltelijk) verloren gaan. In hoofdstuk 4 presen-
teren wij ons onderzoek naar gedragsaspecten die gecoördineerd worden vanuit 
andere hersengebieden dan het cerebellum, waaronder de hippocampus. We laten 
zien dat PTPRR-deficiëntie leidt tot verstoorde herkenning van nieuwe objecten en 
tot een toenemend exploratief gedrag bij de muizen. 
De nieuwe inzichten in PTPRR eiwitfunctie, verkregen aan de hand van cel- en 
diermodellen, zouden kunnen helpen bij het doorgronden van vergelijkbare pro-
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cessen in het menselijk brein. We hebben daarom in hoofdstuk 5 informatie verkre-
gen uit rat-, muis- en celmodellen gelegd naast literatuur- en databasegegevens 
die tot op heden bekend zijn voor humaan PTPRR. Opvallend is dat naast de Ptprr 
transcripten die in de muis en rat gevonden worden, humane PTPRR genexpressie 
extra transcripten oplevert, waarvan de voorspelde eiwitten belangrijke domeinen 
missen en waarschijnlijk een regulerende rol hebben. Verder bespreken we data die 
wijzen op een link tussen verandering in PTPRR expressie en ziekten zoals kanker en 
psychoneuropathologieën. 
Tot slot vat ik in hoofdstuk 6 de resultaten verkregen in de verschillende onder-
zoeken samen en plaats deze in een bredere context. 
Concluderend, onze bevindingen benadrukken dat PTPRR eiwitten van essen-
tieel belang zijn voor neuronale differentiatie en communicatie in het zoogdier-
brein en dus voor het leren en gedrag. Dit proefschrift, samen met de toename 
aan gegevens over PTPRR afwijkingen bij humane aandoeningen, zoals verstoorde 
celgroei en differentiatie, illustreert de potentiële waarde van kennis over de rol 
van deze eiwitfamilie voor verder onderzoek van ziekte en gezondheid bij de mens.
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AA  arachidonic acid 
ADHD  attention deficit hyperactivity disorder
acc. nr.  accession number
ACSF  artificial cerebrospinal fluid
AMPAR  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
ARMS  ankyrin-rich membrane-spanning
a.u.  arbitrary units
AUD  alcohol use disorders
BDNF  brain-derived neurotrophic factor
Cdc  cell division cycle 
Cdk5  cyclin-dependent protein kinase 5 
CF  climbing fiber
DMEM  Dulbecco’s Modified Eagle’s Medium
DNMT3B DNA methyltransferase 3B
DUSP  dual specificity phosphatase
EGF  epidermal growth factor
eGFP  enhanced green fluorescent protein
EPSC  excitatory postsynaptic current
ERK  extracellular signal-regulated kinase
FAHD2  fumarylacetoacetate hydrolase domain-containing protein 2
FCS  fetal calf serum
GAPDH  glyceraldehyde 3-phosphate dehydrogenase
GSEA  gene set enrichment analyse
GWAS  genome wide association studies
HePTP  hematopoietic tyrosine phosphatase
IP  immunoprecipitation
IP3  inositol trisphosphate
ITI  inter-trial interval
JNK  c-Jun N-terminal kinase
KIM  kinase interaction motif
KIS  kinase-specificity sequence
LFP  local field potential
LMW  low molecular weight
LTD  long-term depression
MALDI-TOF matrix assisted laser desorption/ionisation time-of-flight
MAPK   mitogen-activated protein kinase
MAPKK  MAP kinase kinase 
MAPKKK MAP kinase kinase kinase
MDD  major depressive disorder
MEK  mitogen-activated protein kinase/extracellular signal-regulated   
  kinase kinase
mGLuR  metabotropic glutamate receptor
MKP  MAPK phosphatase
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MWM  Morris water maze
NMDAR N-methyl D-aspartate receptor
NMR   nuclear magnetic resonance
NGF  nerve growth factor
NT  neurotrophin
PDB  protein data bank
PC  Purkinje cell
PF  parallel fiber
PI3-K  phosphatidylinositol-4,5-bisphosphate 3-kinase 
PKA  protein kinase A
PKC  protein kinase C
PLA2   phospholipase A2
PLCγ  phospholipase Cγ 
PP  protein phosphatases
PP1  protein phosphatase 1
PPF  paired-pulse facilitation
PTP   protein tyrosine phosphatase
PTP-LP  PTP-like phytase
PTPRR   protein tyrosine phosphatase receptor-type R
PTX  picrotoxin
pY  phosphotyrosine
RKIP   Raf kinase inhibitory protein 
RTK  receptor tyrosine kinase
TrkA  tropomyosin receptor kinase A
SNP  single nucleotide polymorphism
SP  signal peptide
STAT  signal transducer and activator of transcription 
STEP  striatal-enriched protein tyrosine phosphatase
Tg  trigeminal ganglion
TM  transmembrane
Tn  trigeminal nucleus
WT  wild-type  
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DANKWOORD
Het brein functioneert doordat hersencellen samen een netwerk vormen waarbin-
nen ze met elkaar communiceren, elkaar aansturen en elkaar feedback geven. Dit 
netwerk is dynamisch. In de tijd verzwakken of verdwijnen sommige connecties, 
terwijl andere juist worden versterkt en er zelfs nieuwe verbindingen ontstaan. Dat 
jullie nu mijn proefschrift in jullie handen hebben, is te danken aan het netwerk van 
verschillende personen die op hun eigen manier een bijdrage hebben geleverd 
tijdens mijn promotietraject. Hierbij wil ik een aantal van hen persoonlijk bedanken. 
Bé, Berry, Ineke en Wiljan, oftewel promotoren en co-promotoren waarin niet voor 
niets het woord ‘motor’ zit. Jullie zijn de drijvende kracht geweest achter het PTPRR 
project. Bé, je hebt mij de mogelijkheid, het vertrouwen en de vrijheid gegeven om 
mijn promotietraject invulling te geven op de afdeling Celbiologie. Het verwerken 
van jouw kritische commentaar hielp me mijn werk naar een hoger niveau te tillen. 
Berry, vanaf de afdeling Neurologie kwam jij regelmatig een bezoekje aan het lab 
brengen. Je interesse werkte zeer motiverend en je klinische inzichten trokken mij 
uit mijn specifieke celbiologische niche en verruimden mijn gedachtegang. Ineke, 
jouw positieve en energieke persoonlijkheid werkte aanstekelijk. Als het gelukt was 
een afspraak met je te plannen, kwam ik altijd vol motivatie en enthousiasme uit 
onze gesprekken vandaan. Wiljan, ik heb ontzag voor jou als wetenschapper, je 
bent gepassioneerd, breed geïnteresseerd en een enorme bron aan kennis. Als 
begeleider kon ik altijd op je rekenen; betrokken, behulpzaam en kritisch. Dankzij 
jou is het inbouwen van controles een tweede natuur geworden. 
Het brein bestaat uit verschillende hersengebieden die onderling signalen uitwis-
selen. Ook de 6de verdieping van het RIMLS bestaat uit verschillende gebieden en, 
net als in het brein, stopt de communicatie niet bij de labgrenzen, maar strekt zich 
via het kennis- en pauzeplein uit naar de andere afdelingen. De fijne werksfeer op 
de 6de verdieping van het RIMLS wordt gevormd door een balans tussen in- en ont-
spanning. Ik denk met een glimlach op mijn gezicht terug aan alle pauzes, vrijdag-
middagborrels, (ladies) movie nights, Sinterklaasavonden, kerstdiners, paaslunches 
en dagjes uit. Ik heb mooie herinneringen aan de celbiologen, Friedls en moldiertjes 
en ik wil graag een aantal van jullie even kort de revue laten passeren. 
Jan, één van mijn paranimfen en mijn maatje in het “PTP-gekkenhuis”. Ik  voelde 
mij altijd welkom om even op een kruk te komen zitten en te praten/klagen over 
werk dan wel niet-werk. Daarnaast hebben we natuurlijk onze gedeelde woon-
plaats, waardoor we trein- en pontmedewerkerervaringen samen konden delen. 
Marieke, mijn andere paranimf, met je directheid, daadkracht en optimisme was 
en is het een feest om in je buurt te zijn. Ik vind je een prachtmens! Annika, mijn 
U- en PTP-genootje. Het was fijn om zoveel (werk)ervaringen onderling te kunnen 
delen. Irene, mijn “oude” U- en PTP-genootje. Ik heb genoten van je Italiaanse 
temperament. Je was denk ik één van de weinigen die literatuurbesprekingen echt 
leuk vond om te doen. Het onderwijs is je dan ook op het lijf geschreven. Gerda, 
daar zaten we dan, 2 bolle buiken tegenover elkaar. Nu met je gezin terug naar je 
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roots in Zuid-Afrika, ik wens jullie veel geluk. Remco, ik ben benieuwd of ik die CD 
van je vroegere bandje ooit nog mag ontvangen... Ingeborg, onze soms serieuze 
 weekendpraat vormde tijdens mijn getyp op het lab een welkome afwisseling. 
Anchel, laten we het maar niet meer over de WK-finale van 2010 hebben. Anke, ik 
wens jou heel veel succes met het afronden van jouw eigen promotietraject. Lieke, 
oftewel Lieky, altijd nog een extra vraag als ik de hoek van je U’tje al om was zodat 
ik weer terug moest lopen. Wat ik, nieuwsgierig als ik ben, altijd deed. Ik vond het 
een toptijd samen! Je praktische hulp, gezelligheid, gelach en goede gesprekken 
binnen en buiten werktijd waren fantastisch. Susan, ik heb respect voor hoe jij de 
balans vindt tussen keihard werken en ontspanning. Weer een keertje koffie doen op 
de woensdag? Walther, op het werk een rustige verschijning, maar op het toneel… 
Ik heb van beide kanten van je genoten. Rinske, google kan niet op tegen jouw 
“ouderwetse” kaartenbakje met protocollen. Frank, door jou ging ik bijna weer in 
Sinterklaas geloven. Mietske, op 24 juli zijn de leuksten geboren,  nietwaar? Huib, 
verstopt in je rariteitenkabinet waar iedereen altijd welkom is, en niet alleen voor de 
materiële zaken. Je  vindingrijkheid is weergaloos, je kookkunst ook  trouwens. Rick, 
tijdens werkbesprekingen waren jouw scherpe blik en praktische tips altijd welkom. 
Jack, is het gek dat ik vooral herinneringen van de vrijdagmiddagborrels aan je 
heb? O ja, toch ook nog wel aan je hulp bij de microscopie. Magda, met je al-
lesziende blik en altijd luisterend oor bleek je niet alleen voor  administratieve  zaken 
waardevol. Celbiologen van na mijn tijd, succes met jullie carrière. Monique, jij 
hebt mij geleerd hoe mij te “gedragen” in muizenland. En wat was dat autoritje 
naar de Chinees gedenkwaardig hè! Erik en Nick, onafhankelijk van het resultaat 
van mijn blotjes, waren mijn bezoekjes aan de Odyssey altijd de moeite waard als 
ik jullie onderweg tegenkwam. Mariska, menigmaal was de reis naar Cuijk tekort 
om al bijgepraat te zijn en zagen we ook de trein later nog op het station arriveren. 
 Esther, van jouw directheid en eerlijkheid geniet ik keer op keer. Nu de laatste 
loodjes van je zwangerschap, ik kom t.z.t. graag op kraambezoek. Stagiaires Inge, 
Brenda, Jeroen, Jesper en Lucette, ik ben met plezier jullie stagebegeleidster 
geweest. Jullie hebben niet alleen bijgedragen aan het onderzoek, maar hebben 
mij ook laten zien hoe leuk het is om iemand iets te leren.  
De hersengebieden kunnen hun functie uitoefenen door de gespecialiseerde  eigen-
schappen van verschillende hersencellen te benutten. Tijdens mijn  promotietraject 
was de samenwerking met diverse mensen met elk hun eigen deskundigheid zeer 
waardevol.
Nael, ondanks dat ik geen onderdeel van je team uitmaakte, nam je altijd de tijd 
voor me. Je hebt een gave om de rode draad te blijven volgen. Daarnaast moest 
ik menigmaal glimlachen om de mailtjes waarin je Belgische afkomst naar voren 
kwam, het is ook gewoon een mooie taal. George, Keiko, Yukio, Yoonhee, Dong-
won, and Teagon, thank you so much for your hospitality, your knowledge, the city 
trip, and letting me taste so many different flavours. Some were challenging (Ko-
rean bomb), some were awful (mais tea), but others were great (Korean bbq). Guy, 
thank you for introducing me in the complex world of electrophysiology. The results 
you and your lab members obtained using the Ptprr -/- mice, significantly increased 
the value of chapter 3. Medewerkers van het CDL, jullie hebben ervoor gezorgd 
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dat het de wildtype en Ptprr -/- muizen aan niets ontbrak. Daarnaast  waardeer ik 
hoe jullie hebben meegedacht en steeds maar weer mijn vragen geduldig hebben 
beantwoord. Beveiliging, jullie hebben me gelukkig bevrijd uit het CDL nadat ik 
mezelf had ingesloten. Hierdoor is een overnachting tussen de muizen mij bespaard 
gebleven.
Zoals eerder al beschreven, zijn hersencellen in staat nieuwe verbindingen aan te 
gaan. Nadat het labwerk er voor mij opzat, heb ik een nieuwe baan gevonden in 
het beroepsonderwijs. 
Nieuwe collega’s van ROC RijnIJssel, ik voelde me meteen welkom bij jullie. 
René, jouw belangeloze steun en interesse zijn goud waard. Ik heb al zoveel van 
je geleerd! Mijn leerlingen, analisten van de toekomst, door jullie word ik steeds 
opnieuw weer enthousiast over de biologie, wetenschap en het werken op een lab. 
Leer ze! 
Sommige connecties in de hersenen zijn sterker dan andere. Binnen mijn netwerk 
worden deze verbindingen gevormd met mijn vrienden en familie.
Corien, van studiemaatje, labmaatje, naar onderwijsmaatje. Ik vind het gewoon 
super om al deze stadia samen met jou te kunnen delen. Woensdagclub, lang leve 
die ene ochtend in de week met chaos, gelach en koffie. Lisette, je lieve gebaren 
kwamen altijd precies op het juiste moment. Voor al die andere mensen in mijn 
omgeving die steeds weer interesse toonden, zal ik voor de laatste keer de vol-
gende vraag beantwoorden: “Hoe is het met je scriptie, studie, verslag, boekje, 
proefschrift?” Nou… Hier is het dan, het is af!
Anita, Hein, Marjan, Bram en Maarten, niet mijn “echte” familie, maar zo voelt 
het wel. Verspreid over het land, maar toch heel hecht. Hoe jullie er altijd voor 
elkaar en voor mij zijn, is heel bijzonder. 
Bea en Harrie, ik ben zo dankbaar voor de vanzelfsprekendheid dat jullie er  altijd 
voor me zijn. Hetzelfde geldt voor jullie; Damiët, Fritz, Paco en Marijn.  Jullie 
 onvoorwaardelijke steun maakte zelfs de aller-allerlaatste loodjes lichter. Paac, 
zouden we deze winter dan eindelijk de latten weer eens onder kunnen binden?  
Niels, Arno & Joeri, mijn jongens, wat zorgen jullie voor een hoop  ondeugendheid, 
gelach en liefde. Alleen al naar jullie kijken helpt zo heerlijk relativeren. Droom jullie 
eigen dromen en geniet van al het moois dat op jullie pad komt. 
Pieter… “als” is dan eindelijk “nu” en wat gaan wij vanaf dat “nu” genieten!!
Heel veel liefs,
Mirthe
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